<SEC-DOCUMENT>0001493152-19-007246.txt : 20190515
<SEC-HEADER>0001493152-19-007246.hdr.sgml : 20190515
<ACCEPTANCE-DATETIME>20190515113553
ACCESSION NUMBER:		0001493152-19-007246
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		40
CONFORMED PERIOD OF REPORT:	20190331
FILED AS OF DATE:		20190515
DATE AS OF CHANGE:		20190515

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Virtual Crypto Technologies, Inc.
		CENTRAL INDEX KEY:			0000797542
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				680080601
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15746
		FILM NUMBER:		19826203

	BUSINESS ADDRESS:	
		STREET 1:		11 HA'AMAL STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			4809174
		BUSINESS PHONE:		972 3-6003375

	MAIL ADDRESS:	
		STREET 1:		11 HA'AMAL STREET
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			4809174

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Emerald Medical Applications Corp.
		DATE OF NAME CHANGE:	20151006

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZAXIS INTERNATIONAL INC
		DATE OF NAME CHANGE:	19950916

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INFERGENE CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>form10-q.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
<FONT STYLE="font-size: 18pt"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT><BR>
<FONT STYLE="font-size: 12pt"><B>Washington, D.C. 20549</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
10-Q</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: center; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<B>X</B>]
<B>QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the quarterly period ended March 31, 2019</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>or</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
<B>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the transition period from __________________ to _______________________</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commission
file number: 000-15746</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B><U>VIRTUAL
CRYPTO TECHNOLOGIES, INC.</U></B></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
<FONT STYLE="font-size: 10pt">(Exact Name Of Registrant As Specified In Its Charter)</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 49%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Delaware</U></B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 49%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>68-0080601</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
    of</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt">Incorporation)</FONT></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
    Employer </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt">Identification No.)</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><U>11
    Ha&rsquo;amal Street, Rosh Ha&rsquo;ayin, Israel</U></B></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><U>4809174</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
    of Principal Executive Offices)</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ZIP
    Code)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registrant&rsquo;s
Telephone Number, Including Area Code: <B>+972 3-600-3375</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in; text-indent: -2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Securities
registered pursuant to Section 12(b) of the Act:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 2in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</FONT></TD>
    <TD STYLE="width: 2%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 30%; text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbol(s)</FONT></TD>
    <TD STYLE="width: 2%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 46%; text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (&sect;232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files). Yes [&nbsp;&nbsp;] No [X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer (as defined in
Rule 12b-2 of the Exchange Act) or a smaller reporting company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; width: 21%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 43%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; width: 30%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer </FONT></TD>
    <TD STYLE="white-space: nowrap; width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]
    (Do not check if a smaller reporting company)</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[X]</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company</FONT></TD>
    <TD STYLE="white-space: nowrap; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[&nbsp;&nbsp;]</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [&nbsp;&nbsp;] No
[X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 15, 2019, the registrant had 112,249,643 shares of common stock issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>VIRTUAL
CRYPTO TECHNOLOGIES, INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.65in; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Item</B></FONT></TD>
    <TD STYLE="width: 0.15in; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD>
    <TD STYLE="width: 0.15in; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.65in; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#M_001"><FONT STYLE="font-size: 10pt"><B>PART
    I - FINANCIAL INFORMATION</B></FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#M_002"><FONT STYLE="font-size: 10pt">FINANCIAL STATEMENTS</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 2.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#M_008"><FONT STYLE="font-size: 10pt">MANAGEMENT&rsquo;S
    DISCUSSION AND ANALYSIS AND RESULTS OF OPERATIONS</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 3.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#M_009"><FONT STYLE="font-size: 10pt">QUANTITATIVE AND
    QUALITATIVE DISCLOSURES ABOUT MARKET RISK</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_001"><FONT STYLE="font-size: 10pt">CONTROLS AND PROCEDURES</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_002"><FONT STYLE="font-size: 10pt"><B>PART
    II - OTHER INFORMATION</B></FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_003"><FONT STYLE="font-size: 10pt">LEGAL PROCEEDINGS</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 1A.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_004"><FONT STYLE="font-size: 10pt">RISK FACTORS</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 2.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_005"><FONT STYLE="font-size: 10pt">UNREGISTERED SALES
    OF EQUITY SECURITIES AND USE OF PROCEEDS</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 3.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_006"><FONT STYLE="font-size: 10pt">DEFAULT UPON SENIOR
    SECURITIES</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 4.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_007"><FONT STYLE="font-size: 10pt">MINE SAFETY DISCLOSURE</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 5.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_008"><FONT STYLE="font-size: 10pt">OTHER INFORMATION</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ITEM 6.</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_009"><FONT STYLE="font-size: 10pt">EXHIBITS</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_010"><FONT STYLE="font-size: 10pt">SIGNATURES</FONT></A></FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="M_001"></A><FONT STYLE="font-size: 10pt"><B>PART
I - FINANCIAL INFORMATION</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="M_002"></A><FONT STYLE="font-size: 10pt"><B>ITEM
1. FINANCIAL STATEMENTS</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#M_003"><FONT STYLE="font-size: 10pt">Condensed
    Consolidated</FONT><FONT STYLE="font-size: 10pt"> Balance Sheets as of March 31, 2019 (Unaudited) and December 31, 2018</FONT></A></FONT></TD>
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#M_004"><FONT STYLE="font-size: 10pt">Condensed
    Consolidated</FONT><FONT STYLE="font-size: 10pt"> Statements of Comprehensive Loss for the Three Months Ended March 31,
    2019 and 2018 (Unaudited)</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#M_005"><FONT STYLE="font-size: 10pt">Condensed
    Consolidated</FONT><FONT STYLE="font-size: 10pt"> Statements of Changes in Stockholders&rsquo; Deficit for the Three Months
    Ended March 31, 2019 (Unaudited) and Year Ended December 31, 2018</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#M_006"><FONT STYLE="font-size: 10pt">Condensed
    Consolidated</FONT><FONT STYLE="font-size: 10pt"> Statements of Cash Flows for the Three Months Ended March 31, 2019 and
    2018 (Unaudited)</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#M_007"><FONT STYLE="font-size: 10pt">Notes
    to Condensed Consolidated Financial Statements</FONT></A></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="M_003"></A><FONT STYLE="font-size: 10pt"><B>Virtual
Crypto Technologies, Inc.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Condensed
Consolidated</B></FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B> Balance
Sheets</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2019</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2018</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">(Unaudited)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Assets</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current assets:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash
    and cash equivalents</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">447,967</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">499,919</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Short term investment</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,242</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
    receivable</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,842</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,516</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total current
    assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">460,809</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">558,677</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total assets</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">460,809</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">558,677</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities and Stockholders&rsquo;
    Deficit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Current liabilities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts payable
    and accrued liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">98,871</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">13,115</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accounts payable
    interest payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,227</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Employee payable</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">7,064</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Short term portion
    of convertible notes (Note 2)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">503,217</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">485,449</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Liabilities
    held for sale</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">469,525</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">469,525</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total current liabilities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,079,<FONT STYLE="font-size: 10pt">840</FONT></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">975,153</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,079,<FONT STYLE="font-size: 10pt">840</FONT></FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">975,153</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stockholders&rsquo; deficit</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Preferred stock, $0.0001 par value;
    10,000,000 shares authorized; none issued and outstanding at March 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Common stock, $0.0001 par value; 490,000,000
    shares authorized; 110,748,391 shares issued and outstanding at March 31, 2019 and December 31, 2018. (Note 3)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,075</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">11,075</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated other comprehensive income</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(19,337</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(19,337</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Additional paid-in capital (Note 3)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,100,794</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,218,691</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accumulated deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(41,711,563</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(41,626,905</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total stockholders&rsquo;
    deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(619,031</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">(416,476</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total liabilities
    and stockholders&rsquo; deficit</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">460,809</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif">558,677</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these interim financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="M_004"></A><FONT STYLE="font-size: 10pt"><B>Virtual
Crypto Technologies, Inc.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Condensed
Consolidated</B></FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B> Statements
of Comprehensive Loss</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Three Months ended March 31, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three
    months<BR>
    ended</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three
    months <BR>
    ended</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2018</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Expenses:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
    and development</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,413</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">54,011</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Sales and marketing</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">310,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">General
    and administrative</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">191,210</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,064,283</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total operating
    expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">200,623</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,428,294</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss from operations</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(200,623</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(1,428,294</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Finance
    income (expense), net</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">115,965</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(19,374,082</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(84,658</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(20,802,376</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Basic and diluted net loss per share</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Basic</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">
    and diluted loss per share</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.00</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(0.51</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted average shares outstanding
    - basic and diluted</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">110<FONT STYLE="font-size: 10pt">,748,391</FONT></FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">41,048,456</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these interim financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="M_005"></A><FONT STYLE="font-size: 10pt"><B>Virtual
Crypto Technologies, Inc.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Condensed
Consolidated</B></FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B> Statement
of Changes in Stockholders&rsquo; Equity (Deficit)</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Three Months Ended March 31, 2019 and the Year Ended December 31, 2018 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-indent: 60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 9pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Common</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Preferred</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Additional
    Paid-in</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Receipt
    on Account&nbsp;of</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Other
    Comprehensive</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Accumulated</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Total
    stockholders&rsquo;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Shares</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amount</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Stock</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Amount</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Capital</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Shares</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Income</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Deficit</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">deficit</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 27%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance
    as of December 31, 2017</FONT></TD><TD STYLE="width: 2%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">22,543,008</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,255</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">529</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">14,968,925</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">80,000</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(19,337</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(16,620,419</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(1,588,576</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Common stock and warrants
    issued for cash</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">27,697,855</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,770</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,938,180</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,940,950</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Common stock issued
    for services</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,329,999</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">433</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,003,866</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,004,299</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Warrants issued for
    services</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">146,376</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">146,376</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Exercise of stock options</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">62,500</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">6</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">57</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">63</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issuance of new convertible
    note with a beneficial conversion feature</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">100,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Change in the terms
    of Convertible Note</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">22,581,508</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">22,581,508</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Partial conversion of
    convertible note to shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">55,543,600</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,554</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">549,836</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">555,390</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Cancellation of Preferred Shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(529</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(150,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(150,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Issuance of Shares in
    respect of proceeds received during 2017</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">571,429</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">57</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">79,943</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(80,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    loss for the year</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(25,006,486</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(25,006,486</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance as of December
    31, 2018</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">110,748,391</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">11,075</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">41,218,691</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(19,337</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(41,626,905</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(416,476</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Warrants issued for
    services</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">28,035</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">28,035</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Extension of convertible
    note</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(145,932</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(145,932</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Net
    loss for the period</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(84,658</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(84,658</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">Balance as of March
    31, 2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">110,748,391</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">11,075</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">41,100,794</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(19,337</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(41,711,563</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">(619,031</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; text-indent: 60pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 60pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these interim financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="M_006"></A><FONT STYLE="font-size: 10pt"><B>Virtual
Crypto Technologies Inc </B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Condensed
Consolidated</B></FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B> Statements
of Cash Flows</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Three Months Ended March 31, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three
                                         months</FONT></P>
                                                                  <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">ended</FONT></P></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">Three
                                         months</FONT></P>
                                                                  <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">ended</FONT></P></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2018</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Operating Activities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(84,658</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(20,802,376</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Shares issued for
    services</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,035</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">892,300</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Finance (income)
    loss arising from change in terms of convertible notes</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(145,932</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">20,165,406</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase in net
    liabilities for sale</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">445,611</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase (decrease)
    in accounts payable and accrued expenses</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">78,692</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(321,158</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amortization of
    debt discount</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">17,768</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Loss from marketable
    securities</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,635</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Decrease in amounts
    due from related party</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(721,530</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase in deferred
    revenues</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase (decrease)
    in accrued interest</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,227</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(65,924</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Increase
    in other receivables</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">28,674</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">12,122</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash used
    in operating activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(66,559</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(345,549</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Investing Activities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selling
    of marketable securities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,607</FONT></P>


</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash provided by investing
    activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">14,607</FONT></P>


</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Financing Activities:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proceeds from sale
    of common stock and warrants (net of issuance expenses)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,575,072</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise of options</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">63</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance of Shares
    in respect of proceeds received during 2017</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">117,150</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Issuance
    of convertible note</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">100,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    cash provided by financing activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,792,285</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net (decrease) increase in cash</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(51,952</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,446,736</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and cash
    equivalents - beginning of period</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">499,919</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,959</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and cash
    equivalents - end of period</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">447,967</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,449,695</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Non-cash transactions:</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conversion to shares of convertible
    loans</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">85,218</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Cancellation of preferred shares</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(150,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of these financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Virtual
Crypto Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the Three Months Ended March 31, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="M_007"></A><FONT STYLE="font-size: 10pt"><B>Notes
to Condensed Consolidated Financial Statements</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
1. The Company and Significant Accounting Policies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Organizational
Background:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Virtual
Crypto Technologies, Inc. (the &ldquo;Company&rdquo;) was incorporated in the State of Ohio in 1989 under a predecessor
name, Zaxis International, Inc. (&ldquo;Zaxis&rdquo;). On August 25, 1995, Zaxis merged with a subsidiary of The InFerGene Company,
a Delaware corporation, which entity changed its name to Zaxis International, Inc. and the Company was reincorporated in Delaware
under the name of Zaxis International, Inc. On December 30, 2014, Zaxis entered into an agreement with Emerald Medical Applications
Ltd., a private limited liability company organized under the laws of the State of Israel (&ldquo;Emerald Israel&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 16, 2015, Zaxis and Emerald Israel executed the Share Exchange Agreement, which closed on July 14, 2015 (the &ldquo;Share
Exchange Agreement&rdquo;) and Emerald Israel became the Company&rsquo;s wholly-owned subsidiary. Emerald Israel was engaged in
the business of developing Emerald Israel&rsquo;s DermaCompare technology and the development, sale and service of imaging solutions
utilizing its DermaCompare software for use in derma imaging and analytics for the detection of skin cancer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2018, the Company formed a new wholly owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies
Ltd. (the &ldquo;Subsidiary&rdquo;), to develop and market software and hardware products facilitating, allowing and supporting
purchase and/or sale of cryptocurrencies through ATMs, tablets, personal computers (&ldquo;PCs&rdquo;) and/or mobile devices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going
Concern:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has incurred significant operating losses and negative cash flows from operating activities in relation to its operations,
since inception. While the Company raised approximately $1.9 million in the year ended December 31, 2018 to fund the operations
of its New Subsidiary, the Company will require additional capital resources in order to support the commercialization of the
New Subsidiary&rsquo;s technology and operations and maintain its research and development activities related to the New Subsidiary&rsquo;s
technology. The Company is addressing its liquidity needs by seeking additional funding from public and/or private sources. There
are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required
for the Company&rsquo;s short and long-term requirements, or at all these conditions raise substantial doubt about the Company&rsquo;s
ability to continue as a going concern. The consolidated financial statements do not include any adjustments to reflect the possible
future effects on recoverability and classification of assets or the amounts and classification of liabilities that may result
from the outcome of this uncertainty</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Basis
of Presentation and Significant Accounting Policies:</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited consolidated financial statements include the accounts of the Company and its wholly owned subsidiary,
the Subsidiary, prepared in accordance with accounting principles generally accepted in the United States of America (&ldquo;GAAP&rdquo;)
and with the instructions to Form 10-Q. The financial statements presented herein have not been audited by an independent registered
public accounting firm but include all material adjustments (consisting of normal recurring adjustments) which are, in the opinion
of management, necessary for a fair statement of the financial condition, results of operations and cash flows for the period.
However, these results are not necessarily indicative of results for any other interim period or for the full fiscal year. The
preparation of financial statements in conformity with GAAP requires us to make certain estimates and assumptions for the reporting
periods covered by the financial statements. These estimates and assumptions affect the reported amounts of assets, liabilities,
revenues and expenses. Actual amounts could differ from these estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
information and footnote disclosures normally included in financial statements in accordance with generally accepted accounting
principles have been omitted pursuant to the rules of the Securities and Exchange Commission (&ldquo;SEC&rdquo;). The accompanying
unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and notes
thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2018, filed with the SEC on March 28,
2019 (the &ldquo;Annual Report&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Recent
Accounting Standards announced</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework &ndash; Changes to the Disclosure
Requirements for Fair Value Measurement. The amendments apply to reporting entities that are required to make disclosures about
recurring or nonrecurring fair value measurements and should improve the cost, benefit, and effectiveness of the disclosures.
ASU 2018-13 categorized the changes into those disclosures that were removed, those that were modified, and those that were added.
The primary disclosures that were removed related to transfers between Level 1 and Level 2 investments, along with the policy
for timing of transfers between levels. In addition, disclosing the valuation processes for Level 3 fair value measurements was
removed. The amendments are effective for all organizations for fiscal years, and interim periods within those fiscal years, beginning
after December 15, 2019. Early adoption is permitted. The Company notes that this guidance will impact its disclosures beginning
January 1, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
2. Convertible Notes.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following convertible promissory notes bear interest at 1% per annually, are convertible at a price of $0.01 per share and are
repayable through January 1, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">March
    31, 2019</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">December
    31, 2018</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; font-size: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Principle</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">503,217</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 16%; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">1,058,611</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Conversion
    of convertible notes to shares</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(555,394</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accrued
    interest</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">8,227</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt; padding-left: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Discount</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">(17,768</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Total</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">511,444</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">485,449</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
3. Stockholders&rsquo; Equity.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes information of outstanding warrants issued to investors and consultants in exchange for their services
as of March 31, 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrants</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Warrant
    Term</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercise
    Price</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif">Exercisable</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 25%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investors &ndash; Class
    F (*) Warrants</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,142,857</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">April 2019</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.14</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,142,857</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investors &ndash; Class G (*)
    Warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,142,857</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">April 2019</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.28</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,142,857</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investors - Class H Warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">750,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 2020 -March 2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.14</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">750,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Investors - Class I Warrants</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">571,429</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">January 2020</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.14</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">571,429</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">(*)
Subsequent to the balance sheet date, these warrants expired.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Note
4. Related Party Transactions.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other
than transactions and balances related to cash and share based compensation to officers and directors and other than the issuances
of convertible debt to certain investors, and payments in respect of consulting fees to certain shareholders with beneficial
holdings of greater that 5% of $75,000 and $ nil during the three months ended March 31, 2019 and 2018, respectively,
the Company did not have any transactions and balances with related parties and executive officers during these periods.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">As
a result of the issuance of the convertible notes in the prior years, certain may hold convertible notes allowing them
to convert the notes in excess of 5% of the Company&rsquo;s issued and outstanding shares of common stock. Accordingly, such investors
may be deemed to be related parties under Item 404(a) of Regulation S-K. In addition, certain investors receive fees for consulting
services provided to the Company, as noted above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Note
5. Subsequent Events.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
May 2, 2019, the company issued 750,000 restricted shares to the Company&rsquo;s CEO and 750,000 restricted shares to the
Company&rsquo;s CFO in the lieu of services provided to the Company. The fair value of the 1,500,000 restricted shares
was $51,300.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="M_008"></A><FONT STYLE="font-size: 10pt"><B>ITEM
2. MANAGEMENT&rsquo;S DISCUSSION AND ANALYSIS AND RESULTS OF OPERATIONS</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Special
Note Regarding Forward-Looking Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>The
following management&rsquo;s discussion and analysis section should be read in conjunction with the Company&rsquo;s unaudited
financial statements as of March 31, 2019 and 2018, and the related </I>statements of comprehensive <I>loss, statement of changes
in stockholders&rsquo; equity (deficit) and statements of cash flows for the three months then ended, and the related notes thereto
contained in this Quarterly Report on Form 10-Q (this &ldquo;Quarterly Report&rdquo;). This management&rsquo;s discussion and
analysis section contains forward-looking statements, such as statements of the Company&rsquo;s plans, objectives, expectations
and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words
&ldquo;believe,&rdquo; &ldquo;plan,&rdquo; &ldquo;intend,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;target,&rdquo; &ldquo;estimate,&rdquo;
&ldquo;expect&rdquo; and the like, and/or future tense or conditional constructions &ldquo;will,&rdquo; &ldquo;may,&rdquo; &ldquo;could,&rdquo;
&ldquo;should,&rdquo; etc., or similar expressions, identify certain of these forward-looking statements. These forward-looking
statements are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed
or implied by the forward-looking statements. These factors include those contained in section captioned &ldquo;Risk Factors&rdquo;
of the Company&rsquo;s Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on
March 29, 2019 (the &ldquo;Annual Report&rdquo;). The Company&rsquo;s actual results could differ materially from those
contemplated in these forward-looking statements as a result of these factors. The Company does not undertake any obligation to
update forward-looking statements to reflect events or circumstances occurring after the date of this Quarterly Report.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Overview
and background</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2018, Virtual Crypto Technologies, Inc. (the &ldquo;Registrant&rdquo; or &ldquo;Company&rdquo;) formed Virtual Crypto
Technologies Ltd as a new wholly-owned subsidiary under the laws of the State of Israel (&ldquo;Virtual Crypto Israel&rdquo;)
and appointed Mr. Alon Dayan, who has served as the Registrant&rsquo;s Chief Executive Officer since June 30, 2018 and has been
a member of the Company&rsquo;s Board of Directors since March 14, 2018, as CEO of Virtual Crypto Israel. Virtual Crypto Israel
was formed to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of
cryptocurrencies through ATMs, tablets, PCs and/or mobile devices (the &ldquo;Products&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 29, 2018, <FONT STYLE="background-color: white">pursuant to resolution of the Registrant&rsquo;s Board of Directors, </FONT>the
Registrant transferred the management shares of the Registrant&rsquo;s former Israeli subsidiary, Emerald Medical Applications
Ltd. (&ldquo;Emerald IL&rdquo;) to Attorney Eviatar Knoller, Esq., with offices in <FONT STYLE="background-color: white">Tel Aviv-Jaffa,
Israel, as trustee (the &ldquo;Trustee&rdquo;) for the purpose of enabling the Trustee to liquidate the management shares and/or
the assets of Emerald IL to satisfy its debts.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Recent
Developments</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Share
Exchange Agreement</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
operations of Virtual Crypto Israel only generated revenues of $100,000 during the year end December 31, 2018 from one customer,
Chiron, who has encountered financial difficulties. During 2018, we spent $790,413 in order to develop our systems in an industry
that has experienced significant difficulties over the last 18 months. We believe that this has led to a decrease in the anticipated
demand for Virtual Crypto Israel&rsquo;s products and services. Therefore, on February 7, 2019, we filed a Form 8-K reporting
that the Registrant entered into a share exchange agreement (the &ldquo;Share Exchange Agreement&rdquo;) with Algomizer Ltd.,
an Israeli Corporation (&ldquo;Algomizer&rdquo;), pursuant to which Algomizer will assign, transfer and deliver its 99.83% holdings
in Viewbix Ltd., an Israeli corporation, to us in exchange for shares of restricted common stock of representing 65% of the issued
and outstanding share capital of the Company on a fully diluted basis on the closing date, excluding certain warrants to purchase
shares of common stock, which will expire in 2020 and with an exercise price representing a valuation equal to $30,000,000 (&ldquo;Fully
Diluted Share Capital&rdquo;). In addition, upon the earlier of: (a) the launch of a live video product to an American consumer
in the U.S by Viewbix Ltd., or (b) the launch of an interactive television product to an American consumer in the U.S., Viewbix
Ltd., we will issue Algomizer additional shares of restricted common stock of the Company representing 5% of the Fully Diluted
Share Capital.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
on the closing date, we will issue Algomizer: (i) warrants to purchase shares of restricted common stock with an exercise price
representing a valuation for the Company of $15,000,000 on Fully Diluted Share Capital basis, which will represent 10% of the
Fully Diluted Share Capital immediately following the closing, which warrants will be exercisable for a period of ten years, and
(ii) warrants to purchase shares of restricted common stock with an exercise price representing a valuation for the Company of
$25,000,000 on Fully Diluted Share Capital basis, which will represent 10% of the Fully Diluted Share Capital immediately following
the closing, which latter warrants will be exercisable for a period of ten years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
closing of the Share Exchange Agreement is conditioned upon us filing an amendment to our certificate of incorporation to change
the Company&rsquo;s name to ViewBix Inc., effecting a reverse split of our shares of common stock at a ratio of 1:15, which we
intend to effect whether or not the transactions under the Share Exchange Agreement will consummate, conversion of our outstanding
convertible notes into shares of restricted common stock and Algomizer obtaining a tax pre-ruling from the Israeli Tax Authority
relating to the Share Exchange Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ViewBix
Ltd., through its ViewBix Studio, provides its clients with a video engagement platform designed to add enhanced branding and
interactive elements &ndash; from call-to-action buttons to email captures &ndash; to digital videos. ViewBix Studio is simple,
intuitive and requires no coding experience, thereby enabling clients to enhance videos and publish them across any platform,
for any device in just minutes. Videos enhanced by Viewbix are compatible with existing ad serving, measurement and analytics
platforms and easily work within existing agency or client processes for launching advertising campaigns. Beyond adding interactions
to video, Viewbix uses second-by-second measurement of engagements to uncover contextual insights as to what, when and how users
are engaging or responding to brand messaging.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Reverse
Stock Split</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 26, 2019, stockholders holding a majority of our outstanding shares of common stock approved an amendment to our certificate
of incorporation in order to affect a reverse stock split of the of our common stock on a 1-for-15 basis. We intend to affect
such reverse stock split once all approvals for such actions are obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Reverse stock split, each fifteen (15) shares of our common stock will be automatically converted, without any further
action by our stockholders, into one share of common stock. No fractional shares will be issued as the result of the reverse stock
split. Instead, each stockholder will be entitled to receive one share of common stock in lieu of the fractional share that would
have resulted from the reverse stock split.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Results
of Operations</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Results
of Operations During the Three Months Ended March 31, 2019 as Compared to the Three Months Ended March 31, 2018</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
research and development expenses were $9,413 for the three months ended March 31, 2019, as compared to $54,011 during the same
period in the prior year. The decrease was due to downsizing of the research and development team expenses and slowdown
in the development for our virtual crypto products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
general and administrative expenses decreased to $191,210 for the three months ended March 31, 2019 as compared to $1,064,283
during the same period in the prior year. The significant decrease was due to non-cash consulting expenses in 2018 paid by way
of issuances of the Company&rsquo;s shares and warrants to certain consultants who assisted in the establishment of the new business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
marketing expenses decreased to $ nil for the three months ended March 31, 2019 as compared to $310,000 during the same period
in the prior year. The significant decrease was due to the reduction in operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
income increased to $115,965 for the three months ended March 31, 2019, as compared to interest expenses of $19,374,082
during the same period in the prior year. The income during the period in 2019 was primarily as a result of the changes of the
terms of certain convertible notes that occurred during the three months ended March 31, 2019. The significant expenses in 2018
is as a result of the changes of the terms of certain convertible notes that occurred during the three months ended March 31,
2018, primarily, the decrease in the conversion price per share from $0.14 to $0.01 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>


<!-- Field: Page; Sequence: 15; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Liquidity
and Capital Resources</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Our
balance sheet as of March 31, 2019 reflects current assets of $460,809 consisting of cash of $447,967 cash and other receivables
of $12,842. We also have $1,079,840 in current liabilities consisting of $98,871 in accounts payable and accrued
liabilities, $8,227 in accrued interest, short-term portion of convertible notes of $503,217 and liabilities held for sale
of $469,525. As of December 31, 2018, we had current assets of $558,677 consisting of $499,919 in cash and other receivables
of $41,516 and marketable securities of $17,242. As of December 31, 2018, we had $975,153 in current liabilities consisting
of $13,115 in accounts payable and accrued liabilities, $7,064 employee payable, and short-term portion of convertible notes of
$485,449 and liabilities held of sale in respect of our discontinued operations of $469,525.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
had negative working capital of $619,031 as of March 31, 2019, as compared to negative working capital of $416,476 at December
31, 2018. Our total liabilities as of March 31, 2019 were $1,079,840, as compared to $975,153 at December 31, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the period ended March 31, 2019, we had negative cash flow from operations of $66,559, which was the result of a net loss
of $84,658, decrease in provision for settlements of convertible loan of $145,932, increase in accrued interest
and amortization of discount on convertible notes of $17,768 loss from marketable securities $2,635 and $28,035 shares
and warrants issued for services, offset by net changes in working capital of $36,901.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the period ended March 31, 2018, we had negative cash flow from continuing operations of $345,449, which was the result of a net
loss of $20,802,376, increase in accrued interest and amortization of discount on convertible notes of $20,165,406 and $892,300shares
and warrants issued for services, offset by net changes in working capital of $600,799.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the three months ended March 31, 2019, we had positive cash flow from investing activities of $14,607 which was the
result of selling marketable securities, as compared to nil at December 31, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the period ended March 31, 2019, we had no cash flow effect from financing activities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">During
the period ended March 31, 2018, </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">we had positive cash flow
from financing activities of $1,792,285, which was the result of $1,575,072 proceeds from issuance of equity, $117,150 of receipt
on account of shares, $100,000 from the issuance of convertible notes and $63 for the eservice of options.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no limitations in the Company&rsquo;s Certificate of Incorporation on the Company&rsquo;s ability to borrow funds or raise
funds through the issuance of shares of its common stock to affect a business combination. The Company&rsquo;s limited resources
and lack of having cash-generating business operations may make it difficult to borrow funds or raise capital. The Company&rsquo;s
limitations to borrow funds or raise funds through the issuance of restricted capital stock required to effect or facilitate a
business combination may have a material adverse effect on the Company&rsquo;s financial condition and future prospects, including
the ability to complete a business combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Until
such time as the Company can generate substantial revenues, the Company expects to finance its cash needs through a combination
of the sale of its equity and/or convertible debt securities, debt financing and strategic alliances and collaborations. The Company
does not have any committed external source of funds. To the extent that the Company raises additional capital through the sale
of its equity and/or convertible debt securities, the ownership interest of its stockholders will be diluted, and the terms of
these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt
financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions,
such as incurring additional debt, making capital expenditures or declaring dividends. To the extent that debt financing ultimately
proves to be available, any borrowing will subject us to various risks traditionally associated with indebtedness, including the
risks of interest rate fluctuations and insufficiency of cash flow to pay principal and interest, including debt of an acquired
business. If the Company raises funds through additional collaborations or strategic alliances with third parties, we may have
to relinquish valuable rights to our future revenue streams and/or distribution arrangements. No assurance can be given that any
future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. If the Company
is unable to raise additional funds through equity and/or debt financings when needed or on attractive terms, the Company may
be required to delay, limit, reduce or terminate the operations of some or all of its business segments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Going
Concern:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company has incurred significant operating losses and negative cash flows from operating activities in relation to its operations,
since inception. While the Company raised approximately $1.9 million in the year ended December 31, 2018 to fund the operations
of its New Subsidiary, the Company will require additional capital resources in order to support the commercialization of the
New Subsidiary&rsquo;s technology and operations and maintain its research and development activities related to the New Subsidiary&rsquo;s
technology. The Company is addressing its liquidity needs by seeking additional funding from public and/or private sources. There
are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required
for the Company&rsquo;s short and long-term requirements, or at all these conditions raise substantial doubt about the Company&rsquo;s
ability to continue as a going concern. The consolidated financial statements do not include any adjustments to reflect the possible
future effects on recoverability and classification of assets or the amounts and classification of liabilities that may result
from the outcome of this uncertainty</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="M_009"></A><FONT STYLE="font-size: 10pt"><B>ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
required for smaller reporting companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>



<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>
<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="p_001"></A><FONT STYLE="font-size: 10pt"><B>ITEM
4. CONTROLS AND PROCEDURES</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Evaluation
of Disclosure Controls and Procedures</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of March 31, 2019, the Company&rsquo;s Chief Executive Officer and Chief Financial Officer conducted an evaluation (the &ldquo;Evaluation&rdquo;)
regarding the effectiveness of the Company&rsquo;s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e)
under the Exchange Act. Based upon the evaluation of these controls and procedures required by Rules 13a-15 or 15d-15, the Company&rsquo;s
Chief Executive Officer and Chief Financial Officer concluded that the Company&rsquo;s disclosure controls and procedures were
effective as of the end of March 31, 2019 under the Committee of Sponsoring Organizations of the Treadway Commission in Internal
Control-Integrated Framework (2013) because of certain material weaknesses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Changes
in Internal Control Over Financial Reporting</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no changes in our internal control over financial reporting or in other factors identified in connection with the evaluation
required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that occurred during the quarter ended March 31, 2019 that have
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Inherent
Limitations on Effectiveness of Controls and Procedures</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 27.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s management, including our Chief Executive Officer and Chief Financial Officer, does not expect that the Company&rsquo;s
disclosure controls and procedures or its internal controls will prevent all errors and all fraud. A control system, no matter
how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system
are met. The Company&rsquo;s control systems are designed to provide such reasonable assurance of achieving their objectives.
Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls
must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls
can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.
These inherent limitations include, but are not limited to, the realities that judgments in decision-making can be faulty and
that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts
of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls
also is based in part upon certain assumptions about the likelihood of future events and there can be no assurance that any design
will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because
of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent
limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="p_002"></A><FONT STYLE="font-size: 10pt"><B>PART
II - OTHER INFORMATION</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="p_003"></A><FONT STYLE="font-size: 10pt"><B>ITEM
1. LEGAL PROCEEDINGS</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">We
are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or
results of operations, except as set forth below. There is no action, suit, proceeding, inquiry or investigation before or by
any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive
officers of our company, threatened against or affecting our company, our common stock, our officers or directors in their capacities
as such, in which an adverse decision could have a material adverse effect, other than as set forth below.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2017, a lawsuit was filed with the Tel Aviv court by Mr. Wayn claiming certain damages to the total amount of $100,000,
under the assertion of wrongful dismissal by the Registrant and Emerald IL. The Registrant believes these claims to be unsubstantiated
and wholly without merit and intends to defend itself against these claims. The Company believes that he will not be successful
in his claim. Nevertheless, the outcome of the proceeding will not materially affect the Registrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2017, a liquidation request was filed with the Tel Aviv District Court by a group of former employees of Emerald IL,
under the assertion of delay of pay and insolvency. On December 20, 2017, at a hearing before the court, it was ordered that the
Emerald IL shall settle its pension debts to the former employees under applicable Israeli law within 21 days and settle its other
debts to them in 60 days, the failure of which would result in a winding-up order (the equivalent of a liquidation) could be given.
Based on the collaboration of Emerald IL and its former employees and the fact that the Company was in negotiation with third-parties
for the infusion of equity capital and has started negotiating the sale of certain assets, the Company&rsquo;s legal advisors
believe that the liquidation claim will be dismissed by the court. The amounts being claimed by the former employees was less
than $96,000 and are included in current liabilities at December 31, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 29, 2018, the &ldquo;Registrant&rdquo;) transferred the ordinary shares of the Registrant&rsquo;s former Israeli subsidiary,
Emerald IL to Attorney Eviatar Knoller, Esq., with offices at <FONT STYLE="background-color: white">20 Lincoln, Tel Aviv-Jaffa
6713412, as trustee (the &ldquo;Trustee&rdquo;). The purpose of the transfer of the management shares to the Trustee, pursuant
to resolution of the Registrant&rsquo;s Board of Directors, was to enable the Trustee to liquidate the management shares and/or
the assets of Emerald IL to satisfy its debts </FONT>and satisfy its financial obligations to former employees. As a result, the
former employees of Emerald IL commenced an action in a court of competent jurisdiction in Israel to liquidate Emerald IL and
use any assets to satisfy the debts owed to the former employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="p_004"></A><FONT STYLE="font-size: 10pt"><B>ITEM
1A. RISK FACTORS</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
risk factors discussed in Part I, &ldquo;Item 1A. Risk Factors&rdquo; in the Company&rsquo;s Annual Report filed on Form 10-K
with the SEC March 29, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="p_005"></A><FONT STYLE="font-size: 10pt"><B>ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">None.&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="p_006"></A><FONT STYLE="font-size: 10pt"><B>ITEM
3. DEFAULTS UPON SENIOR SECURITIES</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="p_007"></A><FONT STYLE="font-size: 10pt"><B>ITEM
4. MINE SAFETY DISCLOSURE</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="p_008"></A><FONT STYLE="font-size: 10pt"><B>ITEM
5. OTHER INFORMATION</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
May 2, 2019 the Company issued 750,000 shares of its common stock to the Chief Executive Officer and 750,000 shares of its common
stock to the Chief Financial Officer in consideration for services provided to the Company during the first quarter of 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="p_009"></A><FONT STYLE="font-size: 10pt"><B>ITEM
6. EXHIBITS</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The following documents are filed as exhibits to this Quarterly Report or incorporated by reference herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; width: 0.75in; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></P></TD>
    <TD STYLE="vertical-align: top; width: 0.1in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1&plusmn;
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534515000051/exh10_4.htm"><FONT STYLE="font-size: 10pt">Share
    Exchange Agreement, dated as of March 15, 2015, among the Company, Emerald Medical Applications Ltd. and the shareholders
    of the Company as set forth on the signature pages to the agreement (Incorporated by reference to Exhibit 10.4 to the Company&rsquo;s
    Current Report on Form 8-K, filed with the SEC on March 16, 2015).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000079754215000006/exh3_1.htm"><FONT STYLE="font-size: 10pt">Certificate
    of Incorporation of the Company (Incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Registration Statement on
    Form S-1, filed with the SEC on August 8, 2017).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000079754215000006/exh3_1a.htm"><FONT STYLE="font-size: 10pt">Certificate
    of Amendment to the Certificate of Incorporation of the Company, reflecting name change to Zaxis International, Inc. (Incorporated
    by reference to Exhibit 3.1(a) to the Company&rsquo;s Registration Statement on Form S-1, filed with the SEC on August 8,
    2015).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000079754215000006/exh3_1b.htm"><FONT STYLE="font-size: 10pt">Certificate
    of Amendment to the Certificate of Incorporation of the Company, reflecting reverse stock split (Incorporated by reference
    to Exhibit 3.1(b) to the Company&rsquo;s Registration Statement on Form S-1, filed with the SEC on August 8, 2015).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.4*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex3-4.htm"><FONT STYLE="font-size: 10pt">Certificate
    of Amendment to the Certificate of Incorporation of the Company, reflecting name change to Virtual Crypto Technologies, Inc.</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000079754215000006/exh3_2.htm"><FONT STYLE="font-size: 10pt">Bylaws
    of the Company (Incorporated by reference to Exhibit 3.1 to the Company&rsquo;s Registration Statement on Form S-1, filed
    with the SEC on August 8, 2017).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534517000276/exh10_42.htm"><FONT STYLE="font-size: 10pt">Certificate
    of Designation of the Company for Series A Preferred Convertible Stock (Incorporated by reference to Exhibit 10.42 to the
    Company&rsquo;s Current Report on Form 8-K, filed with the SEC on September 1, 2017).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000149315215002975/ex4-1.htm"><FONT STYLE="font-size: 10pt">Form
    of Class A Warrant Agreement (Incorporated by reference to Exhibit 4.1 to the Company&rsquo;s Current Report on Form 8-K,
    Amendment No. 1, filed with the SEC on July 15, 2015).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000149315215002975/ex4-2.htm"><FONT STYLE="font-size: 10pt">Form
    of Class E Warrant Agreement (Incorporated by reference to Exhibit 4.2 to the Company&rsquo;s Current Report on Form 8-K,
    Amendment No. 1, filed with the SEC on July 15, 2015).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000079754215000006/exh4_2.htm"><FONT STYLE="font-size: 10pt">Form
    of Class B Warrant Agreement (Incorporated by reference to Exhibit 4.2 to the Company&rsquo;s Registration Statement on Form
    S-1, filed with the SEC on August 8, 2015).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000079754215000006/exh4_3.htm"><FONT STYLE="font-size: 10pt">Form
    of Class C Warrant Agreement (Incorporated by reference to Exhibit 4.3 to the Company&rsquo;s Registration Statement on Form
    S-1, filed with the SEC on August 8, 2015).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534515000030/exh10_3.htm"><FONT STYLE="font-size: 10pt">Loan
    Agreement, dated as of February 2, 2015, between the Company and Emerald Medical Applications Ltd. (Incorporated by reference
    to Exhibit 10.3 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on February 3, 2015).</FONT></A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Page; Sequence: 19; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="width: 0.1in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534515000059/exh10_5.htm"><FONT STYLE="font-size: 10pt">Loan
    Agreement, dated as of March 19, 2015, between the Company and Emerald Medical Applications Ltd. (Incorporated by reference
    to Exhibit 10.5 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on March 24, 2015).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534515000160/exh10_8.htm"><FONT STYLE="font-size: 10pt">Loan
    Agreement, dated as of June 2, 2015, between the Company and Emerald Medical Applications Ltd. (Incorporated by reference
    to Exhibit 10.8 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on June 5, 2015).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000079754215000006/exh10_10.htm"><FONT STYLE="font-size: 10pt">Form
    of Look-Up Agreement between the Company and Selling Securityholders and Class B Warrant Holders (Incorporated by reference
    to Exhibit 10.10 to the Company&rsquo;s Registration Statement on Form S-1, filed with the SEC on August 5, 2015).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534516000587/exh10_20.htm"><FONT STYLE="font-size: 10pt">Equity
    Purchase Agreement, dated as of May 12, 2016, between the Company and Kodiak Capital Group LLC (Incorporated by reference
    to Exhibit 10.20 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on May 18, 2016).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534516000587/exh10_21.htm"><FONT STYLE="font-size: 10pt">Registration
    Rights Agreement, dated as of May 12, 2016, between the Company and Kodiak Capital Group LLC (Incorporated by reference to
    Exhibit 10.21 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on May 18, 2016).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000157587216000372/ex10-22.htm"><FONT STYLE="font-size: 10pt">Securities
    Purchase Agreement, dated as of June 20, 2016, between the Company and Alpha Capital Anstalt (Incorporated by reference to
    Exhibit 10.22 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on June 22, 2016).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000157587216000372/ex10-23.htm"><FONT STYLE="font-size: 10pt">Registration
    Rights Agreement, dated as of June 20, 2016, between the Company and Alpha Capital Anstalt (Incorporated by reference to Exhibit
    10.23 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on June 22, 2016).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000157587216000372/ex10-24i.htm"><FONT STYLE="font-size: 10pt">Convertible
    Note in the principal amount of $400,000, dated as of June 20, 2016, issued to Alpha Capital Anstalt (Incorporated by reference
    to Exhibit 10.24(i) to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on June 22, 2016).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000157587216000372/ex10-24i.htm"><FONT STYLE="font-size: 10pt">Convertible
    Note in the principal amount of $40,000, dated as of June 20, 2016, issued to Alpha Capital Anstalt (Incorporated by reference
    to Exhibit 10.24(ii) to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on June 22, 2016).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000157587216000372/ex10-27.htm"><FONT STYLE="font-size: 10pt">Security
    Agreement, dated as of June 20, 2016, between the Company, Emerald Medical Applications Ltd. and Alpha Capital Anstalt (Incorporated
    by reference to Exhibit 10.27 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on June 22, 2016).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000157587216000399/ex10-30.htm"><FONT STYLE="font-size: 10pt">Securities
    Purchase Agreement, dated July 7, 2016, between the Company and Firstfire Global Opportunities Fund (Incorporated by reference
    to Exhibit 10.30 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on July 29, 2016).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000157587216000399/ex10-31.htm"><FONT STYLE="font-size: 10pt">Registration
    Rights Agreement, dated as of July 7, 2016, between the Company and Firstfire Global Opportunities Fund (Incorporated by reference
    to Exhibit 10.31 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on July 29, 2016).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000157587216000399/ex10-32.htm"><FONT STYLE="font-size: 10pt">Convertible
    Note in the principal amount of $100,000, dated as of July 7, 2016, issued to Firstfire Global Opportunities Fund (Incorporated
    by reference to Exhibit 10.32 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on July 29, 2016).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534517000276/exh10_37.htm"><FONT STYLE="font-size: 10pt">Settlement
    Agreement, dated August as of 7, 2017, among the Company and Alpha Capital Anstalt and Chi Squared Capital, Inc. (Incorporated
    by reference to Exhibit 10.37 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on September 1, 2017).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534517000276/exh10_38.htm"><FONT STYLE="font-size: 10pt">Secured
    Convertible Note due June 20, 2019 issued by the Company to Alpha Anstalt Capital (Incorporated by reference to Exhibit 10.38
    to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on September 1, 2017).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534517000276/exh10_39.htm"><FONT STYLE="font-size: 10pt">Secured
    Convertible Note due June 20, 2019 issued by the Company to Chi Squared Capital, Inc. (Incorporated by reference to Exhibit
    10.39 to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on September 1, 2017).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534517000276/exh10_40.htm"><FONT STYLE="font-size: 10pt">Class
    A Warrants issued by the Company on June 20, 2016 to Alpha Anstalt Capital (Incorporated by reference to Exhibit 10.40 to
    the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on September 1, 2017).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/797542/000129534517000276/exh10_41.htm"><FONT STYLE="font-size: 10pt">Class
    A Warrants issued by the Company on June 20, 2016 to Chi Squared Capital, Inc. (Incorporated by reference to Exhibit 10.41
    to the Company&rsquo;s Current Report on Form 8-K, filed with the SEC on September 1, 2017).</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20&dagger;*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><A HREF="ex10-20.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Services Agreement, dated as of February 15, 2018, between the Company and Yair Fudim.</FONT></A></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex31-1.htm"><FONT STYLE="font-size: 10pt">Certification
    of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act.</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex31-2.htm"><FONT STYLE="font-size: 10pt">Certification
    of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act.</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex32-1.htm"><FONT STYLE="font-size: 10pt">Certification
    of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
    Act of 2002.</FONT></A></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="ex32-2.htm"><FONT STYLE="font-size: 10pt">Certification
    of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
    Act of 2002.</FONT></A></FONT></TD></TR>
</TABLE>


<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS&pound;
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Instance Document</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS&pound;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Schema Document</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL&pound;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Calculation Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF&pound;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Definition Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB&pound;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Label Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE&pound;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Presentation Linkbase Document</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&dagger;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
    contract or compensatory plan or arrangement required to be filed as an exhibit pursuant to the requirements of Item 15(a)(3)
    of Form 10-K.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    herewith.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished
    herewith.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&plusmn;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Schedules
    have been omitted pursuant to Item 601(b)(ii) of Regulation S-K. A copy of any omitted schedule will be furnished supplementally
    to the SEC upon request.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&pound;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    be filed by an amendment to this Quarterly Report.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A NAME="p_010"></A><FONT STYLE="font-size: 10pt"><B>SIGNATURES</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>VIRTUAL
    CRYPTO TECHNOLOGIES, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Alon Dayan</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon
    Dayan</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 15, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Gadi Levin</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gadi
    Levin</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial Officer and Principal Accounting Officer)</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 15, 2019 </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.4
<SEQUENCE>2
<FILENAME>ex3-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
3.4</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STATE
OF DELAWARE</B><BR>
<B>CERTIFICATE OF AMENDMENT</B><BR>
<B>OF</B><BR>
<B>CERTIFICATE OF INCORPORATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerald
Medical Applications Corp., a corporation organized and existing under and by virtue of the General Corporation Law of the State
of Delaware does hereby certify:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST:
That at a meeting of the Board of Directors of Emerald Medical Applications Corp. (the &ldquo;Corporation&rdquo;) resolutions
were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of said Corporation, declaring said amendment
to be advisable and based upon the written consent of stockholders of said Corporation holding a majority of the outstanding shares
of common stock for consideration thereof. The resolution setting forth the proposed amendment is as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RESOLVED,
that the Certificate of Incorporation of this Corporation be amended by changing the Article thereof numbered &ldquo;FIRST&rdquo;
so that, as amended, said Article shall be and read as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FIRST:
The name of the Corporation is: Virtual Crypto Technologies Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">SECOND:
That thereafter, pursuant to resolution of its Board of Directors, and based upon the written consent of holders of a majority
of the shares of common of said Corporation in accordance with Section 228 of the General Corporation Law of the State of Delaware,
the necessary number of shares as required by statute were voted in favor of the amendment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIRD:
That said amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State
of Delaware.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, said Corporation has caused this certificate to be signed this 25<SUP>th</SUP> day of January 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="width: 45%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Ahmed Alimi</I></FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ahmed
    Alimi</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.20
<SEQUENCE>3
<FILENAME>ex10-20.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;<IMG SRC="ex10-20_001.jpg" ALT="" STYLE="height: 961; width: 680"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;<IMG SRC="ex10-20_002.jpg" ALT="" STYLE="height: 961; width: 680"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>ex31-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF CEO PURSUANT TO RULE 13a-14(a) OR 15d-14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SARBANES-OXLEY ACT OF 2002 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Alon Dayan, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Quarterly Report on Form 10-Q of Virtual Crypto Technologies, Inc.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented
in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The issuer&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
procedures (as 4efined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Evaluated the effectiveness of the issuer&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Disclosed in this report any change in the issuer&rsquo;s internal control over financial reporting that occurred during the issuer&rsquo;s
most recent fiscal quarter (the issuer&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the issuer&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The issuer&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the issuer&rsquo;s auditors and the audit committee of the issuer&rsquo;s board of directors (or persons
performing the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the issuer&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 15, 2019</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Alon Dayan</I></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon
    Dayan</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>ex31-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: right; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
31.2 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF CFO PURSUANT TO RULE 13a-14(a) OR 15d-14(a)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>OF
THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I,
Gadi Levin, certify that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
I have reviewed this Quarterly Report on Form 10-Q of Virtual Crypto Technologies, Inc.;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect
to the period covered by this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all
material respects the financial condition, results of operations and cash flows of the issuer as of, and for, the periods presented
in this report;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
The issuer&rsquo;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and
procedures (as 4efined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined
in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the issuer, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed
under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted accounting principles;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Evaluated the effectiveness of the issuer&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on
such evaluation; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Disclosed in this report any change in the issuer&rsquo;s internal control over financial reporting that occurred during the issuer&rsquo;s
most recent fiscal quarter (the issuer&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the issuer&rsquo;s internal control over financial reporting; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
The issuer&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over
financial reporting, to the issuer&rsquo;s auditors and the audit committee of the issuer&rsquo;s board of directors (or persons
performing the equivalent functions):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the issuer&rsquo;s ability to record, process, summarize and report financial information;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the issuer&rsquo;s
internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; padding-right: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    May 15, 2019</FONT></TD>
    <TD STYLE="width: 50%; padding-right: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Gadi Levin</I></FONT></TD>
    <TD STYLE="padding-right: 0.25in; padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gadi
    Levin</FONT></TD>
    <TD STYLE="padding-right: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="padding-right: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="padding-right: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>ex32-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
32.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF CEO PURSUANT TO18 U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO SECTION 906OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Quarterly Report of Virtual Crypto Technologies, Inc. (the &ldquo;Company&rdquo;) on Form 10-Q for the period
ended March 31, 2019 (the &ldquo;Report&rdquo;), as filed with the Securities and Exchange Commission on the date hereof, I, Yair
Fudim, Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Alon Dayan</I></FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alon
    Dayan</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
    May 15, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>ex32-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Exhibit
32.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CERTIFICATION
OF CFO PURSUANT TO18 U.S.C. SECTION 1350,</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AS
ADOPTED PURSUANT TO SECTION 906OF THE SARBANES-OXLEY ACT OF 2002</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Quarterly Report of Virtual Crypto Technologies, Inc. (the &ldquo;Company&rdquo;) on Form 10-Q for the period
ended March 31, 2019 (the &ldquo;Report&rdquo;), as filed with the Securities and Exchange Commission on the date hereof, I, Gadi
Levin, Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Gadi Levin</I></FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gadi
    Levin</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated:
May 15, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex10-20_001.jpg
<TEXT>
begin 644 ex10-20_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 4% XT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7]EZO+87;65O?17GV%Y5CBED 4E=IY;D8(R,YQQ47@3PO=P_#B;0]=LS:2W
MFCDC#JQ".,9!!(__ %"LM/!WB"U^&6IZ;<+'?ZO.$AAC$B[5@20;$#$#H"[
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M-(2<F^MXUEDB,;#"MT()&#^!-8)TG_A"_!NLMIEQ<37*6\ERLD^UR95@5%.
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPXC<$J?0XZ5RLWCR"'5M5TY=$U>9M)*?;)88XF5$8%E8#S-Y! )X4GCI7,^
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MT]IIEE#L-E%NC1%VR-DQ@>C'DCOR:OZ1H6EZ#;O!I-A;V<+MO9(4"AFQC)_
M"O-==U6^U'1=9LM0O;2>73YM-CQ JX=V,3O*._)8@8XP*ZGQQK-YIL,$=CJ;
M6EV\%U/'&MNK^<8HB^"S<*H.,\$G. 1UHL,ZF_L;34[*6RO8(Y[:48DB<95A
MG/(_"L@^%/#$3/$^F68>ZB,#*X!:2,8)09YQP#@>E8'@C4;_ %77+F^O)][3
MZ+IL[Q*,(KNLC''ISN/X^PK+N=6MM0^)^D73:=K%K?I]JM%6YMWCB=%1R"C=
M&).3D'H1Z9HL!WD%EH=U>&:!+2>YMH?L9V.&,<?>,C/ XZ'TK-'@OPC!I<^F
MC3;1+4R":1/,(*MGY6W9RN.V",=JXSX>1QP?\(4]F!OGTR]^T[#]Y!*A!/T=
MOU-7/B#9'3_$D=^+5;BUUVPDTB:,J.9\%H.O0DY&>V!1;4#KI/!_AJ1/)&GP
MQI)9M9[(9&C#P$[F7"D9YYSUY//)JR= T>,Z4[P(&TL>79,\A)CRNP#)/S''
M'.>>>M>?Z5KLES9/JWD11W?A72)K6X6XR$%T"%9=P[ 0=L_ZP59N-7U'6--B
MAUB&V-Q9:SI;QR0QE%=9'C.<%FP1N(SGTX%%A)G9V/A;0[/59=2L[<BX,KR'
M%P[(LC9WL$+%58Y.2 #R:WZX;X<QI'+XN1!A5\1W6/Q2,G]37<TAA1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !2-G:<=<4M(1D$4 <+<>(]5_X2272'FL
M]/N5O$^RQ743;;ZU^7<4?.-XR_ ] ".<U8C^(%@+2&:>PU)7GO+BTACAMFF:
M0Q,0S )DXP#GN,$<XS4]]X+BU#S(+O4[R>T:\6\$,NUS&X8-M1RNY5R!P#G&
M1G!I;/P;':7FG7"W\[I87=U=0QLJX_?AMRD@#(!=B#3 6/Q_X=D ;[>(X6MW
MN8YI49$D1"0^TD#)4CD=:=;>.='O9[""T%U*][<R6H'V=D,4B)O8.K@%>".W
M?/3FH!X(QHFH:*=4F_LNX5Q!"L:A[<LY<X?^(;CP".!QS5BY\.:E=MI%S-K$
M;:AITLD@F%H DF]&3&S=QPWKVHT V[U[I;*=K)(7N@C>2LS%4+8XW$ G&>N*
MX@>-]8MM!U&;4;"SCO;+4HK!YHYB;4!R@,A8\@+O^8=C@>N.B%MXF'AIH#?:
M?_;9+ 7(@80XW\'9G(.SWQGUK&?PQXANO#+Z??7&D/,MU'.(X+=XX9U5@SK*
M,DG><DD#KV-(#"O/B'K;Z)I,]M8P6]W>+OVM*"LC+=1P[5W ?*ZN6W=@0>@K
MMAXLL!X1/B5XYUM$B,CQX!D&#@C ."01CK4'@OPS)X<\-6VFWSPW,D$DC1E0
M66)6<L%4MS@>M.\::7+?^!]4TW3K3?-+"5BA0J@)SGN0!W/)%-B"Z\76]@)#
M>Z=J4 1X4W-!E6\UPBX8$@\L,@'/M72 YXKAM5\/RV6CB:QMKZYGNM4LKVY@
M:82-&$DC9@NX@  )T!_2N<.D:_!XC:ZTVVOH]4?5+PS7#\P36;*3&&;.#C"!
M1V(.1Z@SUDPQEE;8N4SM..1GKBH)]-LKJ3S)[2WE<C;NDB#''ISVKQ8K?6VA
M7K6M]XAMV72XGU5GEF$B7HECSM9N<L/,'R<8 ]J]6T5K+29?^$>CU"\N[R&+
M[0?MLK2S%'9L$N>HR"/;BBP$L%UH;I>-!)8%;1L77EE3Y13IOQTQCC/3%64L
MM.O;4$6UO+;SD38,:E7)_B([GWKS;4M(NX=1\6:]HT+SZE'<-9WEHK_+<P&"
M-Q@8X=?,!&.N&&#FD^VW1\4Z/;2>([O2@MK9_8[1;=I(KQ2K>8" <9^Z"3C:
M![T6 ]1:QMG61&@B*R@"0%!AP.F?6J%P^BZ-):K-]CM)+B<1VXV*ADE((PO^
MT1D5YW+'XMAE6&*_U.9(KB;1)G>0[BLGS078PN"561=S?[(]Z[SQ!X>MM=\,
M2:5?3R;=BE;GCS$=.0_3&X$9_.D!:MIM'&LW-K;?95U-462=(POF!3T+8YY]
MZT8X(H7=TC56D(+L!@L>F3ZUY=87EP_PHG\107,SWNI/'/J%Y <.$618Y"O/
M&V)"!CIR>M9]L+K5;S1=.;7-5&C7.JW<=A<P7SI+-;K#N7,@.6 D! )YP/S=
MA'J>GW]AK-M<-:,LL23202@H0-ZDJP(/7D?C2ZKJVFZ'8_;-3GCMK5&"^8X.
MU2>G;BO+_#GB+3M!\0W[ZW<7-O;BZU#[#(K2.DH65FF\Q /OJ "#SQGH1SVO
MBN_L]2^'TM[#_I%E=+ Z_NBWF(TB<;<9Y!Z8[TAFY-JVG0^6);F(>="]PG.0
M\:;=S#U W+^=01>)=(EM+"[BO8WM]0E$-K(F2)'.?E&!_LG\C7*Z'H6H:#XP
ML=-97N-'M;*Z%C<G):%7>+]P_&,+M^4]Q@=JB\+::ME\1=>T]89AI]AY=Q8Q
MO%^[ADF4F4HV/?ID]30!V6M:_IV@1VTFI3-"MS.MO$1&SY=N@.T''3J>*J7/
MBO2K;5SIDLLPG62*%V6)S'&\O^K5G P">,9]1ZBLOXDP7-QHNGK:VT]Q(NI0
M.5AC+E5!.20.@]ZHWMI?1ZWJ.FKI]W-_:&LV.HQ78CS$L<9@+AGZ*5^SM@=]
MR^M,"&SN/!LGA6Z\*Q7MT=*AAN%:69I%!6)@90DI&&VDCIGCIGFNAL_%^AC1
M9[B"6X\BQAB9EDB=9"CC]V0& +;N@]3Q7"VWA;6;G2&\,-926S62ZCMO)D'D
MSB5SY6"/[VXY'8+SU%:FE6DZVVI:CJ_AV]N+::SLK&73C LC.T8.]]A/S*I;
MC')P2!0!WMKJD-SI?]H/#/:1 ,S+=1F)D"DY)!Z#C/TYK*A\:Z1/IJWD<C!I
M8);FWMI,)-<1)GYD0G.#CC..O:LYO#U\?A;J>AQF19I+>ZCM$)^98RS^2A/K
MLV _C7-Q//J<6AZQIFC/>6L_A^;3W%OM!MIL#Y2&(Q@JR=>Y_% >CZ=K5KJ.
MDP:B#Y*20),Z2LH:(,N[#<X! /-/U#5K?3M%NM58-+;V\#3MY6"2JJ2<9(!X
M'K7E/_")ZM%>W#0Z#)M6TTR5K</'&L\D)7?$SD[2<9]1\O7G-=[X&T1=#\._
M8QILMBOFNPMYKD3L <<D@8&?09^IH CC\=VDUE'-#I>J-=2W3VL-BT2K-(Z*
M&8@%L!0#]XD#]*OV?BBVE6[.H6MSI'V0J)3J.R-3NS@JX8JPR".#5/Q/IVI#
M5]&US3+07\VGM*CV?FK&9$D4 LK-QN7:.#UR>165JT7B+5;[2-5;P\XAL+I]
M^FO>1,\Z/$5\SKY8*DG +'//([@'82:QIL6TR7]J@90Z[IE&Y3T(YY%']L:;
MY;2_;[7RED,;/YZX#CJI.>OM7DEUX"U/;(J^'$G4Z3=Q0AGA/D223R/"@RW!
M57&2/EST/%3ZGX=&FZO9S76C0QV5QJ&E+'"HCV-*%E1_ESU&5R3UQ3L!Z/I\
MN@:#I=I:VES96MD^?LJ^> KY.3L)//+=O6K$=_I$=W.D5W9+<.2TJK(H<E1@
MEAUR ._3%>8W'A/4X]+U"S3PEYZWBWGV62*:#=9[Y"T2X9@J  YRF3S[4VQ\
M(:N]_P#;I_#TD$TFN0SL[R0EQ;LCB;<RN<K\QR,Y.>AHL!Z9JOB/3M*T:759
M9Q+;)&9 8"'+J.I4 _-@<\55M/%^G7:6K-'=0"YNI+-?/A*A9D)!5CT&2I ]
M>G7BN>\&^'+6P\17B6[13:=HTDD&G!3N,!G"2RH3ZC@#'9L&M'X@1I=:5I^F
M1LJW=[J5N(!G!RL@=V'?Y54L?I2 ZN2YAB:-7D16D.$#, 6/7 ]:E$J$XW#=
MZ9KS3XG:%<ZV)8K?P[+?22:>4BNX63?%*)495^9@$7@EB.2.,BL^T\+71ODU
M6'P]+9:D?$'F^?A?,6W>(Y)8'E-Y(/YXH ](.N6P\1KH92?[2UJ;L/M^38&"
MD9SUR1QCO56;Q7I\-[JEHL=U//IB1O=+#;LY4.,KC ^8XYXSQ[\5Q?@71[C3
MO$VG/)X>O-/:'1#9WEQ*B[9IPZ,6W*QW9PQR>>>U/U.SO!XO\2S2KXEMK6X%
MJ;>;24R9"B?, <'O@<XZD=* /3(YDEC#H05(S5/5]7M=#TJYU*]+BVMDWR%%
M+-CV K@3HCCQ7#;"WG@L?$834KVV>7#VTL!5F''9G>(-@]0><&L*#2+A-)\1
M6]CHVK6R7VBR+)%/$[M)<I+("2^,,Y!!SW&.N*8'K&I:[8:3:075Y*Z1W$J0
MQ;(GD+N_W0%4$Y/TJ&UU/3?$-O?V<,Y=H6:VNHBK(\9(Z$, 1D=#C![5S_CB
M8V_AK2KIUFC6#4+.:9DB+F)%8%F( /  /45S5RFLQGQ1>Z<]Y-;O<6LTU^]M
MLFN+=1B6.(+MSL7D,H&<L,Y.:+ >GZ1IL6DZ/9Z;"[R1VL*Q(\A!9@HP"<=Z
MO8VJ !^%>(:CII%O;/:7_B0PQ:/?7%LTK30DLA#PC QTRV W) 7VKL]*\0:Q
M9>$++7-7-H^E)ID,LDF9/M3R^6N05VXY?/Z46$=?:ZG8W]U=V]M,DLUI((IU
M7_EFQ4'!_ U<V*.0 ..PKR'29+CPGXJT?[4R)'XMMW-V8BQ(N]Q<.,CY<^<%
MP/3VKE+*>\F\+0WLWB77%OI](U"Y93?2<S03#R^#R 06X& <46&>\VUS8B]E
MTV",)-"JS-&(2J@,3@@XVDYST-2-I-DUY;79MT$]J'$+ 8V;\;L >N!7GWAO
MQE%;RWVH:QJ4GV--)TR>3?EEADD!5B ,D98KG_ZU:?Q%G5(=.MY-6U#3DG:<
M"2TF,666)F4,5&3R. .OX46 [1K2!R[-#&QD(+DH#NQTSZX[4BV=LDOFK!$)
M,D[@@SD]>?>O.M4UB\N_@WINJC5KFVO)$M%>XA?8[L9%1P3CKRQXQR*HF^U&
MR^(']CWOB>]AELWC-C'<Q-(+VV:(^82L84.P8'YCTV].N2PF>D:I?:;I%B9]
M0:.*V\P?,4)&]FX. #SN/7UIE_+I&EQP->""W66Y6.(E,9F?.,8'#')Y^M>4
M:9XAN[7PYJ-Q'XIN;N2TO;*>2[6030RI)+M9<,H:,E>6C)&W:,'!(J74-;M-
M0NM-&HZ[.-;C\1Q!]*>7:L:+<80",#D!-K;N<^O-%AG?:-X(LM)N;>X>;[6]
MH2;1Y8(UDB!4K@NJAG^5B/F/.><GFM^:QLI[F*YN+6WDGAXBE>,%DZ?=)Y'/
MI7C>H>)]2?PWK-Y%XLFAU6*WD^V:?Y9#0.MP%RC8^0 -MXSG(YR.(]4FE;4M
M.M[W6;^\L[#7K)!-)<8(6:%),MCKM<<9Y 8T6%<]G.F6+>=FT@_?D-+^Z7]X
M0<@MQSSZUG:SJ?A[17:35IK.!KJ,JYE4%I$'7=QDJ,]^!GWK$\<ZG+:7VE6S
MZU)I%C<I<E[N-E3$J(K1J68$8^^<=]N/:L3PMJ,^M>+_  WJFH7.V]N?#TC.
MBX42XE7^'T/WN,<J.U(9WE^NB6.F))?0V45A;%/+\R-=D9) 7 Q@<D8QZU<B
MTRQ@O);R&SMX[F48DF2(!W^K#DUY+XSN[.V\3^,8KS41:R2:99O"DC\,!)RP
M!X)4@<?[1K1U?Q1?6WB"]TNYUT66GIJ2PF^*+NA#VPD1"<8'SY'(R0,&G8#T
M2\M=+@MKVXO8K1()4S=R3(H5U48_>$\$ >M9.G6_@W7--?3--BT.^L8'#O;6
MRQ21QL<X)5<@$X;GZU0GFAUCX9/-J^KP-%-"1)J,,)$9^? <(>W"G_ZU<MKE
MU=R//8ZI=V]M?PW6FM<:GICF,3VSS%5$F22I7+-R2#QVXI >CS>&-"N9DGN-
M%TZ26-51)'M4+*J_= .. .P[4R;PKH-U;3V\VD64D%Q/]IE1H%(DE_OGU;WK
MS_5?$FI'7;BUM_$0N;.[.I6,D+0I";62*+<FS^)F!X+'@YX'2HD\2ZCIGA_1
M;>UUZPL(8M#@O$FOTWK.0<21DJ,_*NWA?FRW?L[";/1;KPIH-Y-!-<Z-I\LE
MN%6%WMD+1A>@4XR .P%-\11>&W@@E\1II9BC<B)M0\O:&(Z OQDBL3Q7KFHV
M^O>&-'L;]+*/6#.);KR@SJ40,@4/D<DXP0>M8]CJC^(=6\#7^H>29;A=1B=4
MCS'-M&,@'. 0F[_/(D,[73=,T"RO(I-.M;&&X-L(X_("J3"#D  ?PY/TK2EL
M[>:YAN)(4:: L8G9<E,C!P>V1Q7(ZQ9QK\1M&NT1%EATJ\,!8[5WJ8U /MAV
M_P BLB#Q+XEEM;2V:[M;?5VOXK2[@GLBQMP\;,"-LN'4E200>1Z$4 =W9Z%I
MNGWT][:V4$-Q.,22(F"W))_,G)]33]2M+"Z%O]NCB=8KB.2'S/X90V4(]\]/
MK7#VOBS78[Q_/NM.OX0+V-EMK62$)-;@' +.21DD'Z<47=QJ]]X8AN]7^PW$
M8U+3+FRGMQMW*T\);*Y.,%F&<\CFBP'9R^']*FLK^S:RA^SZ@S/=(%P)68 ,
MQQW( Y]JSXO!7A^PA?R[5XX_,BF;==2D;HN4)RW; _*E\2:Q?:-=Z0T;VJ6-
MU<&UN))D9C&[*?*(P0,%P%.?[PZ5RM[XCU#6?"6I3WUCITMK96Y34(+F*5!]
MI5P=N#_ $PQY/WAUYP@.[TW2;'26NWLH_*-[<-=3_,6WRL ">2<=!P/2M05Y
M-?7^HZG?W44\HF2R\4VL5LA7"1@ #'')'()]R?45WOAO5;G5;*X-W'"ES;7<
MMM)Y))1BC8R,\],?CF@#<HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"<
M FEII^Z<XZ=Z ..G\97]MJ.I6T^AE(H+2ZN;247*L;@0%0V0/N9+C&3GU JU
MX:\2W>LW5Y9:GI#:;?6L<4QC$XF1DD#;2& '/RL",=N]0CP#HAOKBZW7^^<W
M&Y!>RA,3\R*%#8 ).?K@]A6EI_AVSTW6+K4H)+DR7-O%;M&\I9 L8(7 /3J>
M_<GN:8C+_P"$W2"YU"/4],NK&.U@>X1G97:9$?82%4G!W%< ]<UGZ9XNO8O%
M/B2UU+SF@AN;6'3[8H@E,DL1<Q@@X/ #<G@$\U93X:Z;$)8([[4#8O;W%NMG
M)*'C1)F#-C(W9##<"23GO5>+X<S(EU+)XEU"74I[F&ZCO61,Q21(8PP3&TY1
MBISG/%%T%ANA^.RD!BU:+4)KN:^NXH(H;3S'2.)P"K"/(RH8 D9K37XC^%7X
M.ILI,0F0-;R@R(7V!D&WYP6X&,YINB^"WTK4+2]FU::[FA>ZDD+0JGG-.5+$
M[>!@KGCUJI9^$-:L-,;24U>TNM*1&ABLKFQR)(V?.V1]V3A<J" .,$@XHT V
M8_&OAYFM4.H&-[IML23021MG?LY#*"OS<?-C)K2O=9TK3I88K_4+2V>8XB6>
M94+GVR>>H_.N*'@_Q%!#IPM[ZV-W:SDK>R2R&2& R[O)Y!\Y-F!ABO(%6/'6
MC^(-6\Z'3K.WN;2?3+BU(+(DB2OC:P9AG;@'(!'7VH:0)W.MM-7T[4;J\M+2
M[CFGLG"7"(>8V(R ?\]JSH?%.G2W\UC(EU;SQH\J"XMGC$R(<,T>1\V/;GD'
M'-9GA?2]1L?&'B:ZNK!H+:_>WEMVWJR';'M<<'(.[/4=ZHMJZ2^,WU#4='UJ
M+[#'-!9YL&:)5ZR3;P#RX"@#L%'J:$,Z;1?%&D^()+F"SEE$]N1YL%Q \,B@
M]#M< X/K4]M=Z3>:W=I;M#)J=DJPW&%/F1JWS*I..AZ^G%<GX-UJPUWQ3J>I
M+)<_;+F"-4MY;*2+[+!&2 I=A@LS.6P#^>*P]7N=0TGQUJWB#1HS<R0ZBEC?
M6P./,BDMH!$>_P!V4-T&?F/;- 'I-CJ6EWUY?6]C/%)/;R!;H1K]U\8PQQ@G
M Q[8I_\ :&E_VS'IQG@_M$0&=(3]\1YVEA[9&/PKRRU?2]$TW5=-DUJYTR >
M(VA>6WF*'+6RG#N3N5<JQR#GY1VKLO"&I6]]X*TOQ-J-W;W%S'IY\^^VA=B\
M-("1Z%!GW7I2 ZF.YMI;F>".5&FAP)4!R4R,C(]QS5G(/%>0Z%>W6G>,M&\0
MW<?V>T\5VY20K<%E,S,TD&5/0^5M08]3TQDY=MK%_%HFK:O/XIO28K:]6[,%
MPLIBF%RJQ&.$G*?)P>!C<#G/0 ]AGO\ 3=->UM9Y$@-U)Y4"%2 [G)VCC&>M
M$NJ:9!JEMIDDR+>S(TD$.TY91U(XQ7E^EWT-PMG:_P!N-J,=GXIA^SRRW/G,
M\;P J-Q))Y9C]0<=*ZGQ2TH^('A6*VNHK>Y>WOQ&TD9D&=L1Y4$9X![B@#IM
M.U73M8CN&L9UF6WG>VF^4C9(OWE.1U&14A:RTC2F(18+*SA^ZB'$<:+T"@=@
M.@KQ&^OK>W@OXKG6+FT\SQ%J*2M:RF")F6(</SG[VW !_BZ\5>BUZ"[N-/GN
M?$7]HS3Z7'"+>&Y9'MY/LKLS/&IVRJS9).,JVT=!3L![#INHV>JZ?#?V,HEM
M9T#QOM*Y7Z$ C\:@NM8LK/6+#2Y3(MU?B0V^(R5;8-S#=T!QSSUKQ.QU;3],
M\.V@N-5OH;:ZTBU>46=PPP1=,C,#R%&"0Q&.!QS6I;ZBUYIFBC2KZ:ZN$GUJ
M"P?S"[OB.0Q ,W/W=A!/MFE8#VLE#P<?C1E3_P#JKP/5KRRO/"VHW&@W5]/;
M0V-BMVL4DOR7'GA7SGG>4W;@/0$]:Z2#3+?3]8LY+2TNHC#XH> ,%E(6%HCD
M9Z;"Q'MUH [;6O%MAH=[]CEM[ZYN!!]HE6SMS(8HL[0[8[$@],GY3Z5K6NHV
M5Y))';W,4DL85I8U;+QAAN7<O5<CD9K@_B&I^U+-:1ZQ9ZO;6OFV.H6%N\J3
M/EO]'?:",$@'#8'/7K61K>FWE[9:U)?>'9GU'4(M-G<0VID&Y603(&&>F",9
MS@4P/7=Z A=PR>W<U1N+W2]*M9)[B:WM8%D^=V(0;V/?W)/UKS$^$9+?QI?1
MG1]4C'G*VD75HRBVB01,-K'.8T!;)48W%1U[YMEX9E'@F]3_ (1K6$U.**T6
MX@FCC\N=DG#,R8YD8J6R3_#QD460'MQV[25&<#H.]<EH/Q"TG7Y--CMK>_@_
MM)93:/<1!5E\O[X!#'D#UK4T+Q%;ZU=ZC:0VEW;3:=(L4T=Q$$^\NY2N">",
M'\17FO@[1M9\-6^AWSZ#>7"1O+9202G]]:J[[A.BDX&1D-C&<"D!ZA9ZNMQ
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M70N?[&L/M 8,)?LR;@0, YQGIQ]*;+X9T.:.SBDTFQ,=D2;9# N(2>NT8XZ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT*W>EW%O"UJL<CB*0>9L7/4)D=>AZF@#U&**W@DED1$1YF!D8  NP  R>YP
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MMY;MN9"RL"RDDG:21S6K>>'["^T>'2Y5E%M 8C$4D8/&8R"A#]<@J.<UL44
M8">%--BODNX?M"2KJ#ZB<2DAIFC,39SVVGH*70_"]EX?>8V<ETR-E8XYIBR0
M)DG9&/X5R?Y>E;U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH;Q]?TY+6=F6*9KA0KE>H!)ZC(JQ%XDT.;39-2BUC3WL(VVO<K<H8T/'!;.
M>1Q[BO.M:U6SG\.^'!#<V%Q>)X@LX=0FM@!$]R$#2$$#YN2,D>I],5AI<1_V
M#\01JC_9O$$DBO=6Q 2-(PP$93'#=?O<$Y&>M%AGKEMXO\-WB3/;>(-,E6%#
M)*4NT.Q!U8\\#WZ5)8>*- U6Y^S:=K>FW<^,^7;W22-CUP#7E^B:AIC>#+J*
M_O\ 2;C5SH3I9+:C,D=H+96*.1G!WAB0>^<5'::?X@N?A5>7:K9SJMA"-*^Q
M1'SHH]Y\\9QNW,@'0X..!ZE@/5[+Q)H>I736MCK.GW5POWHH+E'8?@#FHH_%
MGAV:\%G%K^EO=&3RQ"MY&7+YQMVYSG/:O*9[C3;NU^&5MI4MM)?PO!N2WP71
M1Y?FYQR!D,3G'0UC75Q&6\3I/Y0T5O$:_P!I74+[IH8_-<J0 .!GC(Y&1@4@
M/<-1\4Z#I,SPZAK-A;31@,\4DZAU!Z$KG('(YK2AN(KJV2XMY4EBD4/'(C95
M@1D$$=17C^MZLDWQ'DN+'Q)I-E;2:=;2RS73*4G@\P,R@D]UYQW![5Z!X?\
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M.\SHSD,I)7:@)P0/G'2MDZGJMOXA;39]6-XEIKMK$DLT$6\I+ 7*9"@#!/!
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MU5E/V&*PDCFMHY8Y(DR2&4_WBW-;N@Z3'H6AVFFQ2M(ENFP,PQZG@=@,X [
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M)8X;:&.-6W*J1@ 'U '>G_9X3&8S&FPG)7:,$YSG%344 )@>E+110 8HHHH
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M0VC.EQ()5VPE/OASGY<=\]*\ZM?'NL7<EO$%B2\UBTLI=*B,#;-[$BXRW<(
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M>;S;R.=W]XDHJKNS@-@4R;6O%C:S+I=IJFFSWFGV\4LB%%1;O=*P9B2<HH0
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MY5PCSRW,LK)<N"S3H%E[]" O'08%-6 X_7-4DO[#Q3JEE=7L,5UH%C?VX$S
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M6/AJ)[>TU2VU)O#=VDC.DF_SDF A7D??"E]HZ@'@=* .YC^'-I  +7Q%XF@
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MJMMYD5N^^("5H]ORX(RI!QC@CH:;/X2T*Z<2/IL.1-#.-F5&^)=L9P"!\HX
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MM(I!1G/(:/CGGVSPLWB3Q-97$UQ)<6-U9:=JD&F7B+;-')*'6(-*GS'#;I0
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M6YK"]B6.)I'M?+#S<9X 4D'.."#@@@YQ6.GQ$TPV)D%CJ37:W9M'L(XE>=)
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MHH **** "BBB@ HHHH **** "BBB@ IK'"DGTIU% 'F2^,_$K7<$:C1BL_\
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M/W;>:RDJ0 V.@.<\]ZIW'^DWLL+ZO,UPGBU/+6219#  A("*P.T8)'3H/K2
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MRV]V\BO<,N)+:1DD51@]<+CW)]*?'\2+^2;2)SI4"V.HSVENH^T;I0TX/S@
M<*K*Z\@%MI(I@=9;>%=&L];EU:WL]E[([2,RS/MWL,,P3.T,1U(&?SJ3_A'-
M/_MW^V"D[7>[< UQ(8PVS9O$9;:&VY&0,X)]:XQ/B+K?EL&T*W\Z2PFO;98[
MDMN,3E2C J.2JDC'I75Z+XC?6]2DBAAC-DEI;SBX63=EY06V8QCA0#G/\0I
M4H/AUX?AL[NU,=Y-%=6ZV\BSWDLF$0Y0#+<;#RN.F>*LR>"M(GMX;=DN#'';
MW%O\T[,768 2%F))+''4\\FNGHH P+OPM:7?A./PZ)KF*VACBCAE23]['Y9!
M1@WJ"H_*LX^!;8:I+?QW]XCR:C%J$B%E*LZ*RA>G"G=D]Z["B@#AK7X=QQ3Z
M=-<:O=W3VDEY)+YBH//^TC]X#@?+SSQZFKOAGP?)X=G::;7]5U-O+\E$N9R8
MT3Y<83IN&/O=<$UUE% 'G[_#J\CU&ZN[#Q->6GG7EQ>*HA1O+>92K8)YXSD5
M._@"0Z1]@75F0C2[.Q258!E)+9R\<N,\_,?N]*[FB@#DO#'A74M!LM62ZUTW
MU[J,[7#7/V58MDA4+D*"1V''M6*?AM>O;3S/K4<6K-+#<0WMI:>2J31[LRM'
MO*LSAR&/&<#BO1Z*=P.-TKPEJ=CXFLM9O-=-\\.G-93![8(9&:0R%P0< 9P-
MN. HYI8O!7V9O%,L%U^^UQ65-Z?+!E&'3//S.Q.,9X],UV-%%P.(MO".MV>O
MM=6^O1II=R8I+VR-JK&9TB6-L,3\H8(N?I5.Q\&>*+#2SIR^*(+BV@6**TCG
ML%*^4K#Y),'YOE7;G@\GUKT.BBX'(P^$KFW\"W?A^#4/L\\XF*3VZ%%@+L6V
MHN20@SM STK!F\ Z_</J:W-]HUU!J,IFECELG!5]NU65@^05ZC'YBO3**+@<
M;K7A/4M1T/P];1:C$U]H]U;W1GGC)$[1H5.0#QG<36?;^!=2'F"ZNK5UGUBZ
MU"0)N_=I-;/#L7(Y(+Y[5Z%11<#D?!VAZOHMJEMJB:2RV]O':PSV:,)9$3(!
MD)]L<#/.3FG>'?#TMM>:O<:G96K/+JLM[9OD2,JLJJ""1\I^4]/6NLHI >,W
MOAGQE/I-U'>:6DMZ^G3VGFVES&%8M.)%"HQ7:FU<8ZUT6NZ-JHUK5)K'1WFM
MKOPZ;)#%)&H68-(0I4D==PY'%>B8I-H]*=P/-;/PQ<CQ/'-J&@-=V\J6<T<I
MNPJ6KQ1E2'3=EB"21@,/F[5I>$-+UFPUW47ELI++1Y4S';W4J2R1R[R2(F0G
M$."2%;!!/ '-=QM'I1@4@/(-;\*^(KG0O$%II^G744%\K!+&>YAD593.C;H&
MS\L97>65L?-C K2N=)U6WUC473PU]HLKG49'##R6D2-K9$W1;G&TEUY/7':O
M3=HHVCTIW \>C\/Z\(BKZ5.A3P0=- +(<W.2 @P3R< CZUZ3X6M6L?">CVCH
MZ/!8P1,K_>!6-00??BMC:/2@ #I2 6BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *3'-+10 57-I;F?SC!'YPZ2;1N'X]:L44 '04444 -50
MJX'3^5&P8QVIU% #/+'J<>E'EKNW8^;U[T^B@"M]AM?/2?[/%YJ<+)L&X?0T
MDEC:3(J26T3HK;PK(" WK]:M44 0"U@&<1("6WD[1RW][Z^].CACB7;&BH"<
MX4 <^M2T4 1&&,N'VC>,X;'(SUP:;]FAQCRUQDG&!U/7\ZGHH A6")""J*I
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MB0Z:HPL#$L!\V[@DYZ\YSQ52+P/X>ACB2/3]HBNEO5_>N3YZC"ODG)(KI**
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44PRH'"$_,1D"GT
M%%%% !1110!P6E:SXKB\<1Z3KJZ;]FN[:6:!+(,7AVL,;R?8^F,D5WM<#:>%
M_%<'BB\UJ;6=,N))+=H(@UD044;BB9SG9N(9L')(Z]JZ[25U*/2[==7DMY+\
M+B9K8$1DY_A!YZ4 :%%%% !1110!S-[XZT'3]4GTV6YG>ZMU#3I;VDL_D@]W
M**0OXUMZ?J%KJEA!?64RS6LZ!XY%Z,I[UYKHNL6W@OQ%XHAUNPO5N+R^>[@N
MH;5YEN(6Y2,%1U&6X/<FJ/B+4==L=0N4TE+ZR6!;%](L88BD;!R1*LB+P>1@
M@]!R,=:=A7/8ZS=7UO3]#BAFU&X$"33+!&Q4G+MT' /I7FBZYJB>)A,VI:N%
M/B*:S,+Q_N!;(G/&/4C![XK+@\4ZU9:=(9-;O;YA?6C-?6\1=6A=G++Y;)^[
M<!>5 (&%Z9Y+!<]<OM?TW3=3LM/N[GR[J^.VW3RV(<_4# Z]S6K7BDVL76H^
M+=*AN;F[EU"V\072"!T984C'$9SC&!\N#W#-5-?$^L3^#-8OQKVKKJ,5M$+J
MU>U9#!,;@#=&_8%21M Z<YHL%SW>J&H:M8Z5:S7-[<QPQ01F61F/W4!QG'7&
M:\A\1ZE?:-9VMJ_B;7FNWTU]21I)511)\N%RJ@N!\WR'@=3V 2_UBYB\6>(=
M0>_=+O\ X1=9K82 ,BDJC,%5AM^]S@Y^\:+!<]EM+N"_LH+RUD66WG0212+T
M92,@CZBK->)MXXUR*SLKN/5%C\J'2U6U6V0)=-<(QESQURIQM("X[YK8L_%F
MN2>(U5M3AEM&\0S:4;7[,!MC4$@[\YW8P/SHL%SU2BN"\>>(M:T:11I-S8QK
M'937<B2QF21]A4= 0 OS=<YS]#61JGQ UZUN-3D@@T\V=A#8S,LB.9'$Y4,
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M;3W08I;R)%Y<+')#'()"@DX)Z=NE5M7^)$$^B?;O#DL<DD-Y!%<)>6\B$1R
MD$#Y3R!D'IUIV ]%HKG/#VM7.HG7#?"%%T_49;5#&#S&J(P+9)Y^;G'%0:7\
M1/">LK<-8ZU XMXO.F,@:+8F<;CO XR1^=(#JJ*YZR\8^'[^"WFM]4@9;FX^
MS0AB49Y<9V[6P<X(/3D$'N*FN_%&CV>E:AJ3WB/;:?(T5R8OG*2# *8'\66
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M0 M%9=OK5I=:Q=Z5'YPNK54>3?$RJ0PR-K$8/OCI6I0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !2'.#CKVI:* /&!-J\NH:!>KJ$<FJ[-96*XN8@P41R !<
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M8KF/#MAJ,7P[UK2(=.FL-4C-Y%&SJ(Q*[EV1T8=1AU /;'M7%:39>7ILR_\
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MAD78K29!8G 4'YAG:,YJMJ/AVYF\:)JT1WV=WI[:;>P[]I5<EED7U()*_P#
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MXJ/_ (5[:-;^&XY+J0MHB+%N0;/M"+M(5P#R-R*<'/?UIG_"R+!8=SZ3K*W
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT-N8VS*6?HO Z$<X]ZW-%\+P6GC^]LT@B6PLY/[7MU5CE)[A3$01Z#RI2/\
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M-G'R;@VWHH^E7(Y8+[PA867GWAM(_$L=M&3]HMSY#R<+EB&V[),<GT'45Z3
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MJJ ((0JOY@ 0##?WA[]>: /&KW5;BXT?1HY?%L^F"WTY[BVO6D9C--',%(8
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M(N<]3DDGN223FM.O)_AMJT\_B6>U;4I9X9M+BNOLTEP\K1/NVL'+?\M.FXC
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MQSHFKVFCO:)"R216D+*+ER1\TBD[>V< =3UXKI8?"/A^!HS%H]FGESK<IMC
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MXZ9/)]J;I7@35=,EM89K'0]0C,-F)+BZ!=K:2"-8BT:E/FRHR.5P2<^_IU%
M'*>(/#LNM>*M"NIK2TN=-M([I+J.XPV[S%0+A2"#RO?%<YXK\*^(M1UE1I]I
M:2Z9&]K);PFY$"1>6Q+@H$.[/&#G@9QU->G44 >=CP]KL6A:7&ME;M=6FN27
MLD*7 "M$TLK##$#IYB\8_A]>*QHO!NN66;N315OLZC?2-9K?")FCG,;*P<$#
MCRRI![-7KM% 'F^GZ%K>D^(K>XTS1_L=E'%FYM4NHWMIF%OM7R]PWQN'"H2
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M&68G  ]2>U)#/'/$DL4B21NH961LA@>A![BO*HM9NM4\0WUY>2HR'PJ+AK,
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M1I;9KI-6L3;+(8FE%RA4/C.W.<9Z\=>*E37-*D9534K-BPRH$ZDD8SQSZ<T
M:5%9<NIO]NL8K>U^T6MRKL]TDJ[(P "..K;L]O2M$2*<D$$#J0: 'T54>^MH
M[F&U>:)9IPQBC+C=)MQNP.^,C/UJSNXS0 ZBL&;Q3I\.OZ9I +O-J1F$$D8#
M1[H<^8I;L1@C'K6@=0C&J#3O)N/,,/G>9Y3>7C=MQOQC=WQUQS0!>HHJA:ZK
M8WMY=6EM=0RW%H5%Q&C@M$6S@-Z9P?RH OT49HH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW;FYYS")5WC'7Y<YXK(M/$\5[XRN="ABC=8+47'VB.<-D[MI0J!P1GN?PIW
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MD<W1FV,9$+*"?W@8'.,D$CC%5;?X<ZI'X9FT5[70]\$86SOHVD$K[9ED"O\
M+\H)4[BIZXP* .UD\9^&XH$GFUBSB21WC4RRA#O7&Y<'!R,CCW'K5FT\3Z!?
MQR/::UI\ZQ1^;)Y=RC>6G]YL'@>YKFHM%U9;O1YWT&R@*:C)?7@M[OS.3;M"
M"2X!=B7#$]@@ZFL:X\&ZU<^&+'2UT^))TT$V4Q,R!#()8CL)&3A@C<@8Y[4
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MD@5;HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.7NB>*+V1(H1I)L+:UMF$Q:3]R"HW CT/7)JZOC;1#<:A"UTZ-I]PMM<%XF
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M)(EPQ"NCC#*P'WAT.#T/-9:^!+&&UTBUM;JX@BTNUGMH@ I+^:@4NW')ZGC
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M+O48YA(@\I(G5=I//W6Y 'UZ5Z]BJMY96U_:2VEY;Q3V\J[)(I%#*P]"#UH
MXWX?:>4-_<,\4L%I(VF:=)&,YM8F)4[OXCEMI/3]V/QYBT\/:D/%.IM%I%Q:
MZG+K=S<PZJ(@J?96A957S.I!8_=]3GL*];M+2"RM8[:UAC@@B4*D<:A54#L
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MARRE@EM=$T^"2W<R1-%;JI1BNTD8'4BMRB@#F;[P%X6U.PM[*ZT6W>"W4I"
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M2;+Y]D$ID0Y#CYB6.XD').>*]"  Z4M '$^)_!=[K[:PMOJ45K%JEC!:R>9
M964QR.V0=PX*N1CUP<\8,MKX=U[3=3N_L6I68TZ\D:XD2>W9Y(Y2@4A/FQL)
M ///4=\UV-% '&>%?"VH: =:D>6U'VYA)!9VV]8(&"8.T'[H9CD@#C K$LO
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,CP+!(D7EO&R@D@A75@K#)Y'K0!YQ=FZC7Q1=Z'K>I7TUA:VGV?9J,TZ;94
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MSF<?/NRNX9 S@$5Z\IRH-(!:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M\\@CTKHM6L-9_L.TM='>Q::$HL\=U'MAGB"D,F #MSQT'&,56MO'FEW%]<Q
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M\(7FNW>G7;Z[&B.EY+':L(#"TL"G"R,A)P6Y...*Z:@84444 %%%% !1110
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MOQ8FY^V L7:(RH=FWN!SSQ[XJSX;\27=WX/FU[6HHH$B-Q(PA8OMBC=^V!R
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M[&,QVQ920N 0V..N"!ZUO^'/'6F^)K_[-96]VJO ;B&:1%V2QAMA(P25Y[,
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M@MW_ +-T;4$TXS^>H0QDE9V*XY^9T&>WE_6O4)#I^DV=S<LL%K;H&GG<*%
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MR1P71V*)62/>Q52=VW' ;&W(QFLL?#W4(](U#2U\37!L98F@L('MP4LXRZL
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MYLI-7%]>P+.80%N%M@HP5+ *6)Y.> ,@46%<[L^$]!_M1M2&E6BWQF%P9Q&
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M?P-("Y1110 A.!F@'(S2T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444UB0
MI(ZXH YF#P)H-M'J<<%M*BZA$\,H$S'8CY++'D_("22<=Z35? ^DZM'I:SM=
MH=.011O%-M:2/ !CD/\ $IVC([UAP?$>XBAU*74],CC:"*.:WCM;@3%P\S0A
M&8?*&#J <$@9/<5HS>+]5@6"U;PQ<-J\AE/V83H(W2/;O=).X.Y=H(!)/.,9
MIV8B23X?:/-KR:P9;X2I</<K")R(@SIL<!,=&ZGN3WQQ56Q^&&CZ>+8Q7FJ2
M26]U!/')-<!R$B.8X>1@1CT S[TZ]\?O9S3L=$NA961@&H322HK6QE564;,G
M=C>N[!&.<9Q4D?CU'#[]$U%1]N;3XFS"1-.)-FQ?WF>@9B2  %/I1J ^Q\'R
MZ;XDAU*UU>^6W:YNKFZM&D'ERO-T!4 #Y3T)R>!ZU/JGA.75=66ZDU>Z6U6>
M.Y6U"(566,85E)&0,@$CN16!HGBF[TRPUN>^@U*_CAU2[ 9I(SY$42KE2Q91
MV; 'O6N?B%IXGP+'43;[[=6NO*41IYX4QD_-NP=PSQQ18+F;/\+[>XT6UTS^
MT[A(K>Q^Q*PA7D>:DNXCH>4 (Z'DU?M_!=U#DSZR9V;4X]2=C:*N610I48(Q
MD*O/;%2+\1='\BZO&BOTTZW\P&_-JQ@8HVUL,,GKP,@9[5H>'_%FF^)DN3I[
ML9+5E6:)\;DW#*GY20<CT/J#@@BC494TOP@UCX3U'P_<:B\\5X9P)4B$;1K*
M#D 9/0EB#[UD+\.#/I36EYJI>ZCL(;&TN(K?9]G6)MZ,06.YL[<\@';6I_PL
M31?L%K>M]I2&YMKFYC+18.V#/F C/WACI5"Y\=V]F9+I'N[K[3?65K'9M:&-
MK?SD5CVRQ*[FY[X6BPKFWIVC:Q9Z9?I<Z^]YJ-R#Y=P]LJQP';@;8P>F>2,\
MGTKGSX!OU>*]@O=/M[Z/4EU!42T86R'RC&P"[\_-PQYZ_F7^%O&TEWK^KZ7J
MLY\P:M/:6++ 0FU.B%P-N[ )P3DXK0\1^+FTV_N](M;>;[='IDM\EPT#/"I7
M.T-C'7!YR #@=2*-1F.W@;65L(;>'4[29SI]SITK/"T86.>3<9%&6R0% "G\
MQ4VL^ [R]>_%G=PQ17!T\1A]V52V+$@D=SD?E6MI/C32;G1UGGU"(W<$,)NH
MDC;>'< @*F-S;B>-H.>V:TD\2:5-H<^LP7D<MA CO)*@+;0HRP(Z@CN.OM1J
M(YS_ (0_5?/5WGM9%'B-M5ZL,0>64"=/O\_2LG3?A[K%OH^EZ9<2V:PV<6H6
MDCQ2N7,-S@AUROWP<C&<=#GM6M;Z_P",YVTS4%T:PDTF_N$!C1V$]M;N1MD8
MDX)P<D #;C'/4;<7C+P]*)W76;'9 GF2,TH4*F[;NR>JY.-PXR<4:@<M%X/\
M01^&[>R:WT876F26CVKP%U-WY##_ %IVC;E5 &,X.><&MSP1HVIZ1#K3ZG;0
M03:CJDM\L<,WFA0ZJ,%MH[J>W>KT7C;PS/.((?$&F/,SB-4%TF68@8 YYZCI
M3SXQ\-JSJWB#208\[Q]LC^7'7/S<8H"YP^E^&/$>CZ? ATQ+J5](DTN5$N$'
MEL'=DDRV 5;=T'(QT/;HK_2-5TWP5I&FZ=%]KN;'[/'(8]JN40 ,8RYPIP.O
M4 G'-=!)KVE0I:O)JEBB77_'NSW"J)AQ]SGYNHZ>M*-<TMI)T&IV9:WW></M
M"YBVG!W#/&.^:-1G">"_#NK6.MVTE_H4EE:6]K=Q(99XIA^\N1-&!M8G(4D9
MQU'O5&'PKK,^A6]K)HLL%QI^E7MLTC/#_I4DJX54VL>.Y+;1T'KCT%M9EFU'
M2H]/MX+S3[SS3+>QW28B"+\NU>KY;CCICFDUCQ'::7H\VI1D7D<,T<4BP2*2
MI=U3GG'&[.* /-/$OAG7[K2-=LX-#N97O;#3FB96B(5X'#2(?F^]@G&,YQBK
MVN61C\5K!9^&9K>.*_T^XCGLM/&R0>8N]Y) /X1N&T8Q@L<@\>J/*L4;22,J
M(HR6)P /4U1T;6;'Q!I$&IZ?-YUI/G8^TKG!*G@\]011=@>5>&;*>&ZTN Z5
M>VM[!K%XIGDLW50&MY54[L8VY*\].E9$VFM)IEP+;2KN"6P\/36>K9@=/-N\
M$)GC]Z2X+[AD8Y)YKVJ'6+:?7[K1\,+BWMXYV+#AE<L./ILY^HHAU:"2[N;=
MA+#Y$RP[IT,:R,P!&PM][J!QW_#(Q7..\ V=KI_C+QG9Z?;&VL$EM&@C$91!
MF([MH_W@<UQC6MEJ.OZ9;2I-+97&IZR'4LZ@H%W1AO49 P#Q7NP X-5;N]M[
M1)&DD&8XS*R*"S[1U(49)_ &D,X.6\CD^!]O<WTFY18P+*T_\1#*IW9Z\CO4
M":=?>&O%\6EVL8?3_L]Y>:4<?ZN0J-T&/[H)W#V..U>C6TL5U;13Q$F*5 Z%
ME(R",C@\CZ&K!520>,CH: /"]#$:^'K_ %#3?%%U>FVMK74YX;=I1Y9C8M*K
MLTC?.Z[\H,#(!P!BNI\%-JTWBJ[MKN\O&MU>358A)-NS#< "&-@>1MVR<= 1
MP3787>H^'M+NVL;N[TVTEN%,C0RR(C2J<@L5/4<'GZUJP+"P6XB"'>HPZ8^9
M>HY[CDX^M '#_$'3F@NM*\0V%VUGJ<4ZV(D R)(ICL*L.^"=PST(SBDOM(2"
M^T?P;IU_>Z/IZV,MS'/9.L<CO&\8 +$'(^=F8<9)';(KK+J32M1O'TFX-K<W
M$2I.UM*JN5!)"O@^X/-/U#1-+U=$35-/M;U$)*+<PK(%)ZXR.* /*EU+Q#XC
M\.:Y+<:T\=M!H$<\ENEO$5G:2&7=R1N4$IG@]ZZ[X>:Q/K-A<237;_Z-LMOL
M#P!&M]J#!)ZL7!#9Z<X'0UTO]AZ4%N5%A:JMS$()\1*/,C *A&XY4 D 5"FF
M:)HMZ^H)#:V=Q<*ENTI(3>%&$7WP  /I3$<SX6TVPUFV\7?;XUG>YUBZM[AI
M%&[8H"H,XZ!,$=N<U&OB;5[:\EDADMFTBSU>'21"8RTK*RQKYIDW8^](#C;T
M^N1T>H^%="O;J6_N[<I(X'GM'</$DH''[Q58*_''S \<=*>WA/1SK']I"V<3
MF02LBS.(GD PKM'G86  PV,C ]!2&<HGC+78K6(3_P!GM<-;ZH=PA<*9+64(
MIQN)P1NR,_0]JS)?&'BBY+Z=/<:;;W?G:;+%/;6[E=DTJAE8%\G!*YY&1N'&
M01VC^!=!:ZN+HPW1EG$X8_;9MJ><<R;5W87<23P.IJ*;X?:'.LXS>1M+#! )
M([E@T8A*F,J>H8%5.?44] *=GXHUO^VGT2\BT[^T$OU7$6\!K/86,H4G.<J5
M]-Q YZGH/$UK>:AX8U*STZ98[V>V>.%RY7:Q&,Y'(_"L32=/U74-7U'5=7TY
M+"5;4Z?:>7<[I7CW%BY<#Y<G;@=1@D]JO:=X?N6\'1Z-JM_<RW#(?,N5FW2J
M2Y88<CDKP-Q'.WI2 \^TK5VT?2]1;PVEQ:7RW5E:7&E:M-(Z6DCN5+(S,3L8
MN!G@84GGI75:IX[O]-U5M.ET>-9IHK@VC?:@VYXHO,.]=H*H>@.<GT&:M7/@
M."_2Z-[K6HSW,RP(MPRPAHEBD\Q0 $VDEN26!S5;_A7$+:DM[)K6H2L)9Y2K
MK%\S31"-]Q"#/ X[#C X%/0",?$46D.E1WMB9+F>UMIKO[.W$)F.U=J\[N02
M1D8&.M;NO>)_[(O;.QM[">_O;J.698H64;4C +$DGW  [FLV/P1<6\UE-::]
M>6\D=O%:7;1QJ/M,4;908_@8 E=P[$_6M'7?#UU?:O8:OI>HK8:A:I)#ODM_
M.26-\$JR[E/!4$8([T: <S+K-[XL\8Z1::=>WUCI<NDKJL<MOL4N_F ;9,YW
M  [2GJV>PJ_?>*[C0/'WV"_D:32+N*W$<NQ1]EGD:150D<[&\ICDYP<<X-3Z
M'X*;0?$&G7MK>J]G9Z0-,\EX_G;#[S)N!QDD#(Q5V]\._P!JZYJ+:C#:W&E7
MMC#;-"P)<.CR-GT'^L/(YR!2 R1X\M]!TJT&O///>2/<EVM[?.R.*8H790>
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MVY()P:]D#@]*4N!VHU \Q^P1W.HZ)>:?X6O+*V4ZA(\4D8B;YX@.=I(3>W
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MU27P?X?%M';C2;58(G:2.-4P$9L;B .F<<BD!YXFOZDDXUR+9)J4_AC3@9)
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M;F_Q!'$8G=#(Y38,=U*@'%>=VNC:?#=_8K9+RUL+NZTF58K=9X0K,LB2X?\
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M^&=.U6_-W=0EI6M)+,G=UC?&0?7H<>F3ZU1A\(K;:QIE]!?W"PZ;IWV"WMV
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M+JW:.9KV3S#NF52&<MEAM=A@DCIZ"J'A:^/_  G=_:RZG+J+3+<SV\MO?M-
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MFS-]G)!RZ9.YCM7)Z#''4UN^$-#;2/"%KI\Z.D[QEIMYRX9AT9LG)487KT4
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MI4]<'(/N#5_"$=O3K0JH@P@ '8"@!]%9NK:SI^BV?VK4;I+>$ML5FSEFP3@
M<DX!X'H:GT_4;35-/AOK*=)K:9=T<B]&% %NBDW#UJE-JEA;ZA!8S7EO'>7
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M&HS;A];L5-RH>(&8992< _3/%<;?>!M7NKE+HVUI*;.:QGAA>8J+@Q1,CJ6
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M,#M=8UN:TTLW6CV/]L2B98C!!.JGDX/)XX]*V@ZGC=R.M>.V^@W[-.S>&[B
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ML?D"&56.T[6(Z$9HT&:/A_QO;-X7L+[Q#>PP7=PTV<1,@VI*R;BO)10 N2W
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MPN9T53;W:QHY"CIM;T'M7$+KVNW&M:?8RZ@IM[F_U6RFA>) 62-6:(\#/RX
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M,KG?C!&6V[03C-9GC;6-2L?$$-O!XGCT2V?3I9U:2".57E1U !W#/(;H#VH
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M%?C$K $W:MH<R9SPS.I)'XLWYFNF\>V]Q)XP\&7-D(6O([BY2%9R1'EHLY;
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M@YCYQCG&1SP:FOO%^HZCHEU:VNEO#?M:WIGVWNW[+Y+&+<KA<L2P.,8QCM3
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MKR=+5)8)G-V) P10&GSR20>$!4^E>W4W:*+@>=20:DWP<D33M,N+.XDA!%K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12'GO3&^4C
MG S0 \G%)N]J;NYQZ5%DG&%S[T[ 3!SDYHW$_GVJ!<\9!J1B,<'!%.P$U%5?
M-<YV[2>U2HY)(-+E8$M%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !13&8@$]A3$;<[<GZ4
M34F><5#YH!*MU'/2E27<,X(QZ]Z=@L345$9?I^-/5@PR*+ .HHHI %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4C#(XZTM% $%O$T5M'&X4,J!
M2%)(X]">:E7)'S#!],TZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ IK#)/'XTZB@"LR$C&U_KF@1L#C:?K
M5FBGS,"J\;$#Y22/2D$3C&5YJW13YF.Y!@D%2I^M*%YZ$8J:BE<+D94$8Q0$
MSZU)12"Y%MP.AZT,O3KU[5+1BE8+D/EDD#)XH\H   84=L5-BBBR"Y5:(R,
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M4 %%%% !1110 4444 %%%% &9=:);7<YEDDN Q_N2D#\JA_X1JS_ .>]X/\
MMN:V:* ,8>&[0=+F]_[_ )IW_"/P 86\OU'M<&M?'.:* ,C^P(QTU'4A_P!O
M)H_L!?\ H)ZG_P"!'_UJUZ* ,@Z"/^@KJ@_[>/\ ZU)_PC__ %%]5_\  G_Z
MU;%% &/_ &!_U%]5_P# C_ZU)_8!_P"@QJW_ ($#_"MFB@#%;0&)S_;.J_\
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M?^3?X5NT4 87E^)O^>^G?]\O_A2^7XF_Y[:;^3_X5N44 8?E^)?^>NF_D_\
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M71T4 <Y_:?B3_H"K_P!]K_\ %T?VGXC_ .@*O_?:_P#Q=='10!SG]I>(L?\
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M +[%=#10!SXUO5N^@S?]]_\ UJ7^W-4[Z!/_ -]__6K?HH P/[<U3_H 3_\
M?S_ZU']N:I_T )_^_G_V-;]% '/_ -N:G_T +C_OO_[&@ZYJ?_0 G_[[_P#L
M:Z"B@# &NZF1_P @"?\ [^?_ &-']NZG_P! "Y_[[_\ K5OT4 8']NZG_P!
M"Y_[[_\ K4#7M2)YT&X'ON/_ ,36_10!@_V[J/\ T Y_^^C_ /$T?V[J/_0"
MN/\ OH__ !-;U% &#_;U_P!]#NOPS_\ $T@UZ^/_ # KO]?\*WZ* ,(:]??]
M *[_ ,_A1_;UY_T [S\O_K5NT4 8/]O7O_0"O?R_^M0=?O0?^0#?'\*WJ* ,
M,:]>?] *^_(4?V[>?] .^_(5N44 8?\ ;MY_T [[\A1_;UW_ - .^_(5N44
M8@UR[/\ S [X?\!%']NW7_0$OO\ OD5MT4 8@URX_P"@-?\ _? I3KMQ_P!
M6_\ ^^!_C6U10!C?VY<8_P"0-?Y_W!_C5VVO)+B(.]I-$?[K@ _SJY10 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex10-20_002.jpg
<TEXT>
begin 644 ex10-20_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 4% XT# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L.]UW3-.B\Z]O!
M;KW)@D!/X;&_G_+C<IFP>I_3_"@#YS\4_M7_ +-7@I;A?&'Q\^$_@\V?_'XW
MB;QUH7AXVGX:W,@!]FV_05UOP<^-_P '_P!H+P5;?$CX*?$OP;\6/ %Y>ZCH
MUEXT\ :YI?B?PS>ZEI!V:Q#I>N:%//!/)$YQ*89F *JT8 9=WK/V6W_YX#\_
M_LJ2"TMK8$6\2P#&/EZ8_$G^E %JBBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R'XT_&#X<_ /X7>-/C'
M\6?$B>$_AQ\/-$E\3>,/$]S9ZE?0Z-H\)$;ZG*FBI+-Y*E@C-#$=NX!MH90W
MR9XG_P""GW[!_@[P;\$_B#XD_:;\ :5X*_:,N]7M?@[XHU5M7LO#OB]?#^LG
MP_KFIIK<_A^*U\/>'_#VNJD4WB/Q4]I:I(\I,K B2NA_X*>6L5Y_P3@_;V%Q
ML9[;]C3]J*\LN<8U%/@KXZ&D," <XE*@CCYB,D $C^6+0/V:/"O[??[ 7_!$
M3]F_5?'UOX3TGXMZQ_P4"T6S\:V=GI'B/4[+Q1X#3XN^(- QH3L(O$+GQ)X)
M*^./#2[05'B2.1CY0"@']DME\=_@]??%Z_\ @%8?$?PG>_&C3_ >G?%F\^&=
MKJT7_":6/PTUK6!H,'C:;1V)F709M>W6PF;>@?:K*=T0?._X:._9Z_X6C_PH
MG_A>/P>_X7AYNW_A3_\ PL3P?_PL[S?[%_X3#=_P@?\ ;7_"4>7_ ,([_P 5
M#YWV;R?L7^E>;Y/S5_,M_P $>%_:A\*_\%+?'_[+W[8EKX)U[XG?L1?L+#]G
MKX8?$OP?H7C+3D\5? :3XH?"37_!&LOXPUM/*\?P>*_#XT*/PCXC8P>+T@\!
M3)X[?QAX_7QAXO>K_P %VOAEXS_8M_;#_9+_ ."Q7PF\/Z%K<7PQUKPY\,OC
M5IMY<-X;U$$#QS_8^MQ:]H?AR?RX_BQ\/_$/COX$>+_$ER^[P:H^&@MTDL_%
M7C!@ ?TC>#OVS?V1OB#X8^(_C[P#^U)^S[XV\#?" >9\5O%OA+XQ_#OQ-X8^
M&H03(R>.=<T+Q)<6_A=LZ5JA1?$DEM)*Z2R)F&$Q"'4/VS/V/M,\?GX8ZK^U
M'^SMIOQ0/AT^,3\.;SXT?#>Q^(/_  C(\(#QR?&H\%2>(T\1KX:/P['_  E@
M\2" 6@\)$7@G\C+U_"Y^RY\#OVA_ _Q^\7_\$XOBU\#].T/P1_P68\(?LY^-
MO$>K^'=9UG4=5^&?[.F@^-?'_P 6_'.C:$1X;&/$?A/X<ZY\5/A?XV/BP^#O
M^$*\:?\ ",>.L^,O^1,\9?JKJGPK^&8_X.-/#_P6F\&Z-=?##7OV3=1^$=YX
M3N+,'3?^$#/[)FO:!_8IR0-B^&]#_P"$8<==F2.: /W[A_X*J_\ !,ZXL=5U
M.#_@H-^Q6^GZ';_:=7NT_:=^#9%@A_B=3XK!8'IP&<D@"/M7K_P]_:Y_9<^+
M7C*3X:?"_P#:1^!WQ$^(UGX4LO'=QX&\%_%+P9XM\66G@36=*T75M*\;/H.D
MZ\_B-O#=UH>O:-+:>)Q";2X36[>?SS%,@7^5*X_8*_9IT3_@X)G_ &7]8^#O
MP_E_9S\>_LF >#_A/#HA/AGP_P"%U^  \!/HFB("/[!\1?\ "0^!M>\3KXJ1
M_P#A,GX*2A2'K@/VB/\ @F'\3IOVY?VK?CA_P3BD\*?"WX@_\$N%_8WT;X0_
M!R\\'ZOXF/Q)\,^!OV2OA_KVA:%HNN:_XH<^(/$?_"/:+HGA<?\ "4F2/QD/
M#I)D'CH+XU.]L)_-TW=O\OT[ ?UXR?M7?LM6?@?4_BC<?M)_ FU^'FA^)O\
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MCF93/K3D11K"B!MS+NVH#Y/Y@7?_  6=\(V'Q/\ #GP6O/V+_P!O%?BWXS\
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M^QO">BK*Q?6O$$[:7*L<,*O*$1PO!:-?X0?V=?BI^W/KWP:_:0U7]GK]LO\
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MA;QOXD^%G_%#JWB#SQ^]ACH _P!(2LM]2L;>&>>6[@AM[3BZN+A@JCCJ264
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MUQ<"T NOLN,$D?P\D\#(P<?-D#/!K:K L**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .3
MU_0M$\6Z5J6@:_IEAK.AZO8W^F:KI.IVJ:AIVIZ9JJ/IVKZ5JFF.2DT,R.T<
M@<,A.[+!5E#^1V?[,7[/>EV_PXM-'^ _P;T:V^#6J:CK7P<M],^%_@RR'PFU
M;7%F;6M>^&/E>'Q_P@.MS#5M9)/A9H%F678Q#%T3Z(HH X#_ (0CPQ_PEG_"
M??\ ",:+_P )O_8__"-_\)I_8FE?\)5_PCG]K?V]_87]O;?[>_X1_P _Y_\
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MEXI\5:+H&X^'-*US6E8/KD?AT*6@1V8+\L8,8Q&OL]% 'R#\0/V(/V2OB?\
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MG_!(O]C_ /:8\>?'/XD>.[/XKZ)K7[2_A+P!X-^-^D?#/XP^.?AMX6^)-O\
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M']N+QMHG_!,?PU^W?X6\&^!+3Q=XS_9K^$'QSTGP-XX^(,GAKP3INI_%S2?
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MJGAGXV?"/X3:5XA;0/BG&? /P^\8>(_#0\7Z]\+_ (M6W@_PIY,DL]KH,'C
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M-I7Q/\1Z\_P\'Q*;Q^ICUM)DC\8)X1C_ +<F*^"M^TQ?1E%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%9NH_=3\?YB@#2HK^$O_@F5\1_C7^U9XLMO@1\2O\
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M'[ :QXD^%&D_$/PAJ'Q)\/Z4XVOK>N>!5\0R>)=&T1&4,'EM$3:P _C!_/\
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MOBW\3/$5GX2^'7PW\-:QXT\<^(KKY8]"\+Z%I$FNZQJ[;?F_=J%#9!&22H+
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M)H>+?^",_P"TE\0_V'OB+^Q_XT_:W^ 5SJ'B/7?@Q+X5\9^$OV&O"7PSM?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M '.A^)= MM;$A)8 ,A 'W6)(  /3Z*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHIC.$ZT /HKXQ^$7[8OPJ^+GBO\ :%T.VNE\-Z5\"_VA=3_9Q?QAXCUC1+#P
MY\1?'N@>"_ WB/QKI7@5IM=D,C>"O%&OZY\,/%T+(BQ^-? GBG 55VCJM?\
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M%Y)-?1>HW"6]E<74P_=6RBYSZJN2![]?Z5^:/PN^%W@_XE?M,_MI^*I_B?\
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MH,GB2\\-^'O[<\2X6.%/$_B2UBCD959S;EY[+T^L[49O)ASY'G^W!QV_7O\
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MZ#/X:N/A]H'B*+X%K#+XJ\,>+(/&,\R_\(3"JQ>,CLI>,/V/?^"M=KX?%OX
M_P""P$&L^)C=#%W\0?V&_P!FI-- ('R_\4[X<4J5]L$=CUK\T_VY_A]_P6B_
M9X^!^C?M$?%+]O3X0^/_  ?\$/BA\+OB%XO.@_LR>$-0\;^ ]+FUO_A!]?\
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M_@Y4MT,[> ?^"*%^O3[/:?$7]N OT]&^'*@GO]\XXS[9_P#PF_\ P<IG_7_
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MU>:RU>BT[OW6E7H)_&KIVUT_]N5OO^1]=&55!R,]^0"/;ZDCZ=1[TGF!QD<
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M0J. @8H/;+7]D?\ X*/S6MA?6?\ P6 UW4K8D7?VQ?V)?V5#IM_IIS_=7(4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>6W^(7CJ6V\3^)!<>*_"/]KRQ^"[O3V(V_-MI_P;M_\ !+^QN_#.H>'OAO\
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MZ^G3J>/\;>+="\!^$/%'C7Q-?6^F^'_!WA_6?$VLZI<;%CL=(T/3)]6U74R
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MG(:'Q1&%C#^7;,%2-A]E_ _1?CII^C:E=_'/5OAE+K=X+"+1_"?PJT36-/\
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M?I6A[8M'37=8W%I-J:3H>0Z!-^BPX#,0R]+Q#LU9Z_YW_P""<OU9=T?Q-?\
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M&\->#-'C,6DZ/X8$)TO^QHE9Y#Y7EJ\9RS'<'4L2NX@'\.O[7G[:WQF\"_\
M!5VP_P""GW@OP!\==-_9/^&_QMTS]DO1_B7:OK;_  T^+'@+X6:X_@7XZ>"Q
MKF@GQ?X:7PSXL^)'_"UO$W@3PF,)XP\8^'O"_C6)5\<H%7[N_P""T'[?'[;'
MP=_:>\!6'[&W[9=S\%/@_P"*_P!BOPU\==)LK7X*_!SXE:3X[\3'QIX]5-8T
M+6OB%\.O&/B6-?%GA9= S&FU&;07DV*TC9_HDT+]AC]DWPW^SUJ_[*-C\#/
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M_P#LYX7"/ZD]7O=[ZKOY[^779'XO?##_ (.)OVQOC5XQ@\*>$_@K^QQ\+/\
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MQUWQ%K^C_"SP5XZ^&OA2/X/%_$&OZX\,7A3QB)O"2:](UOXSD$4FST3XN?\
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M^6_F?I9'_P ' OP%T[]G7QA^T3X[_95_;/\ A+I-H/ 9^">@_%'X5Z3X<?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17&:C9
MZQ<WFCRVVIWVB0V>M?;+NULH=(O%US3?[(,;Z/JYU9'F@5YG-QYGAR4NITO(
MN/F=$[!.A^O]!0 ^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKGU%Z
M-3N2\]J;+[)$+:V-MAA?"4AR[D[L*ATHH,G#$[-I!( .@HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /E7]G3]HO0OVC
M]-^(NM^'/AY\8_ %C\.?C#XZ^#=];?%[X=Z[\,-8\2ZIX"U6)9/%_@?1O$(:
MZU[X:^)EU&"3PCXJ_=I=LFOPO'X<NO#TMLWU5110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 457G[?A_6L^83Y\GS^?7O\ R_SG..M &AY_M^G_ ->JS:A;
MQC!_GC\>_ISTKQ?2!XP-U/8FWU&WM]*T?(^V:N=2.NG_ +#F,@C..V 3[UU,
M1L=-TOS]4_XDG^F?\>GVS^TOS_6NGZOYOI^.P':V^JB[N+@0\P6P^9O4\9_S
MV^N:M_;/?_QVO$]=\=^#]'M[&$W$^V\_M.S M-5(U33S@#)T7=AS_P 3O PH
M*C .1M%.T>ST2SCM[Z">Y\27VJ79LK3[)=L=-L2>@_L3Q!XD XP?4G(X'&3Z
MN]6^;>VWX[[?UJ!Z^=;M_M-O (+K-R"%_P!&;KVR<]/7.<"G3:O!!;">:&X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT'3KCIQVNT44 %%%% %&&U@@DN)HO-5KEQ<S\Y#'!P.F1QGY0<X&,]*O444
M4Y8X8HYIML0XR20 ./7GJ<]L9HMHX.9X!%BX^;<HZCN <\^_3\JN44 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M142.S9W121[6(&\H=X_OKY4DHP>P?8WJHXR[&<@KQ@=3P=V0PYYR  3D8.<
MD[L #Z*** "BBB@ JO/V_#^M6** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HY_P C_P"O110 44ASV./UHP?4_I_A0 M%'XY_+^@%
M% !1110 4444 %%%% !100#P>1_AS4:Q1JSNL:!Y-I=@HW.57:I9L9;:H"KD
MG"@ <"@"2BBB@ HHHH **** "BBB@ HHI-R],C/U'KC^?'UH 6BBC(]10 F/
MKW[G^GZ>G:EHR#T-!X]/Q.* #@>@HHSGH0:* "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M36-/QWQ>1_RW@=OYU9_MG2O^@E8?^!</_P 50!IT53BO+.;_ %$\#'_9(_\
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MQ'XHQ^0Q^5?7%% 'R%_PPG^RS_T3*?\ \+OXD?\ S5TW_AB#]F7_ *)[KO\
MX=+XH?\ SP:^OZ* /CF;]A+]EN;K\-M1S_V4GXHG^7Q ';_'BH?^& OV4O\
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MR_-\]?VD?";?]?/PLT,GGC^+PZ/UZ5]QT4 ?#LOP]_;7A_=#X_>$;D'^+_A
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C 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>10
<FILENAME>vrcp-20190331.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.26b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: VRCP%2D 20190331 10Q Q1 DFN.xfr; Date: 2019%2D05%2D15T14:48:36Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030003 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:VRCP="http://dermacompare.com/20190331">
    <link:schemaRef xlink:href="vrcp-20190331.xsd" xlink:type="simple" />
    <xbrli:context id="From2019-01-01to2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-15">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_ReceiptonAccountofSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ReceiptonAccountofSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ReceiptonAccountofSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_ReceiptonAccountofSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ReceiptonAccountofSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_custom_ReceiptonAccountofSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ReceiptonAccountofSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_ReceiptonAccountofSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ReceiptonAccountofSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">VRCP:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_ConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">VRCP:ConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_InvestorsMember_custom_ClassFWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VRCP:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ClassFWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_custom_InvestorsMember_custom_ClassFWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VRCP:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ClassFWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_InvestorsMember_custom_ClassGWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VRCP:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ClassGWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_custom_InvestorsMember_custom_ClassGWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VRCP:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ClassGWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_InvestorsMember_custom_ClassHWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VRCP:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ClassHWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_custom_InvestorsMember_custom_ClassHWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VRCP:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ClassHWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_InvestorsMember_custom_ClassIWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VRCP:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ClassIWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_custom_InvestorsMember_custom_ClassIWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">VRCP:InvestorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">VRCP:ClassIWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_OfficersAndDirectorsMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">VRCP:OfficersAndDirectorsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_custom_OfficersAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">VRCP:OfficersAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_custom_OfficersAndDirectorsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">VRCP:OfficersAndDirectorsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-01to2019-05-02_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockMember_srt_ChiefExecutiveOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-01to2019-05-02_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockMember_srt_ChiefFinancialOfficerMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-01to2019-05-02_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000797542</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-01</xbrli:startDate>
        <xbrli:endDate>2019-05-02</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <dei:DocumentType contextRef="From2019-01-01to2019-03-31">10-Q</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2019-01-01to2019-03-31">2019-03-31</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2019-01-01to2019-03-31">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2019-01-01to2019-03-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityFilerCategory contextRef="From2019-01-01to2019-03-31">Non-accelerated Filer</dei:EntityFilerCategory>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">-1588576</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">-416476</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2255</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">14968925</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" decimals="0">80000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-19337</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-16620419</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">11075</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">41218691</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-19337</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-41626905</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">-619031</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">11075</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">41100794</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" decimals="0">-19337</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-41711563</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-03-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-03-31" unitRef="USDPShares" decimals="INF">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-03-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">490000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">490000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">110748391</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">110748391</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">110748391</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-03-31" unitRef="Shares" decimals="INF">110748391</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-84658</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-25006486</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-20802376</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-84658</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-25006486</us-gaap:NetIncomeLoss>
    <dei:EntityCentralIndexKey contextRef="From2019-01-01to2019-03-31">0000797542</dei:EntityCentralIndexKey>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1058611</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">503217</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-03-31_custom_ConvertiblePromissoryNotesMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">62500</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <dei:EntityCommonStockSharesOutstanding contextRef="AsOf2019-05-15" unitRef="Shares" decimals="INF">112249643</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">4329999</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2019-05-01to2019-05-02_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockMember_srt_ChiefExecutiveOfficerMember" unitRef="Shares" decimals="INF">750000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2019-05-01to2019-05-02_us-gaap_SubsequentEventMember_us-gaap_RestrictedStockMember_srt_ChiefFinancialOfficerMember" unitRef="Shares" decimals="INF">750000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">17768</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <dei:EntityRegistrantName contextRef="From2019-01-01to2019-03-31">Virtual Crypto Technologies, Inc.</dei:EntityRegistrantName>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2019-03-31_custom_ConvertiblePromissoryNotesMember" unitRef="Pure" decimals="INF">0.01</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes information&#13;of outstanding warrants issued to investors and consultants in exchange for their services as of March 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrant Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 29%"&gt;&lt;font style="font-size: 10pt"&gt;Investors &amp;#8211; Class F (*) Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,142,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 25%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;April 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,142,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Investors &amp;#8211; Class G (*) Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,142,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;April 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,142,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Investors - Class H Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;January 2020 -March 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Investors - Class I Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;571,429&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;January 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;571,429&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"&gt;(*) Subsequent to the&#13;balance sheet date, these warrants expired.&amp;#160;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">485449</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">511444</us-gaap:NotesPayableCurrent>
    <dei:DocumentFiscalYearFocus contextRef="From2019-01-01to2019-03-31">2019</dei:DocumentFiscalYearFocus>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">8227</us-gaap:InterestPayableCurrentAndNoncurrent>
    <dei:TradingSymbol contextRef="From2019-01-01to2019-03-31">VRCP</dei:TradingSymbol>
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-03-31" unitRef="Shares" xsi:nil="true" />
    <VRCP:CancellationOfPreferredShares contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <VRCP:CancellationOfPreferredShares contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <VRCP:CancellationOfPreferredShares contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <VRCP:CancellationOfPreferredShares contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-150000</VRCP:CancellationOfPreferredShares>
    <VRCP:CancellationOfPreferredShares contextRef="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <VRCP:CancellationOfPreferredShares contextRef="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <VRCP:CancellationOfPreferredShares contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <VRCP:CancellationOfPreferredShares contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-150000</VRCP:CancellationOfPreferredShares>
    <dei:DocumentFiscalPeriodFocus contextRef="From2019-01-01to2019-03-31">Q1</dei:DocumentFiscalPeriodFocus>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-03-31_custom_InvestorsMember_custom_ClassFWarrantMember" unitRef="USDPShares" id="Foot-00-0" decimals="INF">0.14</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-03-31_custom_InvestorsMember_custom_ClassGWarrantMember" unitRef="USDPShares" id="Foot-00-1" decimals="INF">0.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-03-31_custom_InvestorsMember_custom_ClassHWarrantMember" unitRef="USDPShares" decimals="INF">0.14</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-12-31_custom_InvestorsMember_custom_ClassIWarrantMember" unitRef="USDPShares" decimals="INF">0.14</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="From2019-05-01to2019-05-02_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">1500000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross contextRef="From2019-05-01to2019-05-02_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">51300</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2019-03-31_custom_InvestorsMember_custom_ClassFWarrantMember" unitRef="Shares" id="Foot-00-2" decimals="INF">2142857</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2019-03-31_custom_InvestorsMember_custom_ClassGWarrantMember" unitRef="Shares" id="Foot-00-3" decimals="INF">2142857</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2019-03-31_custom_InvestorsMember_custom_ClassHWarrantMember" unitRef="Shares" decimals="INF">750000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="AsOf2019-12-31_custom_InvestorsMember_custom_ClassIWarrantMember" unitRef="Shares" decimals="INF">571429</us-gaap:ClassOfWarrantOrRightOutstanding>
    <VRCP:WarrantTerm contextRef="From2019-01-01to2019-03-31_custom_InvestorsMember_custom_ClassFWarrantMember" id="Foot-00-4">April 2019</VRCP:WarrantTerm>
    <VRCP:WarrantTerm contextRef="From2019-01-01to2019-03-31_custom_InvestorsMember_custom_ClassGWarrantMember" id="Foot-00-5">April 2019</VRCP:WarrantTerm>
    <VRCP:WarrantTerm contextRef="From2019-01-01to2019-03-31_custom_InvestorsMember_custom_ClassHWarrantMember">January 2020 -March 2020</VRCP:WarrantTerm>
    <VRCP:WarrantTerm contextRef="From2019-01-01to2019-03-31_custom_InvestorsMember_custom_ClassIWarrantMember">January 2020</VRCP:WarrantTerm>
    <VRCP:WarrantExercisable contextRef="AsOf2019-03-31_custom_InvestorsMember_custom_ClassFWarrantMember" unitRef="Shares" id="Foot-00-6" decimals="INF">2142857</VRCP:WarrantExercisable>
    <VRCP:WarrantExercisable contextRef="AsOf2019-03-31_custom_InvestorsMember_custom_ClassGWarrantMember" unitRef="Shares" id="Foot-00-7" decimals="INF">2142857</VRCP:WarrantExercisable>
    <VRCP:WarrantExercisable contextRef="AsOf2019-03-31_custom_InvestorsMember_custom_ClassHWarrantMember" unitRef="Shares" decimals="INF">750000</VRCP:WarrantExercisable>
    <VRCP:WarrantExercisable contextRef="AsOf2019-12-31_custom_InvestorsMember_custom_ClassIWarrantMember" unitRef="Shares" decimals="INF">571429</VRCP:WarrantExercisable>
    <dei:EntityEmergingGrowthCompany contextRef="From2019-01-01to2019-03-31">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2019-01-01to2019-03-31">false</dei:EntityExTransitionPeriod>
    <us-gaap:SharesOutstanding contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">22543008</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2017-12-31_us-gaap_PreferredStockMember" unitRef="Shares" decimals="INF">529</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">110748391</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">110748391</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-03-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">2770</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1938180</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <VRCP:StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">27697855</VRCP:StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants>
    <VRCP:StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">433</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">1003866</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">28035</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">146376</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">28035</us-gaap:AdjustmentOfWarrantsGrantedForServices>
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2019-01-01to2019-03-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2019-01-01to2019-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentOfWarrantsGrantedForServices contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">6</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">57</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <VRCP:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">5554</VRCP:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne>
    <VRCP:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <VRCP:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">549836</VRCP:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne>
    <VRCP:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne contextRef="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <VRCP:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne contextRef="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <VRCP:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <VRCP:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">55543600</VRCP:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne>
    <VRCP:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <VRCP:CancellationOfPreferredSharesShares contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" xsi:nil="true" />
    <VRCP:CancellationOfPreferredSharesShares contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="Shares" decimals="INF">-529</VRCP:CancellationOfPreferredSharesShares>
    <VRCP:IssuanceOfSharesInRespectOfProceedsReceivedValue contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">57</VRCP:IssuanceOfSharesInRespectOfProceedsReceivedValue>
    <VRCP:IssuanceOfSharesInRespectOfProceedsReceivedValue contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <VRCP:IssuanceOfSharesInRespectOfProceedsReceivedValue contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">79943</VRCP:IssuanceOfSharesInRespectOfProceedsReceivedValue>
    <VRCP:IssuanceOfSharesInRespectOfProceedsReceivedValue contextRef="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" decimals="0">-80000</VRCP:IssuanceOfSharesInRespectOfProceedsReceivedValue>
    <VRCP:IssuanceOfSharesInRespectOfProceedsReceivedValue contextRef="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <VRCP:IssuanceOfSharesInRespectOfProceedsReceivedValue contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <VRCP:IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">571429</VRCP:IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares>
    <VRCP:IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:OperatingExpenses contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">200623</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">1428294</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-200623</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-1428294</us-gaap:OperatingIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2019-01-01to2019-03-31" unitRef="Shares" decimals="INF">110748391</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="From2018-01-01to2018-03-31" unitRef="Shares" decimals="INF">41048456</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-66559</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-345549</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-28674</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-12122</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">8227</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-65924</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInDueFromRelatedParties contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">721530</us-gaap:IncreaseDecreaseInDueFromRelatedParties>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">78692</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-321158</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">28035</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">892300</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">1792285</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:ProceedsFromShortTermDebt contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromShortTermDebt contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">100000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">63</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">1575072</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">499919</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">447967</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 1. The Company and Significant Accounting&#13;Policies.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Organizational Background:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Virtual Crypto Technologies, Inc. (the &amp;#8220;Company&amp;#8221;)&#13;was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (&amp;#8220;Zaxis&amp;#8221;). On August&#13;25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis&#13;International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30,&#13;2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under&#13;the laws of the State of Israel (&amp;#8220;Emerald Israel&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 16, 2015, Zaxis and Emerald Israel&#13;executed the Share Exchange Agreement, which closed on July 14, 2015 (the &amp;#8220;Share Exchange Agreement&amp;#8221;) and Emerald Israel&#13;became the Company&amp;#8217;s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel&amp;#8217;s&#13;DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use&#13;in derma imaging and analytics for the detection of skin cancer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 17, 2018, the Company formed a new&#13;wholly owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies Ltd. (the &amp;#8220;Subsidiary&amp;#8221;),&#13;to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies&#13;through ATMs, tablets, personal computers (&amp;#8220;PCs&amp;#8221;) and/or mobile devices.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Going Concern:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has incurred significant operating&#13;losses and negative cash flows from operating activities in relation to its operations, since inception. While the Company raised&#13;approximately $1.9 million in the year ended December 31, 2018 to fund the operations of its New Subsidiary, the Company will require&#13;additional capital resources in order to support the commercialization of the New Subsidiary&amp;#8217;s technology and operations&#13;and maintain its research and development activities related to the New Subsidiary&amp;#8217;s technology. The Company is addressing&#13;its liquidity needs by seeking additional funding from public and/or private sources. There are no assurances, however, that the&#13;Company will be able to obtain an adequate level of financial resources that are required for the Company&amp;#8217;s short and long-term&#13;requirements, or at all these conditions raise substantial doubt about the Company&amp;#8217;s ability to continue as a going concern.&#13;The consolidated financial statements do not include any adjustments to reflect the possible future effects on recoverability and&#13;classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Basis of Presentation and Significant Accounting&#13;Policies:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying unaudited consolidated financial&#13;statements include the accounts of the Company and its wholly owned subsidiary, the Subsidiary, prepared in accordance with accounting&#13;principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;) and with the instructions to Form 10-Q. The&#13;financial statements presented herein have not been audited by an independent registered public accounting firm but include all&#13;material adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair&#13;statement of the financial condition, results of operations and cash flows for the period. However, these results are not necessarily&#13;indicative of results for any other interim period or for the full fiscal year. The preparation of financial statements in conformity&#13;with GAAP requires us to make certain estimates and assumptions for the reporting periods covered by the financial statements.&#13;These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could&#13;differ from these estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Certain information and footnote disclosures&#13;normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant&#13;to the rules of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;). The accompanying unaudited consolidated financial statements&#13;should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form&#13;10-K for the fiscal year ended December 31, 2018, filed with the SEC on March 28, 2019 (the &amp;#8220;Annual Report&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Recent Accounting Standards announced&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In August 2018, the FASB issued ASU 2018-13,&#13;Fair Value Measurement (Topic 820): Disclosure Framework &amp;#8211; Changes to the Disclosure Requirements for Fair Value Measurement.&#13;The amendments apply to reporting entities that are required to make disclosures about recurring or nonrecurring fair value measurements&#13;and should improve the cost, benefit, and effectiveness of the disclosures. ASU 2018-13 categorized the changes into those disclosures&#13;that were removed, those that were modified, and those that were added. The primary disclosures that were removed related to transfers&#13;between Level 1 and Level 2 investments, along with the policy for timing of transfers between levels. In addition, disclosing&#13;the valuation processes for Level 3 fair value measurements was removed. The amendments are effective for all organizations for&#13;fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted. The&#13;Company notes that this guidance will impact its disclosures beginning January 1, 2020.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 2. Convertible Notes.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following convertible promissory notes&#13;bear interest at 1% per annually, are convertible at a price of $0.01 per share and are repayable through January 1, 2020.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;March 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Principle&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;503,217&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,058,611&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Conversion of convertible notes to shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(555,394&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Accrued interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,227&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Discount&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(17,768&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;511,444&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;485,449&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 3. Stockholders&amp;#8217; Equity.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes information&#13;of outstanding warrants issued to investors and consultants in exchange for their services as of March 31, 2019:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrants&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Warrant Term&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Exercisable&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 29%"&gt;&lt;font style="font-size: 10pt"&gt;Investors &amp;#8211; Class F (*) Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,142,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 25%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;April 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 12%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,142,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Investors &amp;#8211; Class G (*) Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,142,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;April 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,142,857&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Investors - Class H Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;January 2020 -March 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;750,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Investors - Class I Warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;571,429&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;January 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.14&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;571,429&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt"&gt;(*) Subsequent to the&#13;balance sheet date, these warrants expired.&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 4. Related Party Transactions.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Other than transactions and balances related&#13;to cash and share based compensation to officers and directors and other than the issuances of convertible debt to certain investors,&#13;and payments in respect of consulting fees to certain shareholders with beneficial holdings of greater that 5% of $75,000 and $&#13;nil during the three months ended March 31, 2019 and 2018, respectively, the Company did not have any transactions and balances&#13;with related parties and executive officers during these periods.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As a result of the issuance of the convertible&#13;notes in the prior years, certain may hold convertible notes allowing them to convert the notes in excess of 5% of the Company&amp;#8217;s&#13;issued and outstanding shares of common stock. Accordingly, such investors may be deemed to be related parties under Item 404(a)&#13;of Regulation S-K. In addition, certain investors receive fees for consulting services provided to the Company, as noted above.&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:AssetsCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">558677</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">460809</us-gaap:AssetsCurrent>
    <us-gaap:Assets contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">558677</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">460809</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">13115</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">98871</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">7064</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">485449</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">503217</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">469525</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">469525</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">975153</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">1079840</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">975153</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">1079840</us-gaap:Liabilities>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CommonStockValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">11075</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">11075</us-gaap:CommonStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">-19337</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">-19337</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">41218691</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">41100794</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">-41626905</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">-41711563</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">558677</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">460809</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;March 31, 2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Principle&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;503,217&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,058,611&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Conversion of convertible notes to shares&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(555,394&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Accrued interest&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8,227&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; padding-left: 10pt"&gt;&lt;font style="font-size: 10pt"&gt;Discount&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(17,768&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;511,444&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;485,449&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-03-31_custom_ConvertiblePromissoryNotesMember">2020-01-01</us-gaap:DebtInstrumentMaturityDate>
    <VRCP:ConversionOfConvertibleNotesToShares contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">-555394</VRCP:ConversionOfConvertibleNotesToShares>
    <VRCP:ConversionOfConvertibleNotesToShares contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">2959</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">499919</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">447967</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2018-03-31" unitRef="USD" decimals="0">1449695</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-51952</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">1446736</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">50000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">17768</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2018-01-01to2018-03-31" unitRef="USD" xsi:nil="true" />
    <VRCP:FinanceExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">115965</VRCP:FinanceExpense>
    <VRCP:FinanceExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-19374082</VRCP:FinanceExpense>
    <us-gaap:ShortTermInvestments contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">17242</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">41516</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">12842</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <VRCP:AccountsPayableInterestPayable contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <VRCP:AccountsPayableInterestPayable contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">8227</VRCP:AccountsPayableInterestPayable>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-03-31" unitRef="USDPShares" decimals="INF">-0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2018-01-01to2018-03-31" unitRef="USDPShares" decimals="INF">-0.51</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:SellingAndMarketingExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:SellingAndMarketingExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">310000</us-gaap:SellingAndMarketingExpense>
    <VRCP:AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-145932</VRCP:AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote>
    <VRCP:AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <VRCP:AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote contextRef="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <VRCP:AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">-145932</VRCP:AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote>
    <VRCP:AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote contextRef="From2019-01-01to2019-03-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <VRCP:AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote contextRef="From2019-01-01to2019-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <VRCP:AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <VRCP:FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-145932</VRCP:FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes>
    <VRCP:FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">20165406</VRCP:FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes>
    <VRCP:IncreaseInNetLiabilitiesForSale contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <VRCP:IncreaseInNetLiabilitiesForSale contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">445611</VRCP:IncreaseInNetLiabilitiesForSale>
    <VRCP:ConversionToSharesOfConvertibleLoans contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <VRCP:ConversionToSharesOfConvertibleLoans contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">85218</VRCP:ConversionToSharesOfConvertibleLoans>
    <VRCP:OrganizationalBackgroundPolicyTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Organizational Background:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Virtual Crypto Technologies, Inc. (the &amp;#8220;Company&amp;#8221;)&#13;was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (&amp;#8220;Zaxis&amp;#8221;). On August&#13;25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis&#13;International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30,&#13;2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under&#13;the laws of the State of Israel (&amp;#8220;Emerald Israel&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On March 16, 2015, Zaxis and Emerald Israel&#13;executed the Share Exchange Agreement, which closed on July 14, 2015 (the &amp;#8220;Share Exchange Agreement&amp;#8221;) and Emerald Israel&#13;became the Company&amp;#8217;s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel&amp;#8217;s&#13;DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use&#13;in derma imaging and analytics for the detection of skin cancer.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On January 17, 2018, the Company formed a&#13;new wholly owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies Ltd. (the &amp;#8220;Subsidiary&amp;#8221;),&#13;to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies&#13;through ATMs, tablets, personal computers (&amp;#8220;PCs&amp;#8221;) and/or mobile devices.&lt;/p&gt;</VRCP:OrganizationalBackgroundPolicyTextBlock>
    <VRCP:GoingConcernPolicyTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Going Concern:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company has incurred significant operating&#13;losses and negative cash flows from operating activities in relation to its operations, since inception. While the Company raised&#13;approximately $1.9 million in the year ended December 31, 2018 to fund the operations of its New Subsidiary, the Company will&#13;require additional capital resources in order to support the commercialization of the New Subsidiary&amp;#8217;s technology and operations&#13;and maintain its research and development activities related to the New Subsidiary&amp;#8217;s technology. The Company is addressing&#13;its liquidity needs by seeking additional funding from public and/or private sources. There are no assurances, however, that the&#13;Company will be able to obtain an adequate level of financial resources that are required for the Company&amp;#8217;s short and long-term&#13;requirements, or at all these conditions raise substantial doubt about the Company&amp;#8217;s ability to continue as a going concern.&#13;The consolidated financial statements do not include any adjustments to reflect the possible future effects on recoverability&#13;and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty&lt;/p&gt;</VRCP:GoingConcernPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;Basis of Presentation and Significant Accounting&#13;Policies:&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying unaudited consolidated financial&#13;statements include the accounts of the Company and its wholly owned subsidiary, the Subsidiary, prepared in accordance with accounting&#13;principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;) and with the instructions to Form 10-Q. The&#13;financial statements presented herein have not been audited by an independent registered public accounting firm but include all&#13;material adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair&#13;statement of the financial condition, results of operations and cash flows for the period. However, these results are not necessarily&#13;indicative of results for any other interim period or for the full fiscal year. The preparation of financial statements in conformity&#13;with GAAP requires us to make certain estimates and assumptions for the reporting periods covered by the financial statements.&#13;These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could&#13;differ from these estimates.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Certain information and footnote disclosures&#13;normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant&#13;to the rules of the Securities and Exchange Commission (&amp;#8220;SEC&amp;#8221;). The accompanying unaudited consolidated financial&#13;statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report&#13;on Form 10-K for the fiscal year ended December 31, 2018, filed with the SEC on March 28, 2019 (the &amp;#8220;Annual Report&amp;#8221;).&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ExcessCapital contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1900000</us-gaap:ExcessCapital>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-03-31_custom_OfficersAndDirectorsMember_srt_MinimumMember" unitRef="Pure" decimals="INF">0.05</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments contextRef="AsOf2019-03-31_custom_OfficersAndDirectorsMember" unitRef="USD" decimals="0">75000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments contextRef="AsOf2018-03-31_custom_OfficersAndDirectorsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:DebtInstrumentDescription contextRef="From2019-01-01to2019-03-31">The issuance of the convertible notes in the prior years, certain may hold convertible notes allowing them to convert the notes in excess of 5% of the Company's issued and outstanding shares of common stock. Accordingly, such investors may be deemed to be related parties under Item 404(a) of Regulation S-K. In addition, certain investors receive fees for consulting services provided to the Company, as noted above.</us-gaap:DebtInstrumentDescription>
    <dei:EntitySmallBusiness contextRef="From2019-01-01to2019-03-31">true</dei:EntitySmallBusiness>
    <us-gaap:MarketableSecuritiesGainLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">-2635</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss contextRef="From2018-01-01to2018-03-31" unitRef="USD" xsi:nil="true" />
    <VRCP:IssuanceOfSharesInRespectOfProceedsReceived contextRef="From2019-01-01to2019-03-31" unitRef="USD" xsi:nil="true" />
    <VRCP:IssuanceOfSharesInRespectOfProceedsReceived contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">-117150</VRCP:IssuanceOfSharesInRespectOfProceedsReceived>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">191210</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">1064283</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">9413</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">54011</us-gaap:ResearchAndDevelopmentExpense>
    <VRCP:ChangeInTermsOfConvertibleNote contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <VRCP:ChangeInTermsOfConvertibleNote contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <VRCP:ChangeInTermsOfConvertibleNote contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">22581508</VRCP:ChangeInTermsOfConvertibleNote>
    <VRCP:ChangeInTermsOfConvertibleNote contextRef="From2018-01-01to2018-12-31_custom_ReceiptonAccountofSharesMember" unitRef="USD" xsi:nil="true" />
    <VRCP:ChangeInTermsOfConvertibleNote contextRef="From2018-01-01to2018-12-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="USD" xsi:nil="true" />
    <VRCP:ChangeInTermsOfConvertibleNote contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <VRCP:ChangeInTermsOfConvertibleNote contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">22581508</VRCP:ChangeInTermsOfConvertibleNote>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;Note 5. Subsequent Events.&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On May 2, 2019, the company issued 750,000&#13;restricted shares to the Company&amp;#8217;s CEO and 750,000 restricted shares to the Company&amp;#8217;s CFO in the lieu of services&#13;provided to the Company. The fair value of the 1,500,000 restricted shares was $51,300.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2019-01-01to2019-03-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;u&gt;Recent Accounting Standards announced&lt;/u&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In August 2018, the FASB issued ASU 2018-13,&#13;Fair Value Measurement (Topic 820): Disclosure Framework &amp;#8211; Changes to the Disclosure Requirements for Fair Value Measurement.&#13;The amendments apply to reporting entities that are required to make disclosures about recurring or nonrecurring fair value measurements&#13;and should improve the cost, benefit, and effectiveness of the disclosures. ASU 2018-13 categorized the changes into those disclosures&#13;that were removed, those that were modified, and those that were added. The primary disclosures that were removed related to transfers&#13;between Level 1 and Level 2 investments, along with the policy for timing of transfers between levels. In addition, disclosing&#13;the valuation processes for Level 3 fair value measurements was removed. The amendments are effective for all organizations for&#13;fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted. The&#13;Company notes that this guidance will impact its disclosures beginning January 1, 2020.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">14607</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="From2018-01-01to2018-03-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">14607</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2018-01-01to2018-03-31" unitRef="USD" xsi:nil="true" />
    <link:footnoteLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="#Foot-00-0" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-1" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-2" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-3" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-4" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-5" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-6" xlink:label="Foot-00_loc" />
      <link:loc xlink:type="locator" xlink:href="#Foot-00-7" xlink:label="Foot-00_loc" />
      <link:footnoteArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" xlink:from="Foot-00_loc" xlink:to="Footnote-01" order="1" />
      <link:footnote xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:label="Footnote-01" xml:lang="en-US">Subsequent to the balance sheet date, these warrants expired.</link:footnote>
    </link:footnoteLink>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>11
<FILENAME>vrcp-20190331.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.26b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: VRCP%2D 20190331 10Q Q1 DFN.xfr; Date: 2019%2D05%2D15T14:48:36Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030003 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaKLSbP9z5Z8+ekhvWBwbclaXykpjcx0qinfhTYGQccD -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2018-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:VRCP="http://dermacompare.com/20190331" elementFormDefault="qualified" targetNamespace="http://dermacompare.com/20190331">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://dermacompare.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/StatementsOfComprehensiveLoss" id="StatementsOfComprehensiveLoss">
	  <link:definition>00000004 - Statement - Condensed Consolidated  Statements of Comprehensive Loss (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/StatementOfChangesInStockholdersEquityDeficit" id="StatementOfChangesInStockholdersEquityDeficit">
	  <link:definition>00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/CompanyAndSignificantAccountingPolicies" id="CompanyAndSignificantAccountingPolicies">
	  <link:definition>00000007 - Disclosure - The Company and Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/ConvertibleNotes" id="ConvertibleNotes">
	  <link:definition>00000008 - Disclosure - Convertible Notes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/StockholdersEquity" id="StockholdersEquity">
	  <link:definition>00000009 - Disclosure - Stockholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
	  <link:definition>00000010 - Disclosure - Related Party Transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000011 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/CompanyAndSignificantAccountingPoliciesPolicies" id="CompanyAndSignificantAccountingPoliciesPolicies">
	  <link:definition>00000012 - Disclosure - The Company and Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/ConvertibleNotesTables" id="ConvertibleNotesTables">
	  <link:definition>00000013 - Disclosure - Convertible Notes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
	  <link:definition>00000014 - Disclosure - Stockholders' Equity (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000015 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/ConvertibleNotesDetailsNarrative" id="ConvertibleNotesDetailsNarrative">
	  <link:definition>00000016 - Disclosure - Convertible Notes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/ConvertibleNotes-ScheduleOfConvertibleNotesDetails" id="ConvertibleNotes-ScheduleOfConvertibleNotesDetails">
	  <link:definition>00000017 - Disclosure - Convertible Notes - Schedule of Convertible Notes (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/StockholdersEquity-SummaryOfOutstandingWarrantsDetails" id="StockholdersEquity-SummaryOfOutstandingWarrantsDetails">
	  <link:definition>00000018 - Disclosure - Stockholders' Equity - Summary of Outstanding Warrants (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/RelatedPartyTransactionsDetailsNarrative" id="RelatedPartyTransactionsDetailsNarrative">
	  <link:definition>00000019 - Disclosure - Related Party Transactions (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://dermacompare.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000020 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="vrcp-20190331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="vrcp-20190331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="vrcp-20190331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="vrcp-20190331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2018-01-31" schemaLocation="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2019-01-31" schemaLocation="https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
    <element id="VRCP_CancellationOfPreferredShares" name="CancellationOfPreferredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_WarrantTerm" name="WarrantTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_WarrantExercisable" name="WarrantExercisable" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" name="StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne" name="StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne" name="StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_CancellationOfPreferredSharesShares" name="CancellationOfPreferredSharesShares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue" name="IssuanceOfSharesInRespectOfProceedsReceivedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares" name="IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ConversionOfConvertibleNotesToShares" name="ConversionOfConvertibleNotesToShares" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_FinanceExpense" name="FinanceExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AccountsPayableInterestPayable" name="AccountsPayableInterestPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote" name="AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" name="FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_IncreaseInNetLiabilitiesForSale" name="IncreaseInNetLiabilitiesForSale" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ConversionToSharesOfConvertibleLoans" name="ConversionToSharesOfConvertibleLoans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_OrganizationalBackgroundPolicyTextBlock" name="OrganizationalBackgroundPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_GoingConcernPolicyTextBlock" name="GoingConcernPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_IssuanceOfSharesInRespectOfProceedsReceived" name="IssuanceOfSharesInRespectOfProceedsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ChangeInTermsOfConvertibleNote" name="ChangeInTermsOfConvertibleNote" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ExercisePriceOneMember" name="ExercisePriceOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_MrWaynMember" name="MrWaynMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_MrAlimiAhmedMember" name="MrAlimiAhmedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ClassEWarrantMember" name="ClassEWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AxelSpringerPlugMember" name="AxelSpringerPlugMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_PlayAcceleratorGmbHMember" name="PlayAcceleratorGmbHMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ChironRefineriesLtdMember" name="ChironRefineriesLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_NewThirdPartyInvestorsMember" name="NewThirdPartyInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AlphaAndChiOptionMember" name="AlphaAndChiOptionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_JanuaryTwoThousandEighteenConvertibleNotesMember" name="JanuaryTwoThousandEighteenConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_SeriesAPreferredConvertibleStockMember" name="SeriesAPreferredConvertibleStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AccreditedInvestordMember" name="AccreditedInvestordMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ClassFWarrantMember" name="ClassFWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ClassGWarrantMember" name="ClassGWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_TwoAccreditedInvestordMember" name="TwoAccreditedInvestordMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AugustTwoThousandSeventeenFinancingMember" name="AugustTwoThousandSeventeenFinancingMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ClassAWarrantMember" name="ClassAWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ClassBWarrantMember" name="ClassBWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ConsultantsMember" name="ConsultantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_JanuaryTwoThousandEighteenTwentyThreeConvertibleNotesMember" name="JanuaryTwoThousandEighteenTwentyThreeConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_JanuaryTwoThousandEighteenTwentyFourConvertibleNotesMember" name="JanuaryTwoThousandEighteenTwentyFourConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ConsultingAgreementMember" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ClassHWarrantMember" name="ClassHWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_InvestorsMember" name="InvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AlimiAhmedMember" name="AlimiAhmedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ReceiptonAccountofSharesMember" name="ReceiptonAccountofSharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AlphaCapitalAnsaltAndChiSquaredIncMember" name="AlphaCapitalAnsaltAndChiSquaredIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_VirtualCryptoIsraelMember" name="VirtualCryptoIsraelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AccountsPayableRelatedPartyMember" name="AccountsPayableRelatedPartyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_EmployeePayableMember" name="EmployeePayableMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ShortTermPortionOfConvertibleNotesMember" name="ShortTermPortionOfConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_FurnitureAndOfficeEquipmentMember" name="FurnitureAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_GoldMedLtdMember" name="GoldMedLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_MazPartnerMember" name="MazPartnerMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AlphaAnstaltCapitalMember" name="AlphaAnstaltCapitalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_IlanMalkaMember" name="IlanMalkaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_FirstfireGlobalOpportunitiesFundLTCMember" name="FirstfireGlobalOpportunitiesFundLTCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_SettlementAgreementMember" name="SettlementAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AlphaandChiSquaredMember" name="AlphaandChiSquaredMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_SeriesAConvertiblePreferredStockMember" name="SeriesAConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_OneLakhConvertibleNotesMember" name="OneLakhConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_PublicisGroupeNintyMember" name="PublicisGroupeNintyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_EUROCurrencyMember" name="EUROCurrencyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_TwoThousandSixteenSecuredConvertibleNoteAgreementMember" name="TwoThousandSixteenSecuredConvertibleNoteAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AlphaMember" name="AlphaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ClassIWarrantMember" name="ClassIWarrantMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_TwoAccreditedInvestorsMember" name="TwoAccreditedInvestorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_AyinNunChafYeuztLtdMember" name="AyinNunChafYeuztLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_TwoThousandSeventeenStockIncentivePlanMember" name="TwoThousandSeventeenStockIncentivePlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ChiefExecutiveOfficerAndFounderMember" name="ChiefExecutiveOfficerAndFounderMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_IsraeliMember" name="IsraeliMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_ConvertiblePromissoryNotesMember" name="ConvertiblePromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_OfficersAndDirectorsMember" name="OfficersAndDirectorsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="VRCP_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>12
<FILENAME>vrcp-20190331_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.26b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: VRCP%2D 20190331 10Q Q1 DFN.xfr; Date: 2019%2D05%2D15T14:48:36Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030003 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://dermacompare.com/role/DocumentAndEntityInformation" xlink:href="vrcp-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/BalanceSheets" xlink:href="vrcp-20190331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/BalanceSheetsParenthetical" xlink:href="vrcp-20190331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StatementsOfComprehensiveLoss" xlink:href="vrcp-20190331.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StatementOfChangesInStockholdersEquityDeficit" xlink:href="vrcp-20190331.xsd#StatementOfChangesInStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StatementsOfCashFlows" xlink:href="vrcp-20190331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/CompanyAndSignificantAccountingPolicies" xlink:href="vrcp-20190331.xsd#CompanyAndSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotes" xlink:href="vrcp-20190331.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StockholdersEquity" xlink:href="vrcp-20190331.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/RelatedPartyTransactions" xlink:href="vrcp-20190331.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/SubsequentEvents" xlink:href="vrcp-20190331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/CompanyAndSignificantAccountingPoliciesPolicies" xlink:href="vrcp-20190331.xsd#CompanyAndSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotesTables" xlink:href="vrcp-20190331.xsd#ConvertibleNotesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StockholdersEquityTables" xlink:href="vrcp-20190331.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="vrcp-20190331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotesDetailsNarrative" xlink:href="vrcp-20190331.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotes-ScheduleOfConvertibleNotesDetails" xlink:href="vrcp-20190331.xsd#ConvertibleNotes-ScheduleOfConvertibleNotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StockholdersEquity-SummaryOfOutstandingWarrantsDetails" xlink:href="vrcp-20190331.xsd#StockholdersEquity-SummaryOfOutstandingWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="vrcp-20190331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/SubsequentEventsDetailsNarrative" xlink:href="vrcp-20190331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AccountsPayableInterestPayable" xlink:label="loc_VRCPAccountsPayableInterestPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_VRCPAccountsPayableInterestPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StatementsOfComprehensiveLoss" xlink:title="00000004 - Statement - Condensed Consolidated  Statements of Comprehensive Loss (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_FinanceExpense" xlink:label="loc_VRCPFinanceExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_VRCPFinanceExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StatementOfChangesInStockholdersEquityDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesGainLoss" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapMarketableSecuritiesGainLoss" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromRelatedParties" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromRelatedParties" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInOtherReceivables" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" xlink:label="loc_VRCPFinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_VRCPFinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IncreaseInNetLiabilitiesForSale" xlink:label="loc_VRCPIncreaseInNetLiabilitiesForSale" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_VRCPIncreaseInNetLiabilitiesForSale" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IssuanceOfSharesInRespectOfProceedsReceived" xlink:label="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceived" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceived" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/CompanyAndSignificantAccountingPolicies" xlink:title="00000007 - Disclosure - The Company and Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotes" xlink:title="00000008 - Disclosure - Convertible Notes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StockholdersEquity" xlink:title="00000009 - Disclosure - Stockholders' Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - Related Party Transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/SubsequentEvents" xlink:title="00000011 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/CompanyAndSignificantAccountingPoliciesPolicies" xlink:title="00000012 - Disclosure - The Company and Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotesTables" xlink:title="00000013 - Disclosure - Convertible Notes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StockholdersEquityTables" xlink:title="00000014 - Disclosure - Stockholders' Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000015 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000016 - Disclosure - Convertible Notes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotes-ScheduleOfConvertibleNotesDetails" xlink:title="00000017 - Disclosure - Convertible Notes - Schedule of Convertible Notes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNotesPayableCurrent" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNotesPayableCurrent" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNotesPayableCurrent" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ConversionOfConvertibleNotesToShares" xlink:label="loc_VRCPConversionOfConvertibleNotesToShares" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNotesPayableCurrent" xlink:to="loc_VRCPConversionOfConvertibleNotesToShares" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StockholdersEquity-SummaryOfOutstandingWarrantsDetails" xlink:title="00000018 - Disclosure - Stockholders' Equity - Summary of Outstanding Warrants (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000019 - Disclosure - Related Party Transactions (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000020 - Disclosure - Subsequent Events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>vrcp-20190331_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.26b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: VRCP%2D 20190331 10Q Q1 DFN.xfr; Date: 2019%2D05%2D15T14:48:36Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030003 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://dermacompare.com/role/DocumentAndEntityInformation" xlink:href="vrcp-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/BalanceSheets" xlink:href="vrcp-20190331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/BalanceSheetsParenthetical" xlink:href="vrcp-20190331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StatementsOfComprehensiveLoss" xlink:href="vrcp-20190331.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StatementOfChangesInStockholdersEquityDeficit" xlink:href="vrcp-20190331.xsd#StatementOfChangesInStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StatementsOfCashFlows" xlink:href="vrcp-20190331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/CompanyAndSignificantAccountingPolicies" xlink:href="vrcp-20190331.xsd#CompanyAndSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotes" xlink:href="vrcp-20190331.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StockholdersEquity" xlink:href="vrcp-20190331.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/RelatedPartyTransactions" xlink:href="vrcp-20190331.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/SubsequentEvents" xlink:href="vrcp-20190331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/CompanyAndSignificantAccountingPoliciesPolicies" xlink:href="vrcp-20190331.xsd#CompanyAndSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotesTables" xlink:href="vrcp-20190331.xsd#ConvertibleNotesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StockholdersEquityTables" xlink:href="vrcp-20190331.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="vrcp-20190331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotesDetailsNarrative" xlink:href="vrcp-20190331.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotes-ScheduleOfConvertibleNotesDetails" xlink:href="vrcp-20190331.xsd#ConvertibleNotes-ScheduleOfConvertibleNotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StockholdersEquity-SummaryOfOutstandingWarrantsDetails" xlink:href="vrcp-20190331.xsd#StockholdersEquity-SummaryOfOutstandingWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="vrcp-20190331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/SubsequentEventsDetailsNarrative" xlink:href="vrcp-20190331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StatementsOfComprehensiveLoss" xlink:title="00000004 - Statement - Condensed Consolidated  Statements of Comprehensive Loss (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StatementOfChangesInStockholdersEquityDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ReceiptonAccountofSharesMember" xlink:label="loc_VRCPReceiptonAccountofSharesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VRCPReceiptonAccountofSharesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:label="loc_VRCPStockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPStockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="loc_us-gaapAdjustmentOfWarrantsGrantedForServices_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentOfWarrantsGrantedForServices_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ChangeInTermsOfConvertibleNote" xlink:label="loc_VRCPChangeInTermsOfConvertibleNote_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPChangeInTermsOfConvertibleNote_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne" xlink:label="loc_VRCPStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne" xlink:label="loc_VRCPStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_CancellationOfPreferredShares" xlink:label="loc_VRCPCancellationOfPreferredShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPCancellationOfPreferredShares_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_CancellationOfPreferredSharesShares" xlink:label="loc_VRCPCancellationOfPreferredSharesShares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPCancellationOfPreferredSharesShares_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue" xlink:label="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceivedValue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceivedValue_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares" xlink:label="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares_80" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote" xlink:label="loc_VRCPAdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPAdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote_80" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_80" xlink:type="arc" order="20" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/CompanyAndSignificantAccountingPolicies" xlink:title="00000007 - Disclosure - The Company and Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotes" xlink:title="00000008 - Disclosure - Convertible Notes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StockholdersEquity" xlink:title="00000009 - Disclosure - Stockholders' Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - Related Party Transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/SubsequentEvents" xlink:title="00000011 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/CompanyAndSignificantAccountingPoliciesPolicies" xlink:title="00000012 - Disclosure - The Company and Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotesTables" xlink:title="00000013 - Disclosure - Convertible Notes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StockholdersEquityTables" xlink:title="00000014 - Disclosure - Stockholders' Equity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000015 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000016 - Disclosure - Convertible Notes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ConvertiblePromissoryNotesMember" xlink:label="loc_VRCPConvertiblePromissoryNotesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_VRCPConvertiblePromissoryNotesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_30" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotes-ScheduleOfConvertibleNotesDetails" xlink:title="00000017 - Disclosure - Convertible Notes - Schedule of Convertible Notes (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StockholdersEquity-SummaryOfOutstandingWarrantsDetails" xlink:title="00000018 - Disclosure - Stockholders' Equity - Summary of Outstanding Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_InvestorsMember" xlink:label="loc_VRCPInvestorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_VRCPInvestorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassFWarrantMember" xlink:label="loc_VRCPClassFWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VRCPClassFWarrantMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassGWarrantMember" xlink:label="loc_VRCPClassGWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VRCPClassGWarrantMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassHWarrantMember" xlink:label="loc_VRCPClassHWarrantMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VRCPClassHWarrantMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassIWarrantMember" xlink:label="loc_VRCPClassIWarrantMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VRCPClassIWarrantMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_WarrantTerm" xlink:label="loc_VRCPWarrantTerm_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPWarrantTerm_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_WarrantExercisable" xlink:label="loc_VRCPWarrantExercisable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPWarrantExercisable_90" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000019 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_OfficersAndDirectorsMember" xlink:label="loc_VRCPOfficersAndDirectorsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_VRCPOfficersAndDirectorsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestments_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription_50" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://dermacompare.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000020 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="loc_srtChiefFinancialOfficerMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefFinancialOfficerMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross_40" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>vrcp-20190331_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.26b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: VRCP%2D 20190331 10Q Q1 DFN.xfr; Date: 2019%2D05%2D15T14:48:36Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030003 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ReceiptonAccountofSharesMember" xlink:label="VRCP_ReceiptonAccountofSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ReceiptonAccountofSharesMember" xlink:to="VRCP_ReceiptonAccountofSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_ReceiptonAccountofSharesMember_lbl" xml:lang="en-US">Receipt on Account of Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US">Other Comprehensive Income [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="us-gaap_ShortTermDebtTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTypeAxis" xlink:to="us-gaap_ShortTermDebtTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTypeAxis_lbl" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ConvertiblePromissoryNotesMember" xlink:label="VRCP_ConvertiblePromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ConvertiblePromissoryNotesMember" xlink:to="VRCP_ConvertiblePromissoryNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_ConvertiblePromissoryNotesMember_lbl" xml:lang="en-US">Convertible Promissory Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_InvestorsMember" xlink:label="VRCP_InvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_InvestorsMember" xlink:to="VRCP_InvestorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_InvestorsMember_lbl" xml:lang="en-US">Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassFWarrantMember" xlink:label="VRCP_ClassFWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassFWarrantMember" xlink:to="VRCP_ClassFWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_ClassFWarrantMember_lbl" xml:lang="en-US">Class F Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassGWarrantMember" xlink:label="VRCP_ClassGWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassGWarrantMember" xlink:to="VRCP_ClassGWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_ClassGWarrantMember_lbl" xml:lang="en-US">Class G Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassHWarrantMember" xlink:label="VRCP_ClassHWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassHWarrantMember" xlink:to="VRCP_ClassHWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_ClassHWarrantMember_lbl" xml:lang="en-US">Class H Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassIWarrantMember" xlink:label="VRCP_ClassIWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassIWarrantMember" xlink:to="VRCP_ClassIWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_ClassIWarrantMember_lbl" xml:lang="en-US">Class I Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_OfficersAndDirectorsMember" xlink:label="VRCP_OfficersAndDirectorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_OfficersAndDirectorsMember" xlink:to="VRCP_OfficersAndDirectorsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_OfficersAndDirectorsMember_lbl" xml:lang="en-US">Officers and Directors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US">Restricted Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="srt_ChiefExecutiveOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefExecutiveOfficerMember" xlink:to="srt_ChiefExecutiveOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefExecutiveOfficerMember_lbl" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xml:lang="en-US">Chief Financial Officer[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_DocumentAndEntityInformationAbstract" xlink:label="VRCP_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_DocumentAndEntityInformationAbstract" xlink:to="VRCP_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">Short term investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US">Other receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Stockholders' Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AccountsPayableInterestPayable" xlink:label="VRCP_AccountsPayableInterestPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AccountsPayableInterestPayable" xlink:to="VRCP_AccountsPayableInterestPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_AccountsPayableInterestPayable_lbl" xml:lang="en-US">Accounts payable interest payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xml:lang="en-US">Employee payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Short term portion of convertible notes (Note 2)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:to="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_lbl" xml:lang="en-US">Liabilities held for sale</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding at March 2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common stock, $0.0001 par value; 490,000,000 shares authorized; 110,748,391 shares issued and outstanding at March 31, 2019 and December 31, 2018. (Note 3)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US">Accumulated other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional paid-in capital (Note 3)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total liabilities and stockholders' deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Expenses:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="us-gaap_SellingAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingAndMarketingExpense" xlink:to="us-gaap_SellingAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingExpenses_lbl" xml:lang="en-US">Total operating expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Loss from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_FinanceExpense" xlink:label="VRCP_FinanceExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_FinanceExpense" xlink:to="VRCP_FinanceExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_FinanceExpense_lbl" xml:lang="en-US">Finance income (expense), net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net loss</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xml:lang="en-US">Basic and diluted net loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and diluted loss per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US">Weighted average shares outstanding - basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_lbl" xml:lang="en-US">Common stock and warrants issued for cash</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:label="VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:to="VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_lbl" xml:lang="en-US">Common stock and warrants issued for cash, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Common stock issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Common stock issued for services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:to="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentOfWarrantsGrantedForServices_lbl" xml:lang="en-US">Warrants issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xml:lang="en-US">Exercise of stock options, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature_lbl" xml:lang="en-US">Issuance of new convertible note with a beneficial conversion feature</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ChangeInTermsOfConvertibleNote" xlink:label="VRCP_ChangeInTermsOfConvertibleNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ChangeInTermsOfConvertibleNote" xlink:to="VRCP_ChangeInTermsOfConvertibleNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_ChangeInTermsOfConvertibleNote_lbl" xml:lang="en-US">Change in the terms of Convertible Note</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne" xlink:label="VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne" xlink:to="VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne_lbl" xml:lang="en-US">Partial conversion of convertible note to shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne" xlink:label="VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne" xlink:to="VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne_lbl" xml:lang="en-US">Partial conversion of convertible note to shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_CancellationOfPreferredShares" xlink:label="VRCP_CancellationOfPreferredShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_CancellationOfPreferredShares" xlink:to="VRCP_CancellationOfPreferredShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_CancellationOfPreferredShares_lbl" xml:lang="en-US">Cancellation of Preferred Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_CancellationOfPreferredSharesShares" xlink:label="VRCP_CancellationOfPreferredSharesShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_CancellationOfPreferredSharesShares" xlink:to="VRCP_CancellationOfPreferredSharesShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_CancellationOfPreferredSharesShares_lbl" xml:lang="en-US">Cancellation of Preferred Shares, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue" xlink:label="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue" xlink:to="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue_lbl" xml:lang="en-US">Issuance of Shares in respect of proceeds received during 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares" xlink:label="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares" xlink:to="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares_lbl" xml:lang="en-US">Issuance of Shares in respect of proceeds received during 2017, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote" xlink:label="VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote" xlink:to="VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote_lbl" xml:lang="en-US">Extension of convertible note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Shares issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" xlink:label="VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" xlink:to="VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes_lbl" xml:lang="en-US">Finance (income) loss arising from change in terms of convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IncreaseInNetLiabilitiesForSale" xlink:label="VRCP_IncreaseInNetLiabilitiesForSale" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IncreaseInNetLiabilitiesForSale" xlink:to="VRCP_IncreaseInNetLiabilitiesForSale_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_IncreaseInNetLiabilitiesForSale_lbl" xml:lang="en-US">Increase in net liabilities for sale</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US">Increase (decrease) in accounts payable and accrued expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="us-gaap_MarketableSecuritiesGainLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesGainLoss" xlink:to="us-gaap_MarketableSecuritiesGainLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MarketableSecuritiesGainLoss_lbl" xml:lang="en-US">Loss from marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties_lbl" xml:lang="en-US">Decrease in amounts due from related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xml:lang="en-US">Increase in deferred revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_lbl" xml:lang="en-US">Increase (decrease) in accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_lbl" xml:lang="en-US">Increase in other receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash used in operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xml:lang="en-US">Selling of marketable securities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash provided by investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from sale of common stock and warrants (net of issuance expenses)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xml:lang="en-US">Exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IssuanceOfSharesInRespectOfProceedsReceived" xlink:label="VRCP_IssuanceOfSharesInRespectOfProceedsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IssuanceOfSharesInRespectOfProceedsReceived" xlink:to="VRCP_IssuanceOfSharesInRespectOfProceedsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="VRCP_IssuanceOfSharesInRespectOfProceedsReceived_lbl" xml:lang="en-US">Issuance of Shares in respect of proceeds received during 2017</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="us-gaap_ProceedsFromShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromShortTermDebt" xlink:to="us-gaap_ProceedsFromShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromShortTermDebt_lbl" xml:lang="en-US">Issuance of convertible note</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash provided by financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net (decrease) increase in cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash and cash equivalents - beginning of period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash and cash equivalents - end of period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncashInvestingAndFinancingItemsAbstract_lbl" xml:lang="en-US">Non-cash transactions:</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ConversionToSharesOfConvertibleLoans" xlink:label="VRCP_ConversionToSharesOfConvertibleLoans" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ConversionToSharesOfConvertibleLoans" xlink:to="VRCP_ConversionToSharesOfConvertibleLoans_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_ConversionToSharesOfConvertibleLoans_lbl" xml:lang="en-US">Conversion to shares of convertible loans</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_CancellationOfPreferredShares" xlink:to="VRCP_CancellationOfPreferredShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="VRCP_CancellationOfPreferredShares_2_lbl" xml:lang="en-US">Cancellation of preferred shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">The Company and Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xml:lang="en-US">Convertible Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Party Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_OrganizationalBackgroundPolicyTextBlock" xlink:label="VRCP_OrganizationalBackgroundPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_OrganizationalBackgroundPolicyTextBlock" xlink:to="VRCP_OrganizationalBackgroundPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_OrganizationalBackgroundPolicyTextBlock_lbl" xml:lang="en-US">Organizational Background</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_GoingConcernPolicyTextBlock" xlink:label="VRCP_GoingConcernPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_GoingConcernPolicyTextBlock" xlink:to="VRCP_GoingConcernPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_GoingConcernPolicyTextBlock_lbl" xml:lang="en-US">Going Concern</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards Announced</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="us-gaap_ConvertibleDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleDebtTableTextBlock" xlink:to="us-gaap_ConvertibleDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of Convertible Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Summary of Outstanding Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExcessCapital" xlink:label="us-gaap_ExcessCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExcessCapital" xlink:to="us-gaap_ExcessCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExcessCapital_lbl" xml:lang="en-US">Approximate amount of capital raised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Debt bearing interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Convertible price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt instrument, maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Principle</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ConversionOfConvertibleNotesToShares" xlink:label="VRCP_ConversionOfConvertibleNotesToShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ConversionOfConvertibleNotesToShares" xlink:to="VRCP_ConversionOfConvertibleNotesToShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_ConversionOfConvertibleNotesToShares_lbl" xml:lang="en-US">Conversion of convertible notes to shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_RangeAxis_2_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_WarrantTerm" xlink:label="VRCP_WarrantTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_WarrantTerm" xlink:to="VRCP_WarrantTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_WarrantTerm_lbl" xml:lang="en-US">Warrant Term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_WarrantExercisable" xlink:label="VRCP_WarrantExercisable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_WarrantExercisable" xlink:to="VRCP_WarrantExercisable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_WarrantExercisable_lbl" xml:lang="en-US">Warrant Exercisable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Shareholders with beneficial holdings percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US">Shareholders with beneficial holdings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="us-gaap_DebtInstrumentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentDescription" xlink:to="us-gaap_DebtInstrumentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentDescription_lbl" xml:lang="en-US">Debt description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Number of shares issued for services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_lbl" xml:lang="en-US">Number of restricted shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_lbl" xml:lang="en-US">Number of restricted shares, value</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AccountsPayableRelatedPartyMember" xlink:label="VRCP_AccountsPayableRelatedPartyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AccountsPayableRelatedPartyMember" xlink:to="VRCP_AccountsPayableRelatedPartyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AccountsPayableRelatedPartyMember_doc" xml:lang="en-US">Accounts Payable - Related Party [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AccreditedInvestordMember" xlink:label="VRCP_AccreditedInvestordMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AccreditedInvestordMember" xlink:to="VRCP_AccreditedInvestordMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AccreditedInvestordMember_doc" xml:lang="en-US">Accredited Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AlimiAhmedMember" xlink:label="VRCP_AlimiAhmedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AlimiAhmedMember" xlink:to="VRCP_AlimiAhmedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AlimiAhmedMember_doc" xml:lang="en-US">Alimi Ahmed [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AlphaAndChiOptionMember" xlink:label="VRCP_AlphaAndChiOptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AlphaAndChiOptionMember" xlink:to="VRCP_AlphaAndChiOptionMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AlphaAndChiOptionMember_doc" xml:lang="en-US">Alpha Chi Option [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AlphaAnstaltCapitalMember" xlink:label="VRCP_AlphaAnstaltCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AlphaAnstaltCapitalMember" xlink:to="VRCP_AlphaAnstaltCapitalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AlphaAnstaltCapitalMember_doc" xml:lang="en-US">Alpha Anstalt Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AlphaCapitalAnsaltAndChiSquaredIncMember" xlink:label="VRCP_AlphaCapitalAnsaltAndChiSquaredIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AlphaCapitalAnsaltAndChiSquaredIncMember" xlink:to="VRCP_AlphaCapitalAnsaltAndChiSquaredIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AlphaCapitalAnsaltAndChiSquaredIncMember_doc" xml:lang="en-US">Alpha Capital Ansalt and Chi Squared Inc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AlphaMember" xlink:label="VRCP_AlphaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AlphaMember" xlink:to="VRCP_AlphaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AlphaMember_doc" xml:lang="en-US">Alpha [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AlphaandChiSquaredMember" xlink:label="VRCP_AlphaandChiSquaredMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AlphaandChiSquaredMember" xlink:to="VRCP_AlphaandChiSquaredMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AlphaandChiSquaredMember_doc" xml:lang="en-US">Alpha and Chi Squared [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AugustTwoThousandSeventeenFinancingMember" xlink:label="VRCP_AugustTwoThousandSeventeenFinancingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AugustTwoThousandSeventeenFinancingMember" xlink:to="VRCP_AugustTwoThousandSeventeenFinancingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AugustTwoThousandSeventeenFinancingMember_doc" xml:lang="en-US">August 2017 Financing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AxelSpringerPlugMember" xlink:label="VRCP_AxelSpringerPlugMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AxelSpringerPlugMember" xlink:to="VRCP_AxelSpringerPlugMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AxelSpringerPlugMember_doc" xml:lang="en-US">Axel Springer Plug [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AyinNunChafYeuztLtdMember" xlink:label="VRCP_AyinNunChafYeuztLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AyinNunChafYeuztLtdMember" xlink:to="VRCP_AyinNunChafYeuztLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AyinNunChafYeuztLtdMember_doc" xml:lang="en-US">Ayin, Nun, Chaf, Yeuzt Ltd [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_CancellationOfPreferredShares" xlink:to="VRCP_CancellationOfPreferredShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_CancellationOfPreferredShares_doc" xml:lang="en-US">Cancellation of Preferred Shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_CancellationOfPreferredSharesShares" xlink:to="VRCP_CancellationOfPreferredSharesShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_CancellationOfPreferredSharesShares_doc" xml:lang="en-US">Cancellation of Preferred Shares, shares.</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ChiefExecutiveOfficerAndFounderMember" xlink:label="VRCP_ChiefExecutiveOfficerAndFounderMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ChiefExecutiveOfficerAndFounderMember" xlink:to="VRCP_ChiefExecutiveOfficerAndFounderMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ChiefExecutiveOfficerAndFounderMember_doc" xml:lang="en-US">Chief Executive Officer and Founder [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ChironRefineriesLtdMember" xlink:label="VRCP_ChironRefineriesLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ChironRefineriesLtdMember" xlink:to="VRCP_ChironRefineriesLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ChironRefineriesLtdMember_doc" xml:lang="en-US">Chiron Refineries Ltd. [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassAWarrantMember" xlink:label="VRCP_ClassAWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassAWarrantMember" xlink:to="VRCP_ClassAWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ClassAWarrantMember_doc" xml:lang="en-US">Class A warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassBWarrantMember" xlink:label="VRCP_ClassBWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassBWarrantMember" xlink:to="VRCP_ClassBWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ClassBWarrantMember_doc" xml:lang="en-US">Class B warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassEWarrantMember" xlink:label="VRCP_ClassEWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassEWarrantMember" xlink:to="VRCP_ClassEWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ClassEWarrantMember_doc" xml:lang="en-US">Class E warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassFWarrantMember" xlink:to="VRCP_ClassFWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ClassFWarrantMember_doc" xml:lang="en-US">Class F Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassGWarrantMember" xlink:to="VRCP_ClassGWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ClassGWarrantMember_doc" xml:lang="en-US">Class G Warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassHWarrantMember" xlink:to="VRCP_ClassHWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ClassHWarrantMember_doc" xml:lang="en-US">Class H warrant [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ClassIWarrantMember" xlink:to="VRCP_ClassIWarrantMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ClassIWarrantMember_doc" xml:lang="en-US">Class I Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ConsultantsMember" xlink:label="VRCP_ConsultantsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ConsultantsMember" xlink:to="VRCP_ConsultantsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ConsultantsMember_doc" xml:lang="en-US">Consultants [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ConsultingAgreementMember" xlink:label="VRCP_ConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ConsultingAgreementMember" xlink:to="VRCP_ConsultingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ConsultingAgreementMember_doc" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ConversionOfConvertibleNotesToShares" xlink:to="VRCP_ConversionOfConvertibleNotesToShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ConversionOfConvertibleNotesToShares_doc" xml:lang="en-US">Conversion of convertible notes to shares.</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_EUROCurrencyMember" xlink:label="VRCP_EUROCurrencyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_EUROCurrencyMember" xlink:to="VRCP_EUROCurrencyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_EUROCurrencyMember_doc" xml:lang="en-US">EURO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_EmployeePayableMember" xlink:label="VRCP_EmployeePayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_EmployeePayableMember" xlink:to="VRCP_EmployeePayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_EmployeePayableMember_doc" xml:lang="en-US">Employee Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ExercisePriceOneMember" xlink:label="VRCP_ExercisePriceOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ExercisePriceOneMember" xlink:to="VRCP_ExercisePriceOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ExercisePriceOneMember_doc" xml:lang="en-US">Exercise Price One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_FinanceExpense" xlink:to="VRCP_FinanceExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_FinanceExpense_doc" xml:lang="en-US">Finance expense.</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_FirstfireGlobalOpportunitiesFundLTCMember" xlink:label="VRCP_FirstfireGlobalOpportunitiesFundLTCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_FirstfireGlobalOpportunitiesFundLTCMember" xlink:to="VRCP_FirstfireGlobalOpportunitiesFundLTCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_FirstfireGlobalOpportunitiesFundLTCMember_doc" xml:lang="en-US">Firstfire Global Opportunities Fund LTC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_FurnitureAndOfficeEquipmentMember" xlink:label="VRCP_FurnitureAndOfficeEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_FurnitureAndOfficeEquipmentMember" xlink:to="VRCP_FurnitureAndOfficeEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_FurnitureAndOfficeEquipmentMember_doc" xml:lang="en-US">Furniture and Office Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_GoldMedLtdMember" xlink:label="VRCP_GoldMedLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_GoldMedLtdMember" xlink:to="VRCP_GoldMedLtdMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_GoldMedLtdMember_doc" xml:lang="en-US">GoldMed Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IlanMalkaMember" xlink:label="VRCP_IlanMalkaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IlanMalkaMember" xlink:to="VRCP_IlanMalkaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_IlanMalkaMember_doc" xml:lang="en-US">Ilan Malka [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_InvestorsMember" xlink:to="VRCP_InvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_InvestorsMember_doc" xml:lang="en-US">Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IsraeliMember" xlink:label="VRCP_IsraeliMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IsraeliMember" xlink:to="VRCP_IsraeliMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_IsraeliMember_doc" xml:lang="en-US">Israeli [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IssuanceOfSharesInRespectOfProceedsReceived" xlink:to="VRCP_IssuanceOfSharesInRespectOfProceedsReceived_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_IssuanceOfSharesInRespectOfProceedsReceived_doc" xml:lang="en-US">Issuance of Shares in respect of proceeds received.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares" xlink:to="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares_doc" xml:lang="en-US">Issuance of Shares in respect of proceeds received shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue" xlink:to="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue_doc" xml:lang="en-US">Issuance of Shares in respect of proceeds received.</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_JanuaryTwoThousandEighteenConvertibleNotesMember" xlink:label="VRCP_JanuaryTwoThousandEighteenConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_JanuaryTwoThousandEighteenConvertibleNotesMember" xlink:to="VRCP_JanuaryTwoThousandEighteenConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_JanuaryTwoThousandEighteenConvertibleNotesMember_doc" xml:lang="en-US">January 2018 Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_JanuaryTwoThousandEighteenTwentyFourConvertibleNotesMember" xlink:label="VRCP_JanuaryTwoThousandEighteenTwentyFourConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_JanuaryTwoThousandEighteenTwentyFourConvertibleNotesMember" xlink:to="VRCP_JanuaryTwoThousandEighteenTwentyFourConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_JanuaryTwoThousandEighteenTwentyFourConvertibleNotesMember_doc" xml:lang="en-US">January 24, 2018 Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_JanuaryTwoThousandEighteenTwentyThreeConvertibleNotesMember" xlink:label="VRCP_JanuaryTwoThousandEighteenTwentyThreeConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_JanuaryTwoThousandEighteenTwentyThreeConvertibleNotesMember" xlink:to="VRCP_JanuaryTwoThousandEighteenTwentyThreeConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_JanuaryTwoThousandEighteenTwentyThreeConvertibleNotesMember_doc" xml:lang="en-US">January 23, 2018 Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_MazPartnerMember" xlink:label="VRCP_MazPartnerMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_MazPartnerMember" xlink:to="VRCP_MazPartnerMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_MazPartnerMember_doc" xml:lang="en-US">Maz Partner [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_MrAlimiAhmedMember" xlink:label="VRCP_MrAlimiAhmedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_MrAlimiAhmedMember" xlink:to="VRCP_MrAlimiAhmedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_MrAlimiAhmedMember_doc" xml:lang="en-US">Mr. Alimi Ahmed [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_MrWaynMember" xlink:label="VRCP_MrWaynMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_MrWaynMember" xlink:to="VRCP_MrWaynMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_MrWaynMember_doc" xml:lang="en-US">Mr. Wayn [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_NewThirdPartyInvestorsMember" xlink:label="VRCP_NewThirdPartyInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_NewThirdPartyInvestorsMember" xlink:to="VRCP_NewThirdPartyInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_NewThirdPartyInvestorsMember_doc" xml:lang="en-US">New Third Party Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_OneLakhConvertibleNotesMember" xlink:label="VRCP_OneLakhConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_OneLakhConvertibleNotesMember" xlink:to="VRCP_OneLakhConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_OneLakhConvertibleNotesMember_doc" xml:lang="en-US">$100,000 Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_PlayAcceleratorGmbHMember" xlink:label="VRCP_PlayAcceleratorGmbHMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_PlayAcceleratorGmbHMember" xlink:to="VRCP_PlayAcceleratorGmbHMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_PlayAcceleratorGmbHMember_doc" xml:lang="en-US">Play Accelerator GmbH [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_PublicisGroupeNintyMember" xlink:label="VRCP_PublicisGroupeNintyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_PublicisGroupeNintyMember" xlink:to="VRCP_PublicisGroupeNintyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_PublicisGroupeNintyMember_doc" xml:lang="en-US">Publicis 90 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ReceiptonAccountofSharesMember" xlink:to="VRCP_ReceiptonAccountofSharesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ReceiptonAccountofSharesMember_doc" xml:lang="en-US">Receipt on Account of Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_SeriesAConvertiblePreferredStockMember" xlink:label="VRCP_SeriesAConvertiblePreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_SeriesAConvertiblePreferredStockMember" xlink:to="VRCP_SeriesAConvertiblePreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_SeriesAConvertiblePreferredStockMember_doc" xml:lang="en-US">Series A Convertible Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_SeriesAPreferredConvertibleStockMember" xlink:label="VRCP_SeriesAPreferredConvertibleStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_SeriesAPreferredConvertibleStockMember" xlink:to="VRCP_SeriesAPreferredConvertibleStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_SeriesAPreferredConvertibleStockMember_doc" xml:lang="en-US">Series A Preferrred Convertible Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_SettlementAgreementMember" xlink:label="VRCP_SettlementAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_SettlementAgreementMember" xlink:to="VRCP_SettlementAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_SettlementAgreementMember_doc" xml:lang="en-US">Settlement Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ShortTermPortionOfConvertibleNotesMember" xlink:label="VRCP_ShortTermPortionOfConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ShortTermPortionOfConvertibleNotesMember" xlink:to="VRCP_ShortTermPortionOfConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ShortTermPortionOfConvertibleNotesMember_doc" xml:lang="en-US">Short Term Portion of Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:to="VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants_doc" xml:lang="en-US">Common stock and warrants issued for cash, shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne" xlink:to="VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne_doc" xml:lang="en-US">Partial conversion of convertible note to shares, shares one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne" xlink:to="VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne_doc" xml:lang="en-US">Partial conversion of convertible note to shares, value one.</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_TwoAccreditedInvestordMember" xlink:label="VRCP_TwoAccreditedInvestordMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_TwoAccreditedInvestordMember" xlink:to="VRCP_TwoAccreditedInvestordMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_TwoAccreditedInvestordMember_doc" xml:lang="en-US">Two Accredited Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_TwoAccreditedInvestorsMember" xlink:label="VRCP_TwoAccreditedInvestorsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_TwoAccreditedInvestorsMember" xlink:to="VRCP_TwoAccreditedInvestorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_TwoAccreditedInvestorsMember_doc" xml:lang="en-US">Two Accredited Investors [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_TwoThousandSeventeenStockIncentivePlanMember" xlink:label="VRCP_TwoThousandSeventeenStockIncentivePlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_TwoThousandSeventeenStockIncentivePlanMember" xlink:to="VRCP_TwoThousandSeventeenStockIncentivePlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_TwoThousandSeventeenStockIncentivePlanMember_doc" xml:lang="en-US">2017 Stock Incentive Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_TwoThousandSixteenSecuredConvertibleNoteAgreementMember" xlink:label="VRCP_TwoThousandSixteenSecuredConvertibleNoteAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_TwoThousandSixteenSecuredConvertibleNoteAgreementMember" xlink:to="VRCP_TwoThousandSixteenSecuredConvertibleNoteAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_TwoThousandSixteenSecuredConvertibleNoteAgreementMember_doc" xml:lang="en-US">2016 Secured Convertible Note Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_VirtualCryptoIsraelMember" xlink:label="VRCP_VirtualCryptoIsraelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_VirtualCryptoIsraelMember" xlink:to="VRCP_VirtualCryptoIsraelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_VirtualCryptoIsraelMember_doc" xml:lang="en-US">Virtual Crypto Israel [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_WarrantExercisable" xlink:to="VRCP_WarrantExercisable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_WarrantExercisable_doc" xml:lang="en-US">Warrant Exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_WarrantTerm" xlink:to="VRCP_WarrantTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_WarrantTerm_doc" xml:lang="en-US">Warrant term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AccountsPayableInterestPayable" xlink:to="VRCP_AccountsPayableInterestPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AccountsPayableInterestPayable_doc" xml:lang="en-US">Accounts payable interest payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote" xlink:to="VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote_doc" xml:lang="en-US">Extension of convretible note.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" xlink:to="VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes_doc" xml:lang="en-US">Finance (income) loss arising from change in terms of convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IncreaseInNetLiabilitiesForSale" xlink:to="VRCP_IncreaseInNetLiabilitiesForSale_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_IncreaseInNetLiabilitiesForSale_doc" xml:lang="en-US">Increase in net liabilities for sale.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ConversionToSharesOfConvertibleLoans" xlink:to="VRCP_ConversionToSharesOfConvertibleLoans_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ConversionToSharesOfConvertibleLoans_doc" xml:lang="en-US">Conversion to shares of convertible loans.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_OrganizationalBackgroundPolicyTextBlock" xlink:to="VRCP_OrganizationalBackgroundPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_OrganizationalBackgroundPolicyTextBlock_doc" xml:lang="en-US">Organizational Background [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_GoingConcernPolicyTextBlock" xlink:to="VRCP_GoingConcernPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_GoingConcernPolicyTextBlock_doc" xml:lang="en-US">Going Concern [Poliy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ConvertiblePromissoryNotesMember" xlink:to="VRCP_ConvertiblePromissoryNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ConvertiblePromissoryNotesMember_doc" xml:lang="en-US">Convertible Promissory Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_OfficersAndDirectorsMember" xlink:to="VRCP_OfficersAndDirectorsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_OfficersAndDirectorsMember_doc" xml:lang="en-US">Officers and Directors [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_ChangeInTermsOfConvertibleNote" xlink:to="VRCP_ChangeInTermsOfConvertibleNote_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="VRCP_ChangeInTermsOfConvertibleNote_doc" xml:lang="en-US">Change in the terms of Convertible Note.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpenses_2_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesGainLoss" xlink:to="us-gaap_MarketableSecuritiesGainLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MarketableSecuritiesGainLoss_2_lbl" xml:lang="en-US">Marketable Securities, Gain (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:to="us-gaap_IncreaseDecreaseInDueFromRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInDueFromRelatedParties_2_lbl" xml:lang="en-US">Increase (Decrease) in Due from Related Parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInOtherReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="VRCP_IssuanceOfSharesInRespectOfProceedsReceived" xlink:to="VRCP_IssuanceOfSharesInRespectOfProceedsReceived_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="VRCP_IssuanceOfSharesInRespectOfProceedsReceived_3_lbl" xml:lang="en-US">IssuanceOfSharesInRespectOfProceedsReceived</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_2_lbl" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_2_lbl" xml:lang="en-US">Notes Payable, Current</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>vrcp-20190331_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.26b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: VRCP%2D 20190331 10Q Q1 DFN.xfr; Date: 2019%2D05%2D15T14:48:36Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x80030003 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://dermacompare.com/role/DocumentAndEntityInformation" xlink:href="vrcp-20190331.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/BalanceSheets" xlink:href="vrcp-20190331.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/BalanceSheetsParenthetical" xlink:href="vrcp-20190331.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StatementsOfComprehensiveLoss" xlink:href="vrcp-20190331.xsd#StatementsOfComprehensiveLoss" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StatementOfChangesInStockholdersEquityDeficit" xlink:href="vrcp-20190331.xsd#StatementOfChangesInStockholdersEquityDeficit" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StatementsOfCashFlows" xlink:href="vrcp-20190331.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/CompanyAndSignificantAccountingPolicies" xlink:href="vrcp-20190331.xsd#CompanyAndSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotes" xlink:href="vrcp-20190331.xsd#ConvertibleNotes" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StockholdersEquity" xlink:href="vrcp-20190331.xsd#StockholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/RelatedPartyTransactions" xlink:href="vrcp-20190331.xsd#RelatedPartyTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/SubsequentEvents" xlink:href="vrcp-20190331.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/CompanyAndSignificantAccountingPoliciesPolicies" xlink:href="vrcp-20190331.xsd#CompanyAndSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotesTables" xlink:href="vrcp-20190331.xsd#ConvertibleNotesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StockholdersEquityTables" xlink:href="vrcp-20190331.xsd#StockholdersEquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="vrcp-20190331.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotesDetailsNarrative" xlink:href="vrcp-20190331.xsd#ConvertibleNotesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/ConvertibleNotes-ScheduleOfConvertibleNotesDetails" xlink:href="vrcp-20190331.xsd#ConvertibleNotes-ScheduleOfConvertibleNotesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/StockholdersEquity-SummaryOfOutstandingWarrantsDetails" xlink:href="vrcp-20190331.xsd#StockholdersEquity-SummaryOfOutstandingWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="vrcp-20190331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://dermacompare.com/role/SubsequentEventsDetailsNarrative" xlink:href="vrcp-20190331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_DocumentAndEntityInformationAbstract" xlink:label="loc_VRCPDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_VRCPDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/BalanceSheets" xlink:title="00000002 - Statement - Condensed Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsAndOtherReceivablesNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AccountsPayableInterestPayable" xlink:label="loc_VRCPAccountsPayableInterestPayable" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_VRCPAccountsPayableInterestPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StatementsOfComprehensiveLoss" xlink:title="00000004 - Statement - Condensed Consolidated  Statements of Comprehensive Loss (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_FinanceExpense" xlink:label="loc_VRCPFinanceExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_VRCPFinanceExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEarningsPerShareBasicAndDilutedAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StatementOfChangesInStockholdersEquityDeficit" xlink:title="00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="70" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ReceiptonAccountofSharesMember" xlink:label="loc_VRCPReceiptonAccountofSharesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_VRCPReceiptonAccountofSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:label="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:label="loc_VRCPStockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPStockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentOfWarrantsGrantedForServices" xlink:label="loc_us-gaapAdjustmentOfWarrantsGrantedForServices" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentOfWarrantsGrantedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ChangeInTermsOfConvertibleNote" xlink:label="loc_VRCPChangeInTermsOfConvertibleNote" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPChangeInTermsOfConvertibleNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne" xlink:label="loc_VRCPStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPStockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne" xlink:label="loc_VRCPStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPStockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_CancellationOfPreferredShares" xlink:label="loc_VRCPCancellationOfPreferredShares" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPCancellationOfPreferredShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_CancellationOfPreferredSharesShares" xlink:label="loc_VRCPCancellationOfPreferredSharesShares" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPCancellationOfPreferredSharesShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue" xlink:label="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceivedValue" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceivedValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares" xlink:label="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote" xlink:label="loc_VRCPAdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPAdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" xlink:label="loc_VRCPFinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_VRCPFinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IncreaseInNetLiabilitiesForSale" xlink:label="loc_VRCPIncreaseInNetLiabilitiesForSale" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_VRCPIncreaseInNetLiabilitiesForSale" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss" xlink:label="loc_us-gaapMarketableSecuritiesGainLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapMarketableSecuritiesGainLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInDueFromRelatedParties" xlink:label="loc_us-gaapIncreaseDecreaseInDueFromRelatedParties" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInDueFromRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInOtherReceivables" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="loc_us-gaapProceedsFromStockOptionsExercised" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromStockOptionsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_IssuanceOfSharesInRespectOfProceedsReceived" xlink:label="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceived" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_VRCPIssuanceOfSharesInRespectOfProceedsReceived" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:label="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ConversionToSharesOfConvertibleLoans" xlink:label="loc_VRCPConversionToSharesOfConvertibleLoans" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_VRCPConversionToSharesOfConvertibleLoans" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_CancellationOfPreferredShares" xlink:label="loc_VRCPCancellationOfPreferredShares" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNoncashInvestingAndFinancingItemsAbstract" xlink:to="loc_VRCPCancellationOfPreferredShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/CompanyAndSignificantAccountingPolicies" xlink:title="00000007 - Disclosure - The Company and Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotes" xlink:title="00000008 - Disclosure - Convertible Notes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="loc_us-gaapDebtDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StockholdersEquity" xlink:title="00000009 - Disclosure - Stockholders' Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/RelatedPartyTransactions" xlink:title="00000010 - Disclosure - Related Party Transactions">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/SubsequentEvents" xlink:title="00000011 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/CompanyAndSignificantAccountingPoliciesPolicies" xlink:title="00000012 - Disclosure - The Company and Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_OrganizationalBackgroundPolicyTextBlock" xlink:label="loc_VRCPOrganizationalBackgroundPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_VRCPOrganizationalBackgroundPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_GoingConcernPolicyTextBlock" xlink:label="loc_VRCPGoingConcernPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_VRCPGoingConcernPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotesTables" xlink:title="00000013 - Disclosure - Convertible Notes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtTableTextBlock" xlink:label="loc_us-gaapConvertibleDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapConvertibleDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StockholdersEquityTables" xlink:title="00000014 - Disclosure - Stockholders' Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000015 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExcessCapital" xlink:label="loc_us-gaapExcessCapital" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapExcessCapital" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotesDetailsNarrative" xlink:title="00000016 - Disclosure - Convertible Notes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableAbstract" xlink:label="loc_us-gaapNotesPayableAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNotesPayableAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis" xlink:label="loc_us-gaapShortTermDebtTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapShortTermDebtTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain" xlink:label="loc_us-gaapShortTermDebtTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeAxis" xlink:to="loc_us-gaapShortTermDebtTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ConvertiblePromissoryNotesMember" xlink:label="loc_VRCPConvertiblePromissoryNotesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShortTermDebtTypeDomain" xlink:to="loc_VRCPConvertiblePromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/ConvertibleNotes-ScheduleOfConvertibleNotesDetails" xlink:title="00000017 - Disclosure - Convertible Notes - Schedule of Convertible Notes (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ConversionOfConvertibleNotesToShares" xlink:label="loc_VRCPConversionOfConvertibleNotesToShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_VRCPConversionOfConvertibleNotesToShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/StockholdersEquity-SummaryOfOutstandingWarrantsDetails" xlink:title="00000018 - Disclosure - Stockholders' Equity - Summary of Outstanding Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_InvestorsMember" xlink:label="loc_VRCPInvestorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_VRCPInvestorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassFWarrantMember" xlink:label="loc_VRCPClassFWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VRCPClassFWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassGWarrantMember" xlink:label="loc_VRCPClassGWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VRCPClassGWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassHWarrantMember" xlink:label="loc_VRCPClassHWarrantMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VRCPClassHWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_ClassIWarrantMember" xlink:label="loc_VRCPClassIWarrantMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_VRCPClassIWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="loc_us-gaapClassOfWarrantOrRightOutstanding" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_WarrantTerm" xlink:label="loc_VRCPWarrantTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPWarrantTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_WarrantExercisable" xlink:label="loc_VRCPWarrantExercisable" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_VRCPWarrantExercisable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="00000019 - Disclosure - Related Party Transactions (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="vrcp-20190331.xsd#VRCP_OfficersAndDirectorsMember" xlink:label="loc_VRCPOfficersAndDirectorsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_VRCPOfficersAndDirectorsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentDescription" xlink:label="loc_us-gaapDebtInstrumentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://dermacompare.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000020 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="loc_us-gaapRestrictedStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaapRestrictedStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srtChiefExecutiveOfficerMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefExecutiveOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ChiefFinancialOfficerMember" xlink:label="loc_srtChiefFinancialOfficerMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_srtChiefFinancialOfficerMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6838365312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>May 15, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Virtual Crypto Technologies, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000797542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,249,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VRCP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6834745168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 447,967<span></span>
</td>
<td class="nump">$ 499,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short term investment</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">17,242<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Other receivable</a></td>
<td class="nump">12,842<span></span>
</td>
<td class="nump">41,516<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">460,809<span></span>
</td>
<td class="nump">558,677<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">460,809<span></span>
</td>
<td class="nump">558,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">98,871<span></span>
</td>
<td class="nump">13,115<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_AccountsPayableInterestPayable', window );">Accounts payable interest payable</a></td>
<td class="nump">8,227<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">7,064<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short term portion of convertible notes (Note 2)</a></td>
<td class="nump">503,217<span></span>
</td>
<td class="nump">485,449<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent', window );">Liabilities held for sale</a></td>
<td class="nump">469,525<span></span>
</td>
<td class="nump">469,525<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,079,840<span></span>
</td>
<td class="nump">975,153<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,079,840<span></span>
</td>
<td class="nump">975,153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 10,000,000 shares authorized; none issued and outstanding at March 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 490,000,000 shares authorized; 110,748,391 shares issued and outstanding at March 31, 2019 and December 31, 2018. (Note 3)</a></td>
<td class="nump">11,075<span></span>
</td>
<td class="nump">11,075<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="num">(19,337)<span></span>
</td>
<td class="num">(19,337)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital (Note 3)</a></td>
<td class="nump">41,100,794<span></span>
</td>
<td class="nump">41,218,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(41,711,563)<span></span>
</td>
<td class="num">(41,626,905)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' deficit</a></td>
<td class="num">(619,031)<span></span>
</td>
<td class="num">(416,476)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' deficit</a></td>
<td class="nump">$ 460,809<span></span>
</td>
<td class="nump">$ 558,677<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_AccountsPayableInterestPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts payable interest payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_AccountsPayableInterestPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6838523472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">490,000,000<span></span>
</td>
<td class="nump">490,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">110,748,391<span></span>
</td>
<td class="nump">110,748,391<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">110,748,391<span></span>
</td>
<td class="nump">110,748,391<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6839020016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated  Statements of Comprehensive Loss (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 9,413<span></span>
</td>
<td class="nump">$ 54,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">310,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">191,210<span></span>
</td>
<td class="nump">1,064,283<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">200,623<span></span>
</td>
<td class="nump">1,428,294<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(200,623)<span></span>
</td>
<td class="num">(1,428,294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_FinanceExpense', window );">Finance income (expense), net</a></td>
<td class="nump">115,965<span></span>
</td>
<td class="num">(19,374,082)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (84,658)<span></span>
</td>
<td class="num">$ (20,802,376)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Basic and diluted net loss per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted loss per share</a></td>
<td class="nump">$ (0.00)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average shares outstanding - basic and diluted</a></td>
<td class="nump">110,748,391<span></span>
</td>
<td class="nump">41,048,456<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_FinanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_FinanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6841768032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)<br></strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Receipt on Account of Shares [Member]</div></th>
<th class="th"><div>Other Comprehensive Income [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2017</a></td>
<td class="nump">$ 2,255<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 14,968,925<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="num">$ (19,337)<span></span>
</td>
<td class="num">$ (16,620,419)<span></span>
</td>
<td class="num">$ (1,588,576)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2017</a></td>
<td class="nump">22,543,008<span></span>
</td>
<td class="nump">529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Common stock and warrants issued for cash</a></td>
<td class="nump">$ 2,770<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,938,180<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants', window );">Common stock and warrants issued for cash, shares</a></td>
<td class="nump">27,697,855<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common stock issued for services</a></td>
<td class="nump">$ 433<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,003,866<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common stock issued for services, shares</a></td>
<td class="nump">4,329,999<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentOfWarrantsGrantedForServices', window );">Warrants issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">146,376<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="nump">62,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature', window );">Issuance of new convertible note with a beneficial conversion feature</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_ChangeInTermsOfConvertibleNote', window );">Change in the terms of Convertible Note</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">22,581,508<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">22,581,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne', window );">Partial conversion of convertible note to shares</a></td>
<td class="nump">$ 5,554<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">549,836<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne', window );">Partial conversion of convertible note to shares, shares</a></td>
<td class="nump">55,543,600<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_CancellationOfPreferredShares', window );">Cancellation of Preferred Shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(150,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_CancellationOfPreferredSharesShares', window );">Cancellation of Preferred Shares, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(529)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue', window );">Issuance of Shares in respect of proceeds received during 2017</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">79,943<span></span>
</td>
<td class="num">(80,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares', window );">Issuance of Shares in respect of proceeds received during 2017, shares</a></td>
<td class="nump">571,429<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(25,006,486)<span></span>
</td>
<td class="num">(25,006,486)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="nump">$ 11,075<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">41,218,691<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(19,337)<span></span>
</td>
<td class="num">(41,626,905)<span></span>
</td>
<td class="num">(416,476)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="nump">110,748,391<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentOfWarrantsGrantedForServices', window );">Warrants issued for services</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">28,035<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">28,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_CancellationOfPreferredShares', window );">Cancellation of Preferred Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote', window );">Extension of convertible note</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(145,932)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(145,932)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(84,658)<span></span>
</td>
<td class="num">(84,658)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2019</a></td>
<td class="nump">$ 11,075<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 41,100,794<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">$ (19,337)<span></span>
</td>
<td class="num">$ (41,711,563)<span></span>
</td>
<td class="num">$ (619,031)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2019</a></td>
<td class="nump">110,748,391<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Extension of convretible note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_AdjustmentsToAdditionalPaidInCapitalExtensionOfConvretibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_CancellationOfPreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cancellation of Preferred Shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_CancellationOfPreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_CancellationOfPreferredSharesShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cancellation of Preferred Shares, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_CancellationOfPreferredSharesShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_ChangeInTermsOfConvertibleNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in the terms of Convertible Note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_ChangeInTermsOfConvertibleNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of Shares in respect of proceeds received shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_IssuanceOfSharesInRespectOfProceedsReceivedDuring2017Shares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of Shares in respect of proceeds received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_IssuanceOfSharesInRespectOfProceedsReceivedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock and warrants issued for cash, shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_StockAndWarrantsIssuedDuringPeriodSharesPreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partial conversion of convertible note to shares, shares one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partial conversion of convertible note to shares, value one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentOfWarrantsGrantedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment for noncash service expenses paid for by granting of warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentOfWarrantsGrantedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 51<br> -URI http://asc.fasb.org/extlink&amp;oid=117331294&amp;loc=d3e34017-109320<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6843319440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (84,658)<span></span>
</td>
<td class="num">$ (20,802,376)<span></span>
</td>
<td class="num">$ (25,006,486)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Shares issued for services</a></td>
<td class="nump">28,035<span></span>
</td>
<td class="nump">892,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes', window );">Finance (income) loss arising from change in terms of convertible notes</a></td>
<td class="num">(145,932)<span></span>
</td>
<td class="nump">20,165,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_IncreaseInNetLiabilitiesForSale', window );">Increase in net liabilities for sale</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">445,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Increase (decrease) in accounts payable and accrued expenses</a></td>
<td class="nump">78,692<span></span>
</td>
<td class="num">(321,158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">17,768<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLoss', window );">Loss from marketable securities</a></td>
<td class="nump">2,635<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties', window );">Decrease in amounts due from related party</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(721,530)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Increase in deferred revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Increase (decrease) in accrued interest</a></td>
<td class="nump">8,227<span></span>
</td>
<td class="num">(65,924)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Increase in other receivables</a></td>
<td class="nump">28,674<span></span>
</td>
<td class="nump">12,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(66,559)<span></span>
</td>
<td class="num">(345,549)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Selling of marketable securities</a></td>
<td class="nump">14,607<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">14,607<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from sale of common stock and warrants (net of issuance expenses)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,575,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_IssuanceOfSharesInRespectOfProceedsReceived', window );">Issuance of Shares in respect of proceeds received during 2017</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">117,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Issuance of convertible note</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,792,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash</a></td>
<td class="num">(51,952)<span></span>
</td>
<td class="nump">1,446,736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents - beginning of period</a></td>
<td class="nump">499,919<span></span>
</td>
<td class="nump">2,959<span></span>
</td>
<td class="nump">2,959<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents - end of period</a></td>
<td class="nump">447,967<span></span>
</td>
<td class="nump">1,449,695<span></span>
</td>
<td class="nump">$ 499,919<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_ConversionToSharesOfConvertibleLoans', window );">Conversion to shares of convertible loans</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">85,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_CancellationOfPreferredShares', window );">Cancellation of preferred shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_CancellationOfPreferredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cancellation of Preferred Shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_CancellationOfPreferredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_ConversionToSharesOfConvertibleLoans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion to shares of convertible loans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_ConversionToSharesOfConvertibleLoans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance (income) loss arising from change in terms of convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_FinanceIncomeLossArisingFromChangeInTermsOfConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_IncreaseInNetLiabilitiesForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase in net liabilities for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_IncreaseInNetLiabilitiesForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_IssuanceOfSharesInRespectOfProceedsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Issuance of Shares in respect of proceeds received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_IssuanceOfSharesInRespectOfProceedsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6831484224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">The Company and Significant Accounting Policies</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 1. The Company and Significant Accounting
Policies.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Organizational Background:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Virtual Crypto Technologies, Inc. (the &#8220;Company&#8221;)
was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (&#8220;Zaxis&#8221;). On August
25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis
International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30,
2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under
the laws of the State of Israel (&#8220;Emerald Israel&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 16, 2015, Zaxis and Emerald Israel
executed the Share Exchange Agreement, which closed on July 14, 2015 (the &#8220;Share Exchange Agreement&#8221;) and Emerald Israel
became the Company&#8217;s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel&#8217;s
DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use
in derma imaging and analytics for the detection of skin cancer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 17, 2018, the Company formed a new
wholly owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies Ltd. (the &#8220;Subsidiary&#8221;),
to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies
through ATMs, tablets, personal computers (&#8220;PCs&#8221;) and/or mobile devices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Going Concern:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has incurred significant operating
losses and negative cash flows from operating activities in relation to its operations, since inception. While the Company raised
approximately $1.9 million in the year ended December 31, 2018 to fund the operations of its New Subsidiary, the Company will require
additional capital resources in order to support the commercialization of the New Subsidiary&#8217;s technology and operations
and maintain its research and development activities related to the New Subsidiary&#8217;s technology. The Company is addressing
its liquidity needs by seeking additional funding from public and/or private sources. There are no assurances, however, that the
Company will be able to obtain an adequate level of financial resources that are required for the Company&#8217;s short and long-term
requirements, or at all these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern.
The consolidated financial statements do not include any adjustments to reflect the possible future effects on recoverability and
classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Basis of Presentation and Significant Accounting
Policies:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited consolidated financial
statements include the accounts of the Company and its wholly owned subsidiary, the Subsidiary, prepared in accordance with accounting
principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and with the instructions to Form 10-Q. The
financial statements presented herein have not been audited by an independent registered public accounting firm but include all
material adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair
statement of the financial condition, results of operations and cash flows for the period. However, these results are not necessarily
indicative of results for any other interim period or for the full fiscal year. The preparation of financial statements in conformity
with GAAP requires us to make certain estimates and assumptions for the reporting periods covered by the financial statements.
These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could
differ from these estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain information and footnote disclosures
normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant
to the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;). The accompanying unaudited consolidated financial statements
should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report on Form
10-K for the fiscal year ended December 31, 2018, filed with the SEC on March 28, 2019 (the &#8220;Annual Report&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Standards announced</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2018, the FASB issued ASU 2018-13,
Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement.
The amendments apply to reporting entities that are required to make disclosures about recurring or nonrecurring fair value measurements
and should improve the cost, benefit, and effectiveness of the disclosures. ASU 2018-13 categorized the changes into those disclosures
that were removed, those that were modified, and those that were added. The primary disclosures that were removed related to transfers
between Level 1 and Level 2 investments, along with the policy for timing of transfers between levels. In addition, disclosing
the valuation processes for Level 3 fair value measurements was removed. The amendments are effective for all organizations for
fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted. The
Company notes that this guidance will impact its disclosures beginning January 1, 2020.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6626460768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Notes</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2. Convertible Notes.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following convertible promissory notes
bear interest at 1% per annually, are convertible at a price of $0.01 per share and are repayable through January 1, 2020.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">March 31, 2019</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%; padding-left: 10pt"><font style="font-size: 10pt">Principle</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">503,217</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,058,611</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Conversion of convertible notes to shares</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(555,394</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Accrued interest</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8,227</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Discount</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(17,768</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">511,444</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">485,449</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6831450000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3. Stockholders&#8217; Equity.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes information
of outstanding warrants issued to investors and consultants in exchange for their services as of March 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrant Term</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercisable</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 29%"><font style="font-size: 10pt">Investors &#8211; Class F (*) Warrants</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,142,857</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 25%; text-align: center"><font style="font-size: 10pt">April 2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">0.14</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,142,857</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Investors &#8211; Class G (*) Warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,142,857</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt">April 2019</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.28</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,142,857</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Investors - Class H Warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt">January 2020 -March 2020</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.14</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Investors - Class I Warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">571,429</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt">January 2020</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.14</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">571,429</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt">(*) Subsequent to the
balance sheet date, these warrants expired.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6625619760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4. Related Party Transactions.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Other than transactions and balances related
to cash and share based compensation to officers and directors and other than the issuances of convertible debt to certain investors,
and payments in respect of consulting fees to certain shareholders with beneficial holdings of greater that 5% of $75,000 and $
nil during the three months ended March 31, 2019 and 2018, respectively, the Company did not have any transactions and balances
with related parties and executive officers during these periods.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As a result of the issuance of the convertible
notes in the prior years, certain may hold convertible notes allowing them to convert the notes in excess of 5% of the Company&#8217;s
issued and outstanding shares of common stock. Accordingly, such investors may be deemed to be related parties under Item 404(a)
of Regulation S-K. In addition, certain investors receive fees for consulting services provided to the Company, as noted above.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6831426112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5. Subsequent Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On May 2, 2019, the company issued 750,000
restricted shares to the Company&#8217;s CEO and 750,000 restricted shares to the Company&#8217;s CFO in the lieu of services
provided to the Company. The fair value of the 1,500,000 restricted shares was $51,300.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6753496992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The Company and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_OrganizationalBackgroundPolicyTextBlock', window );">Organizational Background</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Organizational Background:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Virtual Crypto Technologies, Inc. (the &#8220;Company&#8221;)
was incorporated in the State of Ohio in 1989 under a predecessor name, Zaxis International, Inc. (&#8220;Zaxis&#8221;). On August
25, 1995, Zaxis merged with a subsidiary of The InFerGene Company, a Delaware corporation, which entity changed its name to Zaxis
International, Inc. and the Company was reincorporated in Delaware under the name of Zaxis International, Inc. On December 30,
2014, Zaxis entered into an agreement with Emerald Medical Applications Ltd., a private limited liability company organized under
the laws of the State of Israel (&#8220;Emerald Israel&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 16, 2015, Zaxis and Emerald Israel
executed the Share Exchange Agreement, which closed on July 14, 2015 (the &#8220;Share Exchange Agreement&#8221;) and Emerald Israel
became the Company&#8217;s wholly-owned subsidiary. Emerald Israel was engaged in the business of developing Emerald Israel&#8217;s
DermaCompare technology and the development, sale and service of imaging solutions utilizing its DermaCompare software for use
in derma imaging and analytics for the detection of skin cancer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 17, 2018, the Company formed a
new wholly owned subsidiary under the laws of the State of Israel, Virtual Crypto Technologies Ltd. (the &#8220;Subsidiary&#8221;),
to develop and market software and hardware products facilitating, allowing and supporting purchase and/or sale of cryptocurrencies
through ATMs, tablets, personal computers (&#8220;PCs&#8221;) and/or mobile devices.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_GoingConcernPolicyTextBlock', window );">Going Concern</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Going Concern:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has incurred significant operating
losses and negative cash flows from operating activities in relation to its operations, since inception. While the Company raised
approximately $1.9 million in the year ended December 31, 2018 to fund the operations of its New Subsidiary, the Company will
require additional capital resources in order to support the commercialization of the New Subsidiary&#8217;s technology and operations
and maintain its research and development activities related to the New Subsidiary&#8217;s technology. The Company is addressing
its liquidity needs by seeking additional funding from public and/or private sources. There are no assurances, however, that the
Company will be able to obtain an adequate level of financial resources that are required for the Company&#8217;s short and long-term
requirements, or at all these conditions raise substantial doubt about the Company&#8217;s ability to continue as a going concern.
The consolidated financial statements do not include any adjustments to reflect the possible future effects on recoverability
and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Significant Accounting Policies</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Basis of Presentation and Significant Accounting
Policies:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited consolidated financial
statements include the accounts of the Company and its wholly owned subsidiary, the Subsidiary, prepared in accordance with accounting
principles generally accepted in the United States of America (&#8220;GAAP&#8221;) and with the instructions to Form 10-Q. The
financial statements presented herein have not been audited by an independent registered public accounting firm but include all
material adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair
statement of the financial condition, results of operations and cash flows for the period. However, these results are not necessarily
indicative of results for any other interim period or for the full fiscal year. The preparation of financial statements in conformity
with GAAP requires us to make certain estimates and assumptions for the reporting periods covered by the financial statements.
These estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses. Actual amounts could
differ from these estimates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain information and footnote disclosures
normally included in financial statements in accordance with generally accepted accounting principles have been omitted pursuant
to the rules of the Securities and Exchange Commission (&#8220;SEC&#8221;). The accompanying unaudited consolidated financial
statements should be read in conjunction with the consolidated financial statements and notes thereto included in our Annual Report
on Form 10-K for the fiscal year ended December 31, 2018, filed with the SEC on March 28, 2019 (the &#8220;Annual Report&#8221;).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards Announced</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><u>Recent Accounting Standards announced</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2018, the FASB issued ASU 2018-13,
Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement.
The amendments apply to reporting entities that are required to make disclosures about recurring or nonrecurring fair value measurements
and should improve the cost, benefit, and effectiveness of the disclosures. ASU 2018-13 categorized the changes into those disclosures
that were removed, those that were modified, and those that were added. The primary disclosures that were removed related to transfers
between Level 1 and Level 2 investments, along with the policy for timing of transfers between levels. In addition, disclosing
the valuation processes for Level 3 fair value measurements was removed. The amendments are effective for all organizations for
fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted. The
Company notes that this guidance will impact its disclosures beginning January 1, 2020.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_GoingConcernPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Going Concern [Poliy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_GoingConcernPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_OrganizationalBackgroundPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organizational Background [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_OrganizationalBackgroundPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6753508768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of Convertible Notes</a></td>
<td class="text"><p style="margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">March 31, 2019</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%; padding-left: 10pt"><font style="font-size: 10pt">Principle</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">503,217</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">1,058,611</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Conversion of convertible notes to shares</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(555,394</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-left: 10pt"><font style="font-size: 10pt">Accrued interest</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8,227</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; padding-left: 10pt"><font style="font-size: 10pt">Discount</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(17,768</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">511,444</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">485,449</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6752999232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Summary of Outstanding Warrants</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes information
of outstanding warrants issued to investors and consultants in exchange for their services as of March 31, 2019:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrants</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Warrant Term</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Exercisable</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 29%"><font style="font-size: 10pt">Investors &#8211; Class F (*) Warrants</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,142,857</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 25%; text-align: center"><font style="font-size: 10pt">April 2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">0.14</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 12%; text-align: right"><font style="font-size: 10pt">2,142,857</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Investors &#8211; Class G (*) Warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,142,857</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt">April 2019</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.28</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,142,857</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Investors - Class H Warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt">January 2020 -March 2020</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.14</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">750,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Investors - Class I Warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">571,429</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><font style="font-size: 10pt">January 2020</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.14</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">571,429</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: -0.7pt">(*) Subsequent to the
balance sheet date, these warrants expired.&#160;</p>



<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6629321568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExcessCapital', window );">Approximate amount of capital raised</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExcessCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the company's Total Capital exceeds the minimum required for capital adequacy purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=117337116&amp;loc=SL5958568-112826<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExcessCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6621300592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Notes (Details Narrative) - Convertible Promissory Notes [Member]<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2019 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt bearing interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Convertible price</a></td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument, maturity date</a></td>
<td class="text">Jan.  01,  2020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=VRCP_ConvertiblePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=VRCP_ConvertiblePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6753329296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Notes - Schedule of Convertible Notes (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principle</a></td>
<td class="nump">$ 503,217<span></span>
</td>
<td class="nump">$ 1,058,611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_ConversionOfConvertibleNotesToShares', window );">Conversion of convertible notes to shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(555,394)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Accrued interest</a></td>
<td class="nump">8,227<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(17,768)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Total</a></td>
<td class="nump">$ 511,444<span></span>
</td>
<td class="nump">$ 485,449<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_ConversionOfConvertibleNotesToShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion of convertible notes to shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_ConversionOfConvertibleNotesToShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6841610384">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Outstanding Warrants (Details) - Investors [Member] - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=VRCP_InvestorsMember', window );">Class F Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,142,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_WarrantTerm', window );">Warrant Term</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">April 2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant Exercise Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_WarrantExercisable', window );">Warrant Exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,142,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=VRCP_InvestorsMember', window );">Class G Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,142,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_WarrantTerm', window );">Warrant Term</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">April 2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant Exercise Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_WarrantExercisable', window );">Warrant Exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,142,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=VRCP_InvestorsMember', window );">Class H Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_WarrantTerm', window );">Warrant Term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">January 2020 -March 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant Exercise Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_WarrantExercisable', window );">Warrant Exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=VRCP_InvestorsMember', window );">Class I Warrant [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">571,429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_WarrantTerm', window );">Warrant Term</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">January 2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant Exercise Price</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_VRCP_WarrantExercisable', window );">Warrant Exercisable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">571,429<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Subsequent to the balance sheet date, these warrants expired.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_WarrantExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant Exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_WarrantExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_VRCP_WarrantTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">VRCP_WarrantTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>VRCP_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=VRCP_InvestorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=VRCP_InvestorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=VRCP_ClassFWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=VRCP_ClassFWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=VRCP_ClassGWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=VRCP_ClassGWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=VRCP_ClassHWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=VRCP_ClassHWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=VRCP_ClassIWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=VRCP_ClassIWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6739569712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentDescription', window );">Debt description</a></td>
<td class="text">The issuance of the convertible notes in the prior years, certain may hold convertible notes allowing them to convert the notes in excess of 5% of the Company's issued and outstanding shares of common stock. Accordingly, such investors may be deemed to be related parties under Item 404(a) of Regulation S-K. In addition, certain investors receive fees for consulting services provided to the Company, as noted above.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=VRCP_OfficersAndDirectorsMember', window );">Officers and Directors [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Shareholders with beneficial holdings</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=VRCP_OfficersAndDirectorsMember', window );">Officers and Directors [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Shareholders with beneficial holdings percentage</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=VRCP_OfficersAndDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=VRCP_OfficersAndDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.1</span><table class="report" border="0" cellspacing="2" id="idp6753329296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - Subsequent Event [Member]<br></strong></div></th>
<th class="th">
<div>May 02, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Number of restricted shares</a></td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Number of restricted shares, value | $</a></td>
<td class="nump">$ 51,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Restricted Stock [Member] | Chief Executive Officer [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of shares issued for services</a></td>
<td class="nump">750,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Restricted Stock [Member] | Chief Financial Officer[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of shares issued for services</a></td>
<td class="nump">750,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefFinancialOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>36
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M?_C=A'UOW=[]8^.KH&K@UUVH+U!+ P04    " !Y7*].F5R<(Q &  "<)P
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MJ7L^;NKC0+)^.K $\ZFI^ -02P,$%     @ >5RO3A138[1= P  =0X  !@
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M$/T5R^^[YN;;*HF4N*I:J96BK=H^DX0DUMK&!9)L_[Z O5X7R.8AAO$Y,V?
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M/19#ZQXFBO?CM229[D:K?U!+ P04    " !Y7*].X$U[,#T%  !3'0  &
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M7O-=#NKBU+_"=*[O45?_ U!+ P04    " !Y7*].M /0FBH$   %$P  &
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M'E\V]K\VQ@-*V5SA"+7XP69#0NW#\1;/=ARST?"FFWX0F[]Q\0%02P,$%
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M^U\C.O!2DAL_0JW_8(NAH';A^-Z?S31FD^&PGW\06[YQ\0=02P,$%     @
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M2SWO*%F*_P)7D!@>E&".RD@75U*-SANUL* 4)5[GO==QG^:;PPVV#^ +@*^
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M7P,&C7';@]VK^<G/@9'#,LUD_4LI?P-02P,$%     @ >5RO3E%&QXT: @
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MJ#F?G_J\D&Q8NAA:6VG^!U!+ P04    " !Y7*].VJ]45]0!  #6!   &0
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M2!(423S!^@-!=B$R85*/Z3TF3B/WA(560:%50"B_$)HPV9E0&J^NR:R#,NN
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M@K1,W]DANF"")_N]%1XMQUZKD2+!D_T!<MKR*U=P>M"E7P%02P,$%     @
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M7)53L55.Q5<Y%6/E5)QU>$%G;<?2"NW^(OGT?K&OS]I?SNDW4$L! A0#%
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M;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( 'E<KTZ%5I'7?@(  $$)   8
M          "  ?<(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4
M    " !Y7*].%%-CM%T#  !U#@  &               @ &K"P  >&PO=V]R
M:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ >5RO3C-5OWH^ @  P <
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M965T-RYX;6Q02P$"% ,4    " !Y7*].&A(]*[0!  #2 P  &
M    @ %?(   >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @
M>5RO3OS$?S*S 0  T@,  !@              ( !22(  'AL+W=O<FMS:&5E
M=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( 'E<KT[^P+\ZM0$  -(#   9
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M970Q-"YX;6Q02P$"% ,4    " !Y7*].U(&!]9\!  !> P  &0
M    @ 'Z+0  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    (
M 'E<KTY[PL_>SP$  %X$   9              "  = O  !X;"]W;W)K<VAE
M971S+W-H965T,38N>&UL4$L! A0#%     @ >5RO3E%&QXT: @  !08  !D
M             ( !UC$  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"
M% ,4    " !Y7*].>K5%%/X"   I#0  &0              @ $G-   >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( 'E<KTY<K'_M^ $
M %8%   9              "  5PW  !X;"]W;W)K<VAE971S+W-H965T,3DN
M>&UL4$L! A0#%     @ >5RO3MJO5%?4 0  U@0  !D              ( !
MBSD  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !Y7*].
M HR 5.\4  #"7P  %               @ &6.P  >&PO<VAA<F5D4W1R:6YG
M<RYX;6Q02P$"% ,4    " !Y7*].%2GJ9#D"  #="0  #0
M@ &W4   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( 'E<KT[]/I7)FP(  %X.
M   /              "  1M3  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" !Y7*].G_;#5S4!  !A#0  &@              @ 'C50  >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !Y7*]._XMZ&F@!  !Z#@
M$P              @ %05P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
..'0 = +T'  #I6      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>54</ContextCount>
  <ElementCount>117</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>18</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/BalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Condensed Consolidated  Statements of Comprehensive Loss (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/StatementsOfComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated  Statements of Comprehensive Loss (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/StatementOfChangesInStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/StatementsOfCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - The Company and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/CompanyAndSignificantAccountingPolicies</Role>
      <ShortName>The Company and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Convertible Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://dermacompare.com/role/ConvertibleNotes</Role>
      <ShortName>Convertible Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - The Company and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/CompanyAndSignificantAccountingPoliciesPolicies</Role>
      <ShortName>The Company and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://dermacompare.com/role/CompanyAndSignificantAccountingPolicies</ParentRole>
      <Position>12</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Convertible Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://dermacompare.com/role/ConvertibleNotesTables</Role>
      <ShortName>Convertible Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://dermacompare.com/role/ConvertibleNotes</ParentRole>
      <Position>13</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://dermacompare.com/role/StockholdersEquity</ParentRole>
      <Position>14</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Convertible Notes (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://dermacompare.com/role/ConvertibleNotesDetailsNarrative</Role>
      <ShortName>Convertible Notes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://dermacompare.com/role/ConvertibleNotesTables</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Convertible Notes - Schedule of Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://dermacompare.com/role/ConvertibleNotes-ScheduleOfConvertibleNotesDetails</Role>
      <ShortName>Convertible Notes - Schedule of Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Stockholders' Equity - Summary of Outstanding Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/StockholdersEquity-SummaryOfOutstandingWarrantsDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Outstanding Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Related Party Transactions (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/RelatedPartyTransactionsDetailsNarrative</Role>
      <ShortName>Related Party Transactions (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://dermacompare.com/role/RelatedPartyTransactions</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="vrcp-20190331.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://dermacompare.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://dermacompare.com/role/SubsequentEvents</ParentRole>
      <Position>20</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>vrcp-20190331.xml</File>
    <File>vrcp-20190331.xsd</File>
    <File>vrcp-20190331_cal.xml</File>
    <File>vrcp-20190331_def.xml</File>
    <File>vrcp-20190331_lab.xml</File>
    <File>vrcp-20190331_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2018-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>41
<FILENAME>0001493152-19-007246-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-19-007246-xbrl.zip
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M?CDA=Y9)3U";@&1XUBP*4'$_1'/X4](=V5+RV\QK8+Z5E[#?"7DK]8K\/@5
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MW"ZZHE:OG?[VP]GTZUG-WI'L7W'-R-V^.OF<VYI*[@)^M?"):\<8YB8S,)R
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MW:'H3CR%Z8H%CZX6T2=5OIHG/R7[WR+&5%!L =VT.JCH6CM'-WW_Y+PMOYV
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MLEW@Y88KV\6^UC),*J^IK![LFC,;CHJV/+R;CYNVVZ&R=@'FF.$$W^U @?_
M3'@RM%EPZY9OU]*>O=5JJFO_:P#=::_7/@&U;<!K!&/-7K?1/N1!*_^DU=9'
M;R.'L;;=B\U9-SZ0VS9O\S*;P,8UVG&.WMJ0=\N -?<XEQ][*_\T[*XPK98(
M=]J*,R1S8$KU >4 7[D5ENS&O6?!A)DAONR9C%D!&;TG<8GIAGV[3*$M"FNK
M?5K;<V\:X.J>NM/KX;TE^SL&*SGBJ?NHE.SGO>SC9EWVIE&7X*(+0.0>#%.*
M-^<$%F6DKP%U5UTN*>7H=L)\<#/N\.IE B)9TOY_K=:N*_E#,T160E'TQ#V>
MYJCWFJO */DNV;G\F'^%7DXHQ:L0S&7*?"Q_,CSLQJP+B".-(?L2H:P)$5>R
MNG\V MN\<*V/MA.%V:NZBSF7/^5\-42;Z]?B89AW'Y=>:W:;K7;9W?K"PDLC
M&('!>;(M9OW\^GO ('R(!_K"#.TGF@64(MSM=JNEUJC*3;U<W(4UH=&$Z5DI
MP$%S?&8$["/C_X>7T-%S2X_'FTJR(MUV1U'<Y53+P5G<Q-3U>GT#."&0 A]F
M_6H;?=LI37ZGBV_E)%TJYL(L;K=Z]>6BL KJCQ%#4/>, M8[PU^#S\M+JJU,
MO2C'.G6]U:@MXE@FZ>6(Q<Q%UL4#J[P9,>UTV[V%2I4'R.:Z4]SZUG5=O4^X
MI XE\?=41K^2Y7+K7SJ&/=Y$IFLA^J6#+SH(W5X]551D+?1SW*>XQ+&$J"/'
MC=AK "@\N>CTZO5N:VGXD$%^MNXAGQDBDH>1Y],I?]Q)W!"C"M$KS)>I[?*Y
MQ!:BRILE4C8W5LM.6<Z5=F,.1_+D+:DO)"JJ+'EL@3.YZ1:6EU:G5>O4L]F3
M276F< QH'9@J_!]6ZWTR'-RMOP!M]/U74+S9Y:\B%7A[O9ZNEH')0ZPTA'D\
M4+/9Z;4[:R)\L(>N/;!-L/7"[>*&DN?8)MBK1W; =XYBRW39&U8OUO2JAI>0
MRG(2>&NHTG4MZ3NAD@RH$N3^#L!OOWQWS#0;/]SZ0\.U_VWP;0CMY_@V WY9
MJOU^6++T(F/M.YARQ1=$U6L?A)#%W^@?OB>,SP9>3VMZ_L3S<:J!=]7BJW15
M,%Y+>SNR\6I;3>]U>Z#Y%O,U0YOX#-2>X3W%FFN,647['^/%#C2J%NV* 9)(
M%!3TE(JAJMVZVD4TA+X1G'JK I1Z+=D@%DH!4,]V. *R0=0/;,O&:D2 #'4'
M0AKF?V)NK$45>.PCS)J>#4ISXMT".!6\ZL(<:8RJH6C\,E[H;1A0![#^.P>'
M*+*Z@=H9*MJ*C//9-.MBTIQ3^ (U#W#G<^@6WS-IS5QKU"J<$36]*9E =S]0
M^X#2<#5CZ#.&66"<+UA-QG L[3.S\-(/[6(R 4M!) +MU]"J5FC$P/C"B#KV
MV$:LCIBV8!4;WB&/:Q?\1M@)!>*'#M']Q"FIN E\@SFIL94P^$^I07X?2@G#
MR$MWZ6VZPSD68A2=*>X@$O;"3%K")<[BJJIV)6^)OI!#+.76=#R,_CQ7^WOD
MO&HH'$AB1L_GM:..QSQ ?6:2*B12'M\PU_D0 !#/<5Y/O6<7@"2J6)UJBC2#
MN4-CF%B3?A38+I@+%!V+/3''FV#AE6R106*$YR,$YP8A@2Z%TL:]QJHH6N)L
M"B"TH%_$M=I("N(2++.$5[=&7!W@?X[];_P.-3]%(/ &(:DNWM =!?PN",!O
MX4-Q4TC! -5]#6TSD)=YPS, #RD@U> KO&5BI.B_'\F75>+T#@EFMY(REGB5
M.DB#H;GLF;L=DB5M6I84L[G [%2T!?Z/+-ZL6L0D5$7@IA8:$))$HPO]_<K"
M1!SP.U JB_Z8^)X5F2 Z \-$\TEK\6!?Y37R)(#1!#P"_J!-(K '1D"-G(&L
MD)!"/TS"S>]/P)A.&%L(9H8C[>+Q,W"?+F4)X<.$^0'%.VBHP5[X0<KLWET&
MT[J-E,8>F'=2$5PF>2=R^,E#IE]ZJ'KN^?OHLSJ#&/%@#L4*Q%"92GARVXC
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MH4]Z':"?)(Q %=@<HC(ZD87^!T0N.3V"A'PV<"!H(4P3L B8D@L#2N=#V&#
MT,MYJ/"FAPD  B&PAE"86'>3S(N4??B;X2N<N<:8MDN(E;//.LK^#0W0V'C%
M,8N<D,L2:7448@X(URN0T@B9@(,?OKX/TQXO?&"*!9FV.S0);LCYF'.]Z-TM
MCJ""&*:8UJ+Z1*X16;9(ELG0&\*CZ(Y4FE T1((LK+NZ6(=V<DX@RSV.ZH$F
M/L-I!DV)L%'?HDOF^,I&>N3 = *N"69 #)F+4R2@ ,^ 6TVF5+^[U",*C0G=
M!;@C$(14</CIXN)N9N9')+$)VPU"/S*YX0*+< U1.@S"Z6]DK E*IFV9<"D$
MZFC2 <_(>&)D;OJ,0>\$L_O()0VOWILPNG\/-'QH!WPM0SJ+N.<P'$"]'RDV
MR^$C@Q&"CQ!4 _8=#B4TAF]"YUV 3F8?@Q_NI.)GOQ=3:.!^17(/YY_"%H&0
MP5253R)=6M3"B0@Z"0.B?-M/2X>4@X0QL?&O" M&HZ&$)&0"E?!*6,@)G9"H
M:K\D[@]]B6R#.\HPAF0[KV)&:I$A?2+#*)\FN+B(@YD6N% $C8\%"33)DN@@
M J<UH#MW*+SBH0"7S=@Z9PXZSFD]%R=RX ;X' [E""5,NE8PT21'8^,KN"AN
MJS4&8S0F&:6I,_C],=]ABC$!<3E=(KRX(_I$0@(2E.9U@B?VA<"R^20,\F,*
M%9R$CF.%YBZKHKHC',0G!OZ7-\9$;F85K"O-..7;(+8.]X26#43\V&VI>'8W
M[=J1Z;T4@VZ3H"1N:N!YH8M;'A:('DP_(,;@,2_76S!O0NG)O,V3OVFSF6$<
M%7NB6%&R3V2;/)#>D,R/CYMYH5P ( F)')8L.<2'D_AJF5Q0PZT_.\"S3"E#
M^W!UF5[6+NR$E+YRBS-""</(UV>&)=3OGQ #$5-C&[X\$J1I'EZ6B<_[#.=M
M"J\A2M8N7!=%^YXT!&,^= 0$ IS!/Q+;D9B->;.R"CSD,,7% %^P07&E09>>
MZLVLSJ0 O,.58VPYP@^8AIB*Y-"_NY;A6SB.KH<AL$78HO<3S]W('2)E8?'Z
MXN%GF+GB>4/MXN%WC6^@-_B"WC5X;8UO8W]F!AH;\MS?/8+7-[5NO?;]N?8Q
M-D3:M6^,V;/G?XU%4M<_:)>D[X&<6"O/WRMS05*.;'K); V:=RVAC).)\\IG
M7]+IT8Z4G3E3E;Y4L9IB(ID$.K@#Y[G)WQBR:$\$9IR 2588A%VQQQ,?O*RP
M(0'$/GVPI@,;/I#?(\<)089<M:=5[@1&5>4Z1#<A&WH^;1Y1@X)WM&$5CKQ@
MUO!39Y\9]78,0*R*>##Y8>R!:[7Q%[[@G_[5L, "R? %W"W$;"J;9MI/K93@
M50C@M .Q[1$^HV_XE981=*+&/]>A!WCKA)CV&[@FD-BV"4ZP>*0(_EX$HG'3
MFFR65B> 83=NO')2D5!EQ(_-X9AQCSG!I!-:HL.V.93&O($5&Y'41^%V%'&+
MY_(8+U*0"/&?I^RC$PT1ZL?F/> L3X>1 ?6<XF<<B?3C?8CL79<"[P&\E'@&
MW 5#FU_5K@P?/;7E46R&RT[0+G?'R7Q#3J^DPZ(%(7AT&-G2\4,'0'@-".MP
M_J6.>0(BWHVHT+4UBAM1*CCERC*9SDW!9+'$%KRA9)1Z55/.9FMTO?;N4DTD
MM"F?LP,HJ%$#3^[OF J+0$TQ%/1\(:["F!AB_@5V U<)]6]1SM%[1QBJ5C2>
MF) T@T8?31C?LORF5JWI]$8PDKM/W"=,>.:Q)K>)YLMX>6S)Z?=#?H</<YP
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MFE7#FP:_HVH'\ZD3DAC1.7=5/(_&K1$,'(J@TDI(2=RE02%B9I8L4+40?"A
M,VW8>VO#$#,.)N?:<ZCLT.&V*B,+.-]0UVLC_UF5Q.C;5LE8P'XC55NK49Y5
M89PZVRH<G6W?2-^+Y2#KZ@9W>6JKRSS!Y_B%GS-47$A->.+V4-Y-,O\.W+6P
M/%$Y+.93->2KFJ9JX[!ZU#B8*WN%=!L0*S-L!R+DVP%$[GVV-!0JB\D\5%?<
M10'DWH[+,(,W?BIC#1RMPI;J2M0N:)(WVW:'X\G: 4^!2WU%0F6=\]9G-+%R
M8F*E<?Q$,+L!V1E%)/B\DQ*Y,,;^?JNH76<,/U174G8#XTH)W%ILC)DDFG7.
MY:>GQ*^2>OO0#9G\L,5/V0B":YM> 6JN>O[>,EG0\1>G[@@+D!&@%G9_@A4M
M)FX#U2Q@^40,^X8F\VOIFL7 7/\]Q46""7O@K66V*X/+EG[?T+\?=EZQ4(RY
M/N,O>7[G5'"L6^6BHV%JV-$*6-KBVN(:$5=2N+.0E"%)GG;!#G* 97JH2[1I
M"^3K$)66N$%]/H"7<Y 64P9*#&>T9R-<?UV+&51Y?GH&M-[VO<GM<&/>4<H%
M^\(UQNAY*/R06$5(C"%4[CD$[>JZ9S5&$KAWL]\_G5+>=%D[J>H#Y@AF2J<N
MAX@MGB9G;^=?AFZ^<Y_!2%L)*CM@<K/H%@EWE[3[310R_C! NR,?4H??X;H&
MEC:0A05@JSNP@#V '\VA=COP[6V$;Z&+'[BF6(DZ^VDBR@Z"C,GGOY 6L; N
M1EM\E?MS?=UFW(QS.9^9BYVA4HG6O8W5X VEZM&% =CA&M#@.O@8ZK.1:E_=
MT[3_<)7V[M8.1-.VO1,(ZO0HLSN\16=,4^=RKLU%]S  )2P#<*G^4Z7LK?N#
M0.UP2TR]KQ,T)5.83MI23/VKXQUNRF*5G)RQ6-]1Q.Z6L6'X+7,X1\M3A=AO
M05\S.F2.5S:TA>S3U<383+:WKE\EWC#-1AQT+2A/2=*YM/OJS*X<4\Z^4G_:
M?J#6_1C9N>W=R5@,8*X_.%A+AMH6)]]ZH?6_Z'FJ0QG/H-R5P,F&SK! \@R%
M\DGV08DMZIT=2J2]GH:Y*7(Y 3=1[:U^P6$%]"1#7W&X@>D09*A79N^N06F+
M*67\&7#?R,]TP:-H8VU[@+'IL"EK3J9@QY&F])2.M^50I2Z#\YHHX/2NTA$W
MY^#T9V:#!;+GN.,HZ,S>TG'W'+K HAW;O=_8<34=_A2%GD=0.OK6A$F!Z7S$
M.(X*ZEK'PCN/H'3TM_ X0'S^59L.)FJ%!E91!3;0E*Y#TYE-:)/;:.CNS'#'
M C^SNW3D_Z'<Q95K\"@&$^$JRNU+-IYH ![??415VH&O=%W[7O WEV>!ZP>=
MYG TJF%AZM+UPL3D%25@AU,C-O_S"$I'[RUE[>Q5+M&U'XBOLA$GNDI'C--T
M8Y!LH"E=AZ8[=I5>2SA],'?T,./X1RI85L2B?@N&TK7S J>9'5.)KOU _"$;
M<:*K?,2"*]<QYZJQQ2RMHW2TV2OLX!$)%X.)!-AUD2XB8N\MT!:N?)H!<B64
MKG\0EIBGFF-TE.E,C=M4@O+1FR3P4W9^2'25CCAC\[&7^XWT<XQ]/,7P3A5G
M6O#@K9@(#B"CR#=2E:Z'MXD+WEXUN:*.]G=T_2^88DS%9*5L^HK1EZ[;)R:U
M2YV67* +.DI2<*+*Y!&4CC[VNG7]JSN)?=!&PM*UN9S.'+$ "$#&#H S.DM'
MW9\(Z=T([.&_J;<38KOKXO2EZ]9V)4<^"3B!NZ,1L\!\[6Z67(^+$):NS95P
M<'6P$X>$*>VE8[VA7\WLY"!CY_7)]M*Q!H=\"M.]#M)^ZBE@*D'IZ#L.Y3?4
MN:>QVB?17#K2-I-*CYB$*T<,J=.=F0OA+O?O$;C<OAZT8K-R"X;2M>N#UGY;
M1LV?1U Z>B_$Z7J9DS(%TOM+QQZ<]ZXM0]&KTZFGPYNI2]>KR^&:WD_RE^--
M1*5KT7.'YA>"*(\);AF/UW9Y!*6CO_QXUVT%WVV)%71I/:7C73\T97-S7N+=
M!(^\!#$!DI&C=F<O77,O0Z4DK?U!Z!V>=++/51)=I2-.?;.@$B&31U.Z#LT%
MX[<N;TWHZ%=PO^I$^9Q'4#KZM)<@_O=!N(6?V /T3*&7.8D+\)2N(]84,+J<
M8Z(QV/SME\2-6-O<18QO((H2EZZ5?];"8E5YK+%TE)$R2$R94D(N4LJ, G2E
MZQ($@\)HN,!-@Y7,5;D4I>//^W\XFBA34DN'FA2CI<%3J-.?^)7/LYK_]5U\
M_!]02P,$%     @ >5RO3AC PLC6"@  @7<  !4   !V<F-P+3(P,3DP,S,Q
M7V-A;"YX;6S576U3XS@2_GY5^Q]TV;JZF0\A"3"S SO<%DM@*E4L80DSNW5?
MMH2M$-784E:2(=ROOY9C!SM^DY,X%E,UD!=UJ[N?EM3=DL7G7Q:^AYZ(D)2S
ML\[@H-]!A#G<I>SQK/-UTCV?7(Q&'2059B[V."-G'<8[O_SGAW\@^/?YG]TN
MNJ+$<T_1D#O=$9ORG]$-]LDI^D(8$5AQ\3/ZAKU ?\*OJ$<$NN#^W".*P!?+
MCD_1\<'AQP?4[1KP_4:8R\77N]&*[TRI^6FO]_S\?,#X$W[FXKL\<+@9NPD/
MA$-6O+[=7=S^ZW"(#ON#D_[1T0 -^K^CWP=H>'5SL)B"+D.LH)G^&IKU/\"/
MP8?[P?'I\:?3HX__->Q3817(59_]Q:=^_Z@/_Y?DGSW*OI_J'P]8$@0(,7FZ
MD/2LD]#T^>B B\?>8;\_Z/WYV_7$F1$?=RG32#FD$U-I+GET@Y.3DU[X;=PT
MTW+Q(+RXCZ->+,Z*,WQ+2]HG))'T5(;B77,'J]#1*KM!A2WTNV[<K*L_Z@X.
MNT>#@X5T.['Q0PL*[I$[,D7Z-_C+JE>7"!\[X(18$/ 3OZ<;] "DP"=,G3/W
MDBFJ7C1BT% +#$J$'&>"3,\Z3\*9=V,'T=W^:$*K7N8P>"35OM]!O2TD_15[
MVK*3&2%*5HF6V[@A66[A*Z9F1%$'>[4$RZ7<G91ZP!$-D!Q/]>PCR(PP29_(
M-9>5%C0B;D!6Z&V&V2.1(S91W/D^XQY0R,N_ W"P(9E2ARICV>LP:\CN6,ZN
M//Y<S][K1+N334.)V0L,V0E]9!0L@&$ .PX/8 2SQUON@4U(I;0UV>Q2?@;K
MMJ(/'KGARD30_/:[1'O=L:JA+J+8G51WQ -_<F&&42_W C.)'3TM5]JKBFZ'
M=@L>)/D[ (^_?-)N7VFU@O9['QL['B/[&ROW&%[5'C%IJB;'C9E\572[]%#?
MQ^)E/"W%;T@4IIZ\P0+B?E@?J_UX&Z[->4==/4SIFY.XJ\-_-_"(CE!RA:FK
M@SG')L=!=^4BXT"%.2@XQA_:KC#M&6JV'=?FUZ&ZWE:73W/K5/WQ;D9?)C&D
M!T[@A8G5-;Q/49"%(LPE;LQ'"[V#I \^UGSZRW\#U$4Q5?(E>!%:LD I'HV*
MGY_<I>0]!"%7$36\AM'L0OI"7/U*PASK:F]"$2<4L8J$CL7VN),2U=.)/!=I
MP"-)PVQ]BN5#F+('LON(\;RG':%'/"7C3T+7Z/8'4>;^8_3Q7^=2@@ 7@= )
M8=R!AQ^(%W;[5]1NK5FO/8%UB@+NHW_IZ>4)>]JWS]4%N/4+3"QAD:=8$4/R
M=043CG0N',0%.,A99Q#W@X63<I]L&25JT9-Z+M1LNA1\)*:?"NZ7V3NR+=]$
ME20N($4'/1/Z.%.A]"WB.)EQH>YAF(U@N9/*3T;66=CR6YNA=-@J2F5Z6@=*
M% Y*<*NQFA%Q1QP"CJ6CW!NBJF<),W(SV(Y:A:V6)>S#,=2P:CJW99HK@B 7
M)MM,?4WQ _6H@M2I<GSDM;5@M-_B%^W8X.KPB0B(6T>G6DS:]K=BQ0J&?PW3
M6.>9EQ#0\Q="H@RF#J@&I&VOO<90&IO!.@#7*P&1,U:B5T77]OIK#)V9 :S#
M+:'?>#JD<LXE]KX('LQ'S/$"7?Z 3QVNZVXPI8SG>N,>K%9G_=B,L1GRQ^TC
MOR,3[M ULO45?79A?0T=,44$A/G1VQPH-545D1E,'UJ$R40+^T>GT4BS*FJI
M'BZV3X[%>Y Y67].VQ9%OP5>!*SKAG)5%)IR&[?M224;P+Q:>DL]ZH+[/F<F
MF&1;MAW%&@-2I*1U:,"J$/A!&&J'A9/4$1Y8O+D?'N2Y(6H\O<>+TL2R'J.V
MPUIC+#<TD7U0NR[59L'>+:;NB%W@.56OY\ER("TB:#LN-8>N7&7K(+K3>WZ,
MN)=8,(B99<+UUDZA9=$RH6T[4C4&SMP0UF&8".[TD9X:\5,U9=L!B:ENQ?%N
M/=A:K%+5T:_JH%Z1FI][ZUI>P_N];8GG'RM.[8\?;;(_CMZE.+]O>)O?[ 1R
M2JUC,[5>VTC$IRC%'&GNZ-U7A@-88XC[OL53 5$]A3U>+N9:C9),.:=IJ^N=
M)# X]+[XD#P1C\^UL2/1RI:Z4K*V9\E".#*+G('VUJUORR>7/+W'XOJ44:F6
MYY,J4:LD;'OV-\7-T +6(3<A'O!\!+E_P^([26A:4M,IH6D[@S/%JUIOZZ!:
MJ?::7QK,Z<G&UDR"60W6X"F&,8M*MUU8(,<W 62M6=M0Y$I=!$).R\9W9:XH
MT^%C\62D6ZTW:GNU*+5JGL!V9@2;/0.7BJ8_F$73KTUT++WL"U&&DKW]&RW[
M0^^B'M^G0NP])A*91^M2*G^LJ?(R?P">*&1J2=Z@C\:!3+>"/U$PU:\O7T&#
M$5O-!><.A#456V]U>+19_/2Y4/1_H:^,IT/RH,(-Z8"I6T%\&OC%&AJ06C##
MUP1RO5!J:A[K(J5E2*>WL"?$"42HY!=,6?D*74YEP=*R'9PF1K$ONAI)&>@5
M<SP-EP2(U^/'CJZXF!#Q1!TBQ^+"P]0OP;8FF[:SF*W!WLALUHUCB*4$P9(,
MR?+WB,%*"HFUH_Z@:G812 6AEH@+M"55]-J,VM[-VMX!-C/=&W !DW.]=3S!
MC%_;NV0-.$0=0[X!OQ@&Y JLEGC8LZ8C%# P0_[C6T*^U%06Q@ 9!<(S%]L-
M^T(69GC_]);PKC#7&QC<ZP]PU48Z16L&\:<W!W&.@>P;S4W62T_LA2R_-+BO
M,NIKU^>"2I!7S__+>MN(Z4=;9?;6BO*:ZV8<#8LB?0MQW%KW?4$>3PXC!LHF
MIGN=^>'"!QHJJ0RAL[&@9:2?Q?-EGMK+9]&W*\CF\FCU=#YW"'&E'DX:E'!W
M5NE:U<MXFE>_*M9X U:6%FQ+@,Z<^-_0?-8%@ 6F6$Z_V_E\+@]+?/ZU:I=X
M5L#,QPM(+?7I$B!+?+K4/-;Y<&HT:DG'\_#6J<L%$0Z5K[N0%9-7/JFEVQ&;
M 5MJ'KN!C:^&T=MCAH"F22S=:M@0R#QS["'B?=WMF&&A3RO<$3DGCAI/8^F6
MJ7'NH NCPSH<+-T<,("LMJJV!L5:_[5;LT +):BCB!O=JI7^(-'RE@C*W6P-
M)7HJ_7+AA*G<'5;D<CH%RQ0/['W+T?9ZWH[=LZ64NOYOY9,E-ANS+*O>PIC-
MK6,V&[,LA;/LZ%_=R]E3)^!^TM=[4NEX7 :"P)O[&4$1Q_"ZSP1/],H4O7)M
M]"Q?84DNI<2G=2429&BMC-G0D</")\=2@IZL"YIW:+)A62NO?$]*/.BO2QR1
MHY >I1DT:^.B"^%3\@XR%EZ1H9BN88_=[!KXE!:'6XY*]"Y^U?1AVXKKXU-:
M'54.4_1N2=_\$>&*2^53<A^;C-J]B;[=??(IQ3YD!TO(7)]RKO2PJ NTZF/?
MKF:FXT<#IVM=E1H7T:>4RZS>6>4 U(CW\MG7(N5;/<!>YYX]H\OU]BB\KIN,
M&$2IX17I5]@AY[X>+<4:%%.TG2N6W??'#76PM 28%O@KP\NC\L2-3\B;XI5+
MVG9>NBEP)7:PKX*T=M==I"=$6C><.573AA%QVQFQ.8PU;-%\,7>YJLCPH9-,
M0,B7-<N"*JX9:>OEVVI<S)6QLXJPY5^0284EF7P\-V!.A9N)+E#<1R(V:2<E
M-HLP,TE]<8K<0JAI_/=HDCH=9M+^3!I=K$KDN_J'_NNE\,G_ 5!+ P04
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M$$>>?XH?CV;@A<_14/PZ*P >?$!>F/<H%LZ3[5D /9Q&&L".Y18AS\O=*4O
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MQ(^OANPON'6' 603D*X*RL->QJ-1 'NF7H( *L0J8P!V[,# 9!"GC "(> 3
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M-0%8N&ZH?HBK2(:=_OP1=2]*Y:[[[E_J,W'W1#._/J?EM@M8QU,#@*UMEBT
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M675<40^LP=@9DJ."&^BTEK"P&I,Y!$?8H\H!51Y>)YC$-(@(+L1"34EU(9O
MJ@2MOF'IUW%2.Y9>QN)"!YMYU!4V^PYD*7>$Z8JWH"9>RE6LJ><B9MHE[9O0
MHBC$/Z6B-IO#*GTKK=*U8,()K400N5BXU1_XJ:7H?\J\8+G-[[)91 <C-,]!
M<AW$=!PC+M\]HZ_HM)UQ(;AY0<NUN%5RP&IY%WF1X\8)AWKJ2;CPJ2<O!(C0
M:K3OGRWQIRS/9R3.X_3AG)J<+*AV^A5K9W)Y04>J_BW2@E7WVV=$%\'N=<S3
M_ XE-%445,DB5A\HY FSH]&LT<Z5T6?]G()/0X*#G.;Y"RX^Q<%]G%0!U3)R
M&RC:\A%[6%5M)U8.-U-YL=I*<8&2UI$O1N6!IP:]G1^OPQSW$/V4!:DIOK/>
M"5:M35!LB._<3/4/G[6$^7NIOROR$*3Q'T'ULOD8A-\>"+MN[CI+XG!]AY^+
MCW14^DVJ0DL_6+4X3?2P(OO>J'5'OU<)()8"XDEX&<Y=9+1M/V%&)!VK/X,M
MK#H;%RK'NV.O..%2U8WWJNGMX<R6<9YG9&W:E#/F *N2+-6JF\9Z:VKM!V#G
MC;A],Y^ET6E,<&A8-=*;PJJB49U2<R<<^ :8QL7O91+&KK#\#!G-856/E5;Y
M_L^F![_ ;2]^."GMNF-1YH</0;#Z.LMS7.35I0=%MW:4!E^__YK<)\YJI*=;
MU(19ES3#PJT.D+#S6LCZT@57K"/EB7X_Q?.@3 KTB7F[;F=JK9V1F0%@V0I0
M<1O$#8N^8^J;YXZ4D1*'6=0V9>RI:/FJ^R)+(OI69R' B[6JA&6KKS^ *6B#
M.&F'=\?T3Z@R1K.B(/%]6? 9<3H<OPY@H$Y[97:U,^8#\Z$P2S4\*;SS69E[
MJJ2K%3MM34>4XL809:LD&0&J!KTVJ<=?6Z+:U'>9MQ/BQE)OS2"6NT*=ON0K
M8_2:F7_GZSU137"615[0QX^J4KXFAD9?WX$I>KTV^1A0M?.Z8^NIT#\'Y!OF
M[Z5V;_E%$*<Z^$WV@)X"*YER7+7:";5>!XCY^7TRZF684UPOXIR6F"W2W> D
M*# /'*3IN%JZ JJZJ8JU:U:OZQ2^8U,5-)%J_5$D@T0Z8*KTJEA@4L699@A:
MUN;0"W1%:L5:UB'W1YT$/%7>%UR<!/GBFF2/<82CC^M?<K8AOGF=SL(B?M2.
M)>V] 57F!J+EF&4%8FF@.A%TOT:O63JT;K]#;6>D30M6_5:G%S:M7X4W_/HU
MB9Y8OTU2_NJWV@GAZ'X3__W2C27K;C:P2 /6$UMM1]KTB55XPW]B3:(G/K%-
M4OY;9*:2_<?F9!Z#A.U6I @6) YI5XY],4NC_@<=R^I<K=P="9,RXA,4U9:T
M&]HM/)O/*=8J1MPJ ,29IXQ+BXX\[@&GM9/^ 6I_NOJ2S=P-/^LY5)*0HHMY
M@!IAJ%:&F#14:7N)[#<Y.HWS598'"8_GQU?C<_K;]'U<XDATO;)4V3JZ_'T
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MYPI$:LZF5-V-(?*&F9#)P \DGL(5C/"2ZY;++-NWD)+9#L'5QJ]O6&A8P0W
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M(]6MXR';D>K(*WBGCYL)(]F7[8\>?>X<^/!XP?,HNAY7IK ]W1F7M,L4'_S
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H<"TR,#$Y,#,S,5]P<F4N>&UL4$L%!@     &  8 B@$  )V=      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
